Disease Name,Quantity,Gene Symbol
17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY,1,HSD17B3
"2,4-DIENOYL-CoA REDUCTASE DEFICIENCY",1,NADK2
2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY,1,ACADSB
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY,1,HMGCL
3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY,1,HMGCS2
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY,1,HADH
3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY,1,HIBCH
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY,1,MCCC1
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY,1,MCCC2
"3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME",1,SERAC1
"3-METHYLGLUTACONIC ACIDURIA, TYPE I",1,AUH
"3-METHYLGLUTACONIC ACIDURIA, TYPE III",1,OPA3
"3-METHYLGLUTACONIC ACIDURIA, TYPE IX",1,TIMM50
"3-METHYLGLUTACONIC ACIDURIA, TYPE V",1,DNAJC19
"3-METHYLGLUTACONIC ACIDURIA, TYPE VII",1,CLPB
"3-METHYLGLUTACONIC ACIDURIA, TYPE VIII",1,HTRA2
3MC SYNDROME 1,1,MASP1
3MC SYNDROME 2,1,COLEC11
3MC SYNDROME 3,1,COLEC10
"46,XX SEX REVERSAL 1",1,SRY
"46,XX SEX REVERSAL 4",1,NR5A1
"46,XX SEX REVERSAL 5",1,NR2F2
"46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS",1,WNT4
"46,XY GONADAL DYSGENESIS WITH MINIFASCICULAR NEUROPATHY",1,DHH
"46,XY SEX REVERSAL 1",1,SRY
"46,XY SEX REVERSAL 11",1,DHX37
"46,XY SEX REVERSAL 2",1,NR0B1
"46,XY SEX REVERSAL 3",1,NR5A1
"46,XY SEX REVERSAL 5",1,CBX2
"46,XY SEX REVERSAL 6",1,MAP3K1
"46,XY SEX REVERSAL 7",1,DHH
"46,XY SEX REVERSAL 8",2,"AKR1C4, AKR1C2"
"46,XY SEX REVERSAL 9",1,ZFPM2
5-OXOPROLINASE DEFICIENCY,1,OPLAH
AARSKOG-SCOTT SYNDROME,1,FGD1
ABCD SYNDROME,1,EDNRB
ABDOMINAL OBESITY-METABOLIC SYNDROME 1,1,MTTP
ABDOMINAL OBESITY-METABOLIC SYNDROME 3,1,DYRK1B
ABDOMINAL OBESITY-METABOLIC SYNDROME 4,1,CELA2A
ABETALIPOPROTEINEMIA,1,MTTP
ABLEPHARON-MACROSTOMIA SYNDROME,1,TWIST2
"ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY",1,HEPHL1
ABRUZZO-ERICKSON SYNDROME,1,TBX22
ACATALASEMIA,1,CAT
"ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO",1,MDM2
ACERULOPLASMINEMIA,1,CP
ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY,1,ACAT2
ACETYL-CoA CARBOXYLASE DEFICIENCY,1,ACACA
"ACETYLATION, SLOW",1,NAT2
ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME,1,AAAS
ACHEIROPODY,1,LMBR1
"ACHONDROGENESIS, TYPE IA",1,TRIP11
"ACHONDROGENESIS, TYPE IB",1,SLC26A2
"ACHONDROGENESIS, TYPE II",1,COL2A1
ACHONDROPLASIA,1,FGFR3
"ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS",1,FGFR3
ACHROMATOPSIA 2,1,CNGA3
ACHROMATOPSIA 3,1,CNGB3
ACHROMATOPSIA 4,1,GNAT2
ACHROMATOPSIA 7,1,ATF6
ACID PHOSPHATASE DEFICIENCY,1,ACP2
ACID-LABILE SUBUNIT DEFICIENCY,1,IGFALS
"ACNE INVERSA, FAMILIAL, 1",1,NCSTN
"ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE",1,PSENEN
"ACNE INVERSA, FAMILIAL, 3",1,PSEN1
ACROCALLOSAL SYNDROME,1,KIF7
ACROCAPITOFEMORAL DYSPLASIA,1,IHH
"ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE",1,SLC39A4
ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE,1,PRKAR1A
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE,1,PDE4D
"ACROFACIAL DYSOSTOSIS 1, NAGER TYPE",1,SF3B4
"ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE",1,POLR1A
ACROKERATOSIS VERRUCIFORMIS,1,ATP2A2
ACROMELIC FRONTONASAL DYSOSTOSIS,1,ZSWIM6
ACROMESOMELIC DYSPLASIA 1,1,NPR2
ACROMESOMELIC DYSPLASIA 2A,1,GDF5
ACROMESOMELIC DYSPLASIA 2B,1,GDF5
ACROMESOMELIC DYSPLASIA 2C,1,GDF5
ACROMESOMELIC DYSPLASIA 3,1,BMPR1B
ACROMESOMELIC DYSPLASIA 4,1,PRKG2
ACROMICRIC DYSPLASIA,1,FBN1
"ACTH DEFICIENCY, ISOLATED",1,TBX19
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA,1,GNAS
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2,1,ARMC5
ACTN3 DEFICIENCY,1,ACTN3
ACUTE PROMYELOCYTIC LEUKEMIA,2,"NUMA1, RARA"
"ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF",1,ACADM
"ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF",1,ACADS
"ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF",1,ACADVL
ADAMS-OLIVER SYNDROME 1,1,ARHGAP31
ADAMS-OLIVER SYNDROME 2,1,DOCK6
ADAMS-OLIVER SYNDROME 3,1,RBPJ
ADAMS-OLIVER SYNDROME 4,1,EOGT
ADAMS-OLIVER SYNDROME 5,1,NOTCH1
ADAMS-OLIVER SYNDROME 6,1,DLL4
ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY,1,APRT
"ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES",1,PKLR
"ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO",1,AK1
ADENYLOSUCCINASE DEFICIENCY,1,ADSL
ADERMATOGLYPHIA,1,SMARCAD1
"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",1,ADIPOQ
"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY",1,CYP17A1
"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY",1,CYP21A2
"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY",1,HSD3B2
"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY",1,CYP11B1
"ADRENAL HYPOPLASIA, CONGENITAL",1,NR0B1
"ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE",1,CYP11A1
"ADRENOCORTICAL CARCINOMA, HEREDITARY",1,TP53
ADRENOLEUKODYSTROPHY,1,ABCD1
ADULT SYNDROME,1,TP63
"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1",1,PER2
"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2",1,CSNK1D
"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3",1,PER3
"AFIBRINOGENEMIA, CONGENITAL",3,"FGA, FGB, FGG"
"AGAMMAGLOBULINEMIA 10, AUTOSOMAL DOMINANT",1,SPI1
"AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE",1,IGLL1
"AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE",1,CD79A
"AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE",1,BLNK
"AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT",1,LRRC8A
"AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE",1,CD79B
"AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE",1,PIK3R1
"AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT",1,TCF3
"AGAMMAGLOBULINEMIA 9, AUTOSOMAL RECESSIVE",1,SLC39A7
"AGAMMAGLOBULINEMIA, X-LINKED",1,BTK
"AGENESIS OF CORPUS CALLOSUM, CARDIAC, OCULAR, AND GENITAL SYNDROME",1,CDH2
AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY,1,SLC12A6
AGNATHIA-OTOCEPHALY COMPLEX,1,PRRX1
AICA-RIBOSURIA DUE TO ATIC DEFICIENCY,1,ATIC
AICARDI-GOUTIERES SYNDROME 1,1,TREX1
AICARDI-GOUTIERES SYNDROME 2,1,RNASEH2B
AICARDI-GOUTIERES SYNDROME 3,1,RNASEH2C
AICARDI-GOUTIERES SYNDROME 4,1,RNASEH2A
AICARDI-GOUTIERES SYNDROME 5,1,SAMHD1
AICARDI-GOUTIERES SYNDROME 6,1,ADAR
AICARDI-GOUTIERES SYNDROME 7,1,IFIH1
AICARDI-GOUTIERES SYNDROME 8,1,LSM11
AL KAISSI SYNDROME,1,CDK10
AL-GAZALI SYNDROME,1,B3GALT6
AL-GAZALI-BAKALINOVA SYNDROME,1,KIF7
AL-RAQAD SYNDROME,1,DCPS
"ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME",1,GMPPA
ALAGILLE SYNDROME 1,1,JAG1
ALAND ISLAND EYE DISEASE,1,CACNA1F
ALAZAMI SYNDROME,1,LARP7
ALAZAMI-YUAN SYNDROME,1,TAF6
"ALBINISM, OCULAR, TYPE I",1,GPR143
"ALBINISM, OCULOCUTANEOUS, TYPE IA",1,TYR
"ALBINISM, OCULOCUTANEOUS, TYPE IB",1,TYR
"ALBINISM, OCULOCUTANEOUS, TYPE II",2,"MC1R, OCA2"
"ALBINISM, OCULOCUTANEOUS, TYPE III",1,TYRP1
"ALBINISM, OCULOCUTANEOUS, TYPE IV",1,SLC45A2
"ALBINISM, OCULOCUTANEOUS, TYPE VI",1,SLC24A5
"ALBINISM, OCULOCUTANEOUS, TYPE VII",1,LRMDA
ALCOHOL DEPENDENCE,4,"ADH1B, ADH1C, GABRA2, HTR2A"
"ALCOHOL SENSITIVITY, ACUTE",1,ALDH2
ALEXANDER DISEASE,1,GFAP
ALKAPTONURIA,1,HGD
ALKURAYA-KUCINSKAS SYNDROME,1,KIAA1109
ALLAN-HERNDON-DUDLEY SYNDROME,1,SLC16A2
ALOPECIA UNIVERSALIS CONGENITA,1,HR
"ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME",1,RBM28
ALOPECIA-MENTAL RETARDATION SYNDROME 1,1,AHSG
ALOPECIA-MENTAL RETARDATION SYNDROME 4,1,LSS
ALPHA-1-ANTITRYPSIN DEFICIENCY,1,SERPINA1
ALPHA-2-PLASMIN INHIBITOR DEFICIENCY,1,SERPINF2
ALPHA-AMINOADIPIC AND ALPHA-KETOADIPIC ACIDURIA,1,DHTKD1
ALPHA-FETOPROTEIN DEFICIENCY,1,AFP
"ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF",1,AFP
ALPHA-METHYLACETOACETIC ACIDURIA,1,ACAT1
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY,1,AMACR
ALPHA-THALASSEMIA,2,"HBA1, HBB"
ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME,1,ATRX
"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED",1,ATRX
"ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY",1,RAG1
"ALPORT SYNDROME 1, X-LINKED",1,COL4A5
"ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE",2,"COL4A3, COL4A4"
"ALPORT SYNDROME 3, AUTOSOMAL DOMINANT",1,COL4A3
ALSTROM SYNDROME,1,ALMS1
ALTERNATING HEMIPLEGIA OF CHILDHOOD 1,1,ATP1A2
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2,1,ATP1A3
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS,1,FOXF1
ALVEOLAR SOFT PART SARCOMA,1,ASPSCR1
ALZAHRANI-KUWAHARA SYNDROME,1,SMG8
ALZHEIMER DISEASE,5,"HFE, APP, MPO, NOS3, PLAU"
ALZHEIMER DISEASE 18,1,ADAM10
ALZHEIMER DISEASE 2,1,APOE
ALZHEIMER DISEASE 3,2,"APOE, PSEN1"
ALZHEIMER DISEASE 4,2,"APOE, PSEN2"
"ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO",1,ABCA7
"AMED SYNDROME, DIGENIC",1,ADH5
"AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL",1,MPL
"AMELIA, POSTERIOR, WITH PELVIC AND PULMONARY HYPOPLASIA SYNDROME",1,TBX4
"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1",1,KLK4
"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2",1,MMP20
"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3",1,WDR72
"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4",1,ODAPH
"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5",1,SLC24A4
"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6",1,GPR68
"AMELOGENESIS IMPERFECTA, TYPE IA",1,LAMB3
"AMELOGENESIS IMPERFECTA, TYPE IB",1,ENAM
"AMELOGENESIS IMPERFECTA, TYPE IC",1,ENAM
"AMELOGENESIS IMPERFECTA, TYPE IE",1,AMELX
"AMELOGENESIS IMPERFECTA, TYPE IF",1,AMBN
"AMELOGENESIS IMPERFECTA, TYPE IG",1,FAM20A
"AMELOGENESIS IMPERFECTA, TYPE IH",1,ITGB6
"AMELOGENESIS IMPERFECTA, TYPE IIIA",1,FAM83H
"AMELOGENESIS IMPERFECTA, TYPE IIIB",1,AMTN
"AMELOGENESIS IMPERFECTA, TYPE IIIC",1,RELT
"AMELOGENESIS IMPERFECTA, TYPE IJ",1,ACP4
"AMELOGENESIS IMPERFECTA, TYPE IV",1,DLX3
AMINOACYLASE 1 DEFICIENCY,1,ACY1
"AMYLOIDOSIS, FAMILIAL VISCERAL",4,"FGA, APOA1, LYZ, B2M"
"AMYLOIDOSIS, FINNISH TYPE",1,GSN
"AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED",1,TTR
"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1",1,OSMR
"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2",1,IL31RA
"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3",1,GPNMB
AMYOTROPHIC LATERAL SCLEROSIS 1,4,"DCTN1, NEFH, PRPH, SOD1"
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA,1,TARDBP
AMYOTROPHIC LATERAL SCLEROSIS 11,1,FIG4
AMYOTROPHIC LATERAL SCLEROSIS 12 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA,1,OPTN
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA,1,UBQLN2
"AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE",1,SIGMAR1
AMYOTROPHIC LATERAL SCLEROSIS 18,1,PFN1
AMYOTROPHIC LATERAL SCLEROSIS 19,1,ERBB4
"AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE",1,ALS2
AMYOTROPHIC LATERAL SCLEROSIS 20,1,HNRNPA1
AMYOTROPHIC LATERAL SCLEROSIS 21,1,MATR3
AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA,1,TUBA4A
AMYOTROPHIC LATERAL SCLEROSIS 23,1,ANXA11
AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA,1,TIA1
"AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE",1,SETX
"AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE",1,SPG11
AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA,1,FUS
AMYOTROPHIC LATERAL SCLEROSIS 8,1,VAPB
AMYOTROPHIC LATERAL SCLEROSIS 9,1,ANG
"AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24",1,NEK1
"AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25",1,KIF5A
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1,1,TRPM7
"AMYOTROPHY, HEREDITARY NEURALGIC",1,SEPTIN9
ANALBUMINEMIA,1,ALB
ANAUXETIC DYSPLASIA 2,1,POP1
ANAUXETIC DYSPLASIA 3,1,NEPRO
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS,1,KCNJ2
ANDROGEN INSENSITIVITY SYNDROME,1,AR
"ANDROGEN INSENSITIVITY, PARTIAL",1,AR
"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II",1,SEC23B
"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV",1,KLF1
"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia",1,CDAN1
"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib",1,CDIN1
"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1",1,SLC11A2
"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2",1,STEAP3
"ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY",2,"G6PD, CASK"
"ANEMIA, SIDEROBLASTIC, 1",1,ALAS2
"ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY",1,SLC25A38
"ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY",1,GLRX5
"ANEMIA, SIDEROBLASTIC, 4",1,HSPA9
"ANEMIA, SIDEROBLASTIC, 5",1,HSCB
"ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA",1,ABCB7
"ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES",1,GATA1
ANENCEPHALY 1,1,TRIM36
ANENCEPHALY 2,1,NUAK2
"ANEURYSM, INTRACRANIAL BERRY, 12",1,THSD1
ANGELMAN SYNDROME,1,UBE3A
"ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO",1,XPNPEP2
"ANGIOEDEMA, HEREDITARY, 1",1,SERPING1
"ANGIOEDEMA, HEREDITARY, 3",1,F12
"ANGIOEDEMA, HEREDITARY, 4",1,PLG
"ANGIOEDEMA, HEREDITARY, 5",1,ANGPT1
"ANGIOEDEMA, HEREDITARY, 6",1,KNG1
"ANGIOEDEMA, HEREDITARY, 7",1,MYOF
"ANGIOEDEMA, HEREDITARY, 8",1,HS3ST6
"ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS",1,COL4A1
ANHAPTOGLOBINEMIA,1,HP
"ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS",1,ITPR2
ANIRIDIA 1,2,"PAX6, WT1"
ANIRIDIA 2,1,ELP4
ANIRIDIA 3,1,TRIM44
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE,1,TP63
"ANOREXIA NERVOSA, SUSCEPTIBILITY TO",1,HTR2A
ANTERIOR SEGMENT DYSGENESIS 1,1,PITX3
ANTERIOR SEGMENT DYSGENESIS 2,1,FOXE3
ANTERIOR SEGMENT DYSGENESIS 3,1,FOXC1
ANTERIOR SEGMENT DYSGENESIS 4,1,PITX2
ANTERIOR SEGMENT DYSGENESIS 5,1,PAX6
ANTERIOR SEGMENT DYSGENESIS 6,1,CYP1B1
ANTERIOR SEGMENT DYSGENESIS 7,1,PXDN
ANTITHROMBIN III DEFICIENCY,1,SERPINC1
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS,1,POR
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS,2,"FGFR2, POR"
ANXIETY,1,SLC6A4
"AORTIC ANEURYSM, FAMILIAL THORACIC 10",1,LOX
"AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO",1,FOXE3
"AORTIC ANEURYSM, FAMILIAL THORACIC 4",1,MYH11
"AORTIC ANEURYSM, FAMILIAL THORACIC 6",1,ACTA2
"AORTIC ANEURYSM, FAMILIAL THORACIC 7",1,MYLK
"AORTIC ANEURYSM, FAMILIAL THORACIC 8",1,PRKG1
"AORTIC ANEURYSM, FAMILIAL THORACIC 9",1,MFAP5
AORTIC VALVE DISEASE 1,1,NOTCH1
AORTIC VALVE DISEASE 2,1,SMAD6
APERT SYNDROME,1,FGFR2
"APLASIA CUTIS CONGENITA, NONSYNDROMIC",1,BMS1
APLASIA OF LACRIMAL AND SALIVARY GLANDS,1,FGF10
APLASTIC ANEMIA,5,"IFNG, NBN, SBDS, PRF1, TERT"
"APOCRINE GLAND SECRETION, VARIATION IN",1,ABCC11
APOLIPOPROTEIN C-II DEFICIENCY,1,APOC2
APOLIPOPROTEIN C-III DEFICIENCY,1,APOC3
APPARENT MINERALOCORTICOID EXCESS,1,HSD11B2
ARBOLEDA-THAM SYNDROME,1,KAT6A
ARGININEMIA,1,ARG1
ARGININOSUCCINIC ACIDURIA,1,ASL
AROMATASE DEFICIENCY,1,CYP19A1
AROMATASE EXCESS SYNDROME,1,CYP19A1
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY,1,DDC
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1",1,TGFB3
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10",1,DSG2
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11",1,DSC2
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12",1,JUP
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13",1,CTNNA3
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 14",1,CDH2
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2",1,RYR2
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5",1,TMEM43
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8",1,DSP
"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9",1,PKP2
"ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1",1,ENPP1
"ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2",1,ABCC6
ARTERIAL TORTUOSITY SYNDROME,1,SLC2A10
ARTERIOVENOUS MALFORMATIONS OF THE BRAIN,2,"IL6, KRAS"
"ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT",1,LGI4
"ARTHROGRYPOSIS MULTIPLEX CONGENITA 2, NEUROGENIC TYPE",1,ERGIC1
"ARTHROGRYPOSIS MULTIPLEX CONGENITA 4, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM",1,SCYL2
ARTHROGRYPOSIS MULTIPLEX CONGENITA 5,1,TOR1A
ARTHROGRYPOSIS MULTIPLEX CONGENITA 6,1,NEB
"ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT",1,PPP3CA
"ARTHROGRYPOSIS, DISTAL, TYPE 1A",1,TPM2
"ARTHROGRYPOSIS, DISTAL, TYPE 1B",1,MYBPC1
"ARTHROGRYPOSIS, DISTAL, TYPE 1C",1,MYLPF
"ARTHROGRYPOSIS, DISTAL, TYPE 2A",1,MYH3
"ARTHROGRYPOSIS, DISTAL, TYPE 2B1",1,TNNI2
"ARTHROGRYPOSIS, DISTAL, TYPE 2B2",1,TNNT3
"ARTHROGRYPOSIS, DISTAL, TYPE 2B3",1,MYH3
"ARTHROGRYPOSIS, DISTAL, TYPE 3",1,PIEZO2
"ARTHROGRYPOSIS, DISTAL, TYPE 5",1,PIEZO2
"ARTHROGRYPOSIS, DISTAL, TYPE 5D",1,ECEL1
"ARTHROGRYPOSIS, DISTAL, TYPE 7",1,MYH8
"ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH",1,PIEZO2
"ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES",1,SLC35A3
"ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY",1,NEK9
"ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1",1,VPS33B
"ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2",1,VIPAS39
ARTS SYNDROME,1,PRPS1
ASPARAGINE SYNTHETASE DEFICIENCY,1,ASNS
"ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",1,GOT1
ASPARTYLGLUCOSAMINURIA,1,AGA
"ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1",1,NLGN3
"ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2",1,NLGN4X
"ASPERGILLOSIS, SUSCEPTIBILITY TO",2,"CLEC1A, CLEC7A"
"ASPLENIA, ISOLATED CONGENITAL",1,RPSA
"ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE",2,"TBX21, PTGER2"
"ASTHMA, SUSCEPTIBILITY TO",7,"SCGB3A2, ADRB2, ALOX5, HLA-G, CCL11, TNF, PLA2G7"
"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1",1,PTGDR
"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2",1,NPSR1
"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5",1,IRAK3
"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7",1,CHI3L1
ATAXIA WITH VITAMIN E DEFICIENCY,1,TTPA
"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS",1,DNAJC3
"ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA",1,APTX
"ATAXIA, INTENTION TREMOR, AND HYPOTONIA SYNDROME, CHILDHOOD-ONSET",1,POU4F1
"ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT",1,RNF170
ATAXIA-OCULOMOTOR APRAXIA 3,1,PIK3R5
ATAXIA-OCULOMOTOR APRAXIA 4,1,PNKP
ATAXIA-PANCYTOPENIA SYNDROME,1,SAMD9L
ATAXIA-TELANGIECTASIA,1,ATM
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1,1,MRE11
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2,1,PCNA
"ATELOSTEOGENESIS, TYPE I",1,FLNB
"ATELOSTEOGENESIS, TYPE II",1,SLC26A2
"ATELOSTEOGENESIS, TYPE III",1,FLNB
ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME,1,HOXA1
ATRANSFERRINEMIA,1,TF
"ATRIAL FIBRILLATION, FAMILIAL, 10",1,SCN5A
"ATRIAL FIBRILLATION, FAMILIAL, 11",1,GJA5
"ATRIAL FIBRILLATION, FAMILIAL, 12",1,ABCC9
"ATRIAL FIBRILLATION, FAMILIAL, 13",1,SCN1B
"ATRIAL FIBRILLATION, FAMILIAL, 14",1,SCN2B
"ATRIAL FIBRILLATION, FAMILIAL, 15",1,NUP155
"ATRIAL FIBRILLATION, FAMILIAL, 18",1,MYL4
"ATRIAL FIBRILLATION, FAMILIAL, 3",1,KCNQ1
"ATRIAL FIBRILLATION, FAMILIAL, 4",1,KCNE2
"ATRIAL FIBRILLATION, FAMILIAL, 6",1,NPPA
"ATRIAL FIBRILLATION, FAMILIAL, 7",1,KCNA5
"ATRIAL FIBRILLATION, FAMILIAL, 9",1,KCNJ2
ATRIAL SEPTAL DEFECT 2,1,GATA4
ATRIAL SEPTAL DEFECT 3,1,MYH6
ATRIAL SEPTAL DEFECT 4,1,TBX20
ATRIAL SEPTAL DEFECT 5,1,ACTC1
ATRIAL SEPTAL DEFECT 6,1,TLL1
ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS,1,NKX2-5
ATRIAL SEPTAL DEFECT 8,1,CITED2
ATRIAL SEPTAL DEFECT 9,1,GATA6
ATRIAL STANDSTILL 1,1,GJA5
ATRIAL STANDSTILL 2,1,NPPA
ATRICHIA WITH PAPULAR LESIONS,1,HR
ATRIOVENTRICULAR SEPTAL DEFECT 3,1,GJA1
ATRIOVENTRICULAR SEPTAL DEFECT 4,1,GATA4
ATRIOVENTRICULAR SEPTAL DEFECT 5,1,GATA6
"ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2",1,CRELD1
ATTENTION DEFICIT-HYPERACTIVITY DISORDER,2,"DRD4, DRD5"
"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7",1,TPH2
AU-KLINE SYNDROME,1,HNRNPK
AUDITORY NEUROPATHY AND OPTIC ATROPHY,1,FDXR
"AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1",1,DIAPH3
"AURAL ATRESIA, CONGENITAL",1,TSHZ1
AURICULOCONDYLAR SYNDROME 1,1,GNAI3
AURICULOCONDYLAR SYNDROME 2,1,PLCB4
AURICULOCONDYLAR SYNDROME 3,1,EDN1
AUTISM,1,SNRPN
"AUTISM, SUSCEPTIBILITY TO, 15",1,CNTNAP2
"AUTISM, SUSCEPTIBILITY TO, 16",1,SLC9A9
"AUTISM, SUSCEPTIBILITY TO, 18",1,CHD8
"AUTISM, SUSCEPTIBILITY TO, 19",1,EIF4E
"AUTISM, SUSCEPTIBILITY TO, 20",1,NLGN1
"AUTISM, SUSCEPTIBILITY TO, X-LINKED 1",1,NLGN3
"AUTISM, SUSCEPTIBILITY TO, X-LINKED 2",1,NLGN4X
"AUTISM, SUSCEPTIBILITY TO, X-LINKED 3",1,MECP2
"AUTISM, SUSCEPTIBILITY TO, X-LINKED 4",1,PTCHD1
"AUTISM, SUSCEPTIBILITY TO, X-LINKED 5",1,RPL10
"AUTISM, SUSCEPTIBILITY TO, X-LINKED 6",1,TMLHE
"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1",1,STAT3
"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2",1,ZAP70
"AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM",1,ITCH
"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1",1,FOXD3
"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6",1,SIAE
"AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE",1,COPA
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME,2,"FAS, FASLG"
"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA",1,CASP10
"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III",1,PRKCD
"AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA",1,AIRE
"AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3",2,"ZFAT, TG"
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS,1,NLRP1
AUTOINFLAMMATION WITH EPISODIC FEVER AND LYMPHADENOPATHY,1,RIPK1
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS,1,NLRC4
"AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION",1,PLCG2
"AUTOINFLAMMATION, IMMUNE DYSREGULATION, AND EOSINOPHILIA",1,JAK1
"AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME",1,OTULIN
"AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE",1,TNFAIP3
"AUTOINFLAMMATORY SYNDROME, FAMILIAL, WITH OR WITHOUT IMMUNODEFICIENCY",1,SOCS1
"AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1",1,COL2A1
"AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2",1,TRPV4
"AXENFELD-RIEGER SYNDROME, TYPE 1",1,PITX2
"AXENFELD-RIEGER SYNDROME, TYPE 3",1,FOXC1
AYME-GRIPP SYNDROME,1,MAF
"AZOOSPERMIA, OBSTRUCTIVE, WITH NEPHROLITHIASIS",1,CLDN2
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY,1,CARD11
"B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS",1,TOP2B
BACHMANN-BUPP SYNDROME,1,ODC1
"BACTEREMIA, SUSCEPTIBILITY TO, 1",1,TIRAP
"BACTEREMIA, SUSCEPTIBILITY TO, 2",1,CISH
BAINBRIDGE-ROPERS SYNDROME,1,ASXL3
BAKER-GORDON SYNDROME,1,SYT1
BALLER-GEROLD SYNDROME,1,RECQL4
BAND HETEROTOPIA,1,EML1
BARAITSER-WINTER SYNDROME 1,1,ACTB
BARAITSER-WINTER SYNDROME 2,1,ACTG1
BARALLE-MACKEN SYNDROME,1,COPB1
BARBER-SAY SYNDROME,1,TWIST2
BARDET-BIEDL SYNDROME 1,3,"BBS1, CCDC28B, ARL6"
BARDET-BIEDL SYNDROME 10,1,BBS10
BARDET-BIEDL SYNDROME 11,1,TRIM32
BARDET-BIEDL SYNDROME 12,1,BBS12
BARDET-BIEDL SYNDROME 13,1,MKS1
BARDET-BIEDL SYNDROME 14,2,"CEP290, TMEM67"
BARDET-BIEDL SYNDROME 15,1,WDPCP
BARDET-BIEDL SYNDROME 16,1,SDCCAG8
BARDET-BIEDL SYNDROME 17,1,LZTFL1
BARDET-BIEDL SYNDROME 18,1,BBIP1
BARDET-BIEDL SYNDROME 19,1,IFT27
BARDET-BIEDL SYNDROME 2,1,BBS2
BARDET-BIEDL SYNDROME 20,1,IFT172
BARDET-BIEDL SYNDROME 21,1,CFAP418
BARDET-BIEDL SYNDROME 22,1,IFT74
BARDET-BIEDL SYNDROME 3,1,ARL6
BARDET-BIEDL SYNDROME 4,1,BBS4
BARDET-BIEDL SYNDROME 5,1,BBS5
BARDET-BIEDL SYNDROME 6,1,MKKS
BARDET-BIEDL SYNDROME 7,1,BBS7
BARDET-BIEDL SYNDROME 8,1,TTC8
BARDET-BIEDL SYNDROME 9,1,BBS9
"BARE LYMPHOCYTE SYNDROME, TYPE I",3,"TAP1, TAP2, TAPBP"
"BARE LYMPHOCYTE SYNDROME, TYPE II",4,"CIITA, RFX5, RFXAP, RFXANK"
BARRETT ESOPHAGUS,3,"CTHRC1, MSR1, ASCC1"
BART-PUMPHREY SYNDROME,1,GJB2
BARTH SYNDROME,1,TAFAZZIN
BARTSOCAS-PAPAS SYNDROME 1,1,RIPK4
BARTSOCAS-PAPAS SYNDROME 2,1,CHUK
"BARTTER SYNDROME, TYPE 1, ANTENATAL",1,SLC12A1
"BARTTER SYNDROME, TYPE 2, ANTENATAL",1,KCNJ1
"BARTTER SYNDROME, TYPE 3",1,CLCNKB
"BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS",1,BSND
"BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS",2,"CLCNKA, CLCNKB"
"BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT",1,MAGED2
"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1",4,"PTCH1, RASA1, SMO, PTCH2"
"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7",1,TP53
BASAL CELL NEVUS SYNDROME,3,"SUFU, PTCH1, PTCH2"
"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1",3,"PDGFB, PDGFRB, SLC20A2"
"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4",1,PDGFRB
"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5",1,PDGFB
"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6",1,XPR1
"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE",1,MYORG
"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE",1,JAM2
BASAL LAMINAR DRUSEN,1,CFH
BASAN SYNDROME,1,SMARCAD1
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME,1,MED25
BASILICATA-AKHTAR SYNDROME,1,MSL3
BDV SYNDROME,1,CPE
BEARE-STEVENSON CUTIS GYRATA SYNDROME,1,FGFR2
BEAULIEU-BOYCOTT-INNES SYNDROME,1,THOC6
BECK-FAHRNER SYNDROME,1,TET3
BECKWITH-WIEDEMANN SYNDROME,3,"CDKN1C, IGF2, KCNQ1"
BEHR SYNDROME,1,OPA1
BENIGN CHRONIC PEMPHIGUS,1,ATP2C1
BENT BONE DYSPLASIA SYNDROME,1,FGFR2
BERNARD-SOULIER SYNDROME,3,"GP1BA, GP1BB, GP9"
"BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT",1,GP1BA
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",1,BEST1
BETA-AMINOISOBUTYRIC ACIDURIA,1,AGXT2
BETA-THALASSEMIA,1,HBB
"BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE",1,HBB
BETA-UREIDOPROPIONASE DEFICIENCY,1,UPB1
BETHLEM MYOPATHY 1,3,"COL6A1, COL6A2, COL6A3"
BETHLEM MYOPATHY 2,1,COL12A1
BEUKES HIP DYSPLASIA,1,UFSP2
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY,1,CYP4V2
BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES,1,FREM1
BILE ACID CONJUGATION DEFECT 1,1,BAAT
"BILE ACID MALABSORPTION, PRIMARY, 1",1,SLC10A2
"BILE ACID MALABSORPTION, PRIMARY, 2",1,SLC51B
"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1",1,HSD3B7
"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2",1,AKR1D1
"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3",1,CYP7B1
"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4",1,AMACR
"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5",1,ABCD3
"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6",1,ACOX2
"BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME",1,TTC26
"BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",1,UGT1A1
BIOTINIDASE DEFICIENCY,1,BTD
BIRBECK GRANULE DEFICIENCY,1,CD207
BIRK-BAREL SYNDROME,1,KCNK9
BIRK-LANDAU-PEREZ SYNDROME,1,SLC30A9
BIRT-HOGG-DUBE SYNDROME,1,FLCN
BJORNSTAD SYNDROME,1,BCS1L
BLADDER CANCER,4,"FGFR3, HRAS, KRAS, RB1"
"BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT",1,CHRNA3
BLAU SYNDROME,1,NOD2
"BLEEDING DISORDER, PLATELET-TYPE, 11",1,GP6
"BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO",1,TBXA2R
"BLEEDING DISORDER, PLATELET-TYPE, 15",1,ACTN1
"BLEEDING DISORDER, PLATELET-TYPE, 16",2,"ITGA2B, ITGB3"
"BLEEDING DISORDER, PLATELET-TYPE, 17",1,GFI1B
"BLEEDING DISORDER, PLATELET-TYPE, 18",1,RASGRP2
"BLEEDING DISORDER, PLATELET-TYPE, 19",1,PRKACG
"BLEEDING DISORDER, PLATELET-TYPE, 20",1,SLFN14
"BLEEDING DISORDER, PLATELET-TYPE, 21",1,FLI1
"BLEEDING DISORDER, PLATELET-TYPE, 22",1,EPHB2
"BLEEDING DISORDER, PLATELET-TYPE, 24",1,ITGB3
"BLEEDING DISORDER, PLATELET-TYPE, 8",1,P2RY12
BLEPHAROCHEILODONTIC SYNDROME 1,1,CDH1
BLEPHAROCHEILODONTIC SYNDROME 2,1,CTNND1
"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS",1,FOXL2
BLEPHAROPHIMOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME,1,SMARCA2
"BLEPHAROSPASM, BENIGN ESSENTIAL, SUSCEPTIBILITY TO",1,DRD5
"BLISTERING, ACANTHOLYTIC, OF ORAL AND LARYNGEAL MUCOSA",1,DSG3
"BLOOD GROUP SYSTEM, LANDSTEINER-WIENER",1,ICAM4
"BLOOD GROUP, ABO SYSTEM",1,ABO
"BLOOD GROUP, CHIDO/RODGERS SYSTEM",1,C4A
"BLOOD GROUP, COLTON SYSTEM",1,AQP1
"BLOOD GROUP, CROMER SYSTEM",1,CD55
"BLOOD GROUP, DIEGO SYSTEM",1,SLC4A1
"BLOOD GROUP, DOMBROCK SYSTEM",1,ART4
"BLOOD GROUP, DUFFY SYSTEM",1,ACKR1
"BLOOD GROUP, GERBICH SYSTEM",1,GYPC
"BLOOD GROUP, GLOBOSIDE SYSTEM",1,B3GALNT1
"BLOOD GROUP, I SYSTEM",1,GCNT2
"BLOOD GROUP, INDIAN SYSTEM",1,CD44
"BLOOD GROUP, JOHN MILTON HAGEN SYSTEM",1,SEMA7A
"BLOOD GROUP, JUNIOR SYSTEM",1,ABCG2
"BLOOD GROUP, KIDD SYSTEM",1,SLC14A1
"BLOOD GROUP, LANGEREIS SYSTEM",1,ABCB6
"BLOOD GROUP, LEWIS SYSTEM",1,FUT3
"BLOOD GROUP, MN",1,GYPA
"BLOOD GROUP, P1PK SYSTEM",2,"A4GALT, B3GALNT1"
"BLOOD GROUP, RH SYSTEM",1,RHD
"BLOOD GROUP, Ss",1,GYPB
"BLOOD GROUP, VEL SYSTEM",1,SMIM1
BLOOD GROUP--FROESE,1,SLC4A1
BLOOD GROUP--KELL SYSTEM,1,KEL
BLOOD GROUP--LUTHERAN INHIBITOR,1,KLF1
BLOOD GROUP--LUTHERAN SYSTEM,1,BCAM
BLOOD GROUP--OK,1,BSG
BLOOD GROUP--SCIANNA SYSTEM,1,ERMAP
BLOOD GROUP--SWANN SYSTEM,1,SLC4A1
BLOOD GROUP--WALDNER TYPE,1,SLC4A1
BLOOD GROUP--WRIGHT ANTIGEN,1,SLC4A1
BLOOM SYNDROME,1,BLM
BLUE CONE MONOCHROMACY,2,"OPN1MW, OPN1LW"
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10,1,FFAR4
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12,1,PCSK1
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14,1,FTO
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18,1,MRAP2
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19,1,ADCY3
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,1,MC4R
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4,1,UCP2
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9,1,MC3R
BOHRING-OPITZ SYNDROME,1,ASXL1
BOMBAY PHENOTYPE,2,"FUT1, FUT2"
"BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS",1,PLOD3
BONE MARROW FAILURE SYNDROME 1,1,SRP72
BONE MARROW FAILURE SYNDROME 2,1,ERCC6L2
BONE MARROW FAILURE SYNDROME 3,1,DNAJC21
BONE MARROW FAILURE SYNDROME 4,1,MYSM1
BONE MARROW FAILURE SYNDROME 5,1,TP53
BONE MARROW FAILURE SYNDROME 6,1,MDM4
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1,1,LRP5
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12,1,UGT2B17
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16,1,WNT1
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17,1,LGR4
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18,1,PLS3
BOOMERANG DYSPLASIA,1,FLNB
BORJESON-FORSSMAN-LEHMANN SYNDROME,1,PHF6
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME,1,NR2F1
BOSMA ARHINIA MICROPHTHALMIA SYNDROME,1,SMCHD1
BOTHNIA RETINAL DYSTROPHY,1,RLBP1
BOUCHER-NEUHAUSER SYNDROME,1,PNPLA6
BOUDIN-MORTIER SYNDROME,1,NPR3
BOWEN-CONRADI SYNDROME,1,EMG1
"BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY",1,RPS23
"BRACHYDACTYLY, TYPE A1",1,IHH
"BRACHYDACTYLY, TYPE A1, C",1,GDF5
"BRACHYDACTYLY, TYPE A1, D",1,BMPR1B
"BRACHYDACTYLY, TYPE A2",3,"BMP2, BMPR1B, GDF5"
"BRACHYDACTYLY, TYPE B1",1,ROR2
"BRACHYDACTYLY, TYPE B2",1,NOG
"BRACHYDACTYLY, TYPE C",1,GDF5
"BRACHYDACTYLY, TYPE D",1,HOXD13
"BRACHYDACTYLY, TYPE E1",1,HOXD13
"BRACHYDACTYLY, TYPE E2",1,PTHLH
BRACHYDACTYLY-SYNDACTYLY SYNDROME,1,HOXD13
BRACHYOLMIA TYPE 3,1,TRPV4
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES,1,PAPSS2
"BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS",1,CSF1R
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS,1,NFIA
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES,1,COL4A1
BRAIN SMALL VESSEL DISEASE 2,1,COL4A2
BRAIN SMALL VESSEL DISEASE 3,1,COLGALT1
BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY,1,BCKDK
BRANCHIOOCULOFACIAL SYNDROME,1,TFAP2A
BRANCHIOOTIC SYNDROME 1,1,EYA1
BRANCHIOOTIC SYNDROME 3,1,SIX1
BRANCHIOOTORENAL SYNDROME 1,2,"EYA1, SIX1"
BRANCHIOOTORENAL SYNDROME 2,1,SIX5
BREAST CANCER,22,"CHEK2, AKT1, ESR1, HMMR, KRAS, ATM, NQO2, SLC22A18, PHB1, PIK3CA, RAD51, BRCA1, BRCA2, TP53, XRCC3, PALB2, BRIP1, CASP8, RAD54L, PPM1D, RB1CC1, CDH1"
"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",1,BRCA1
"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2",1,BRCA2
"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3",1,RAD51C
"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",1,RAD51D
"BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2",1,PTPRF
BRITTLE CORNEA SYNDROME 1,1,ZNF469
BRITTLE CORNEA SYNDROME 2,1,PRDM5
BRODY DISEASE,1,ATP2A1
BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1,2,"CFTR, SCNN1B"
BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2,1,SCNN1A
BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3,1,SCNN1G
BROOKE-SPIEGLER SYNDROME,1,CYLD
BROWN-VIALETTO-VAN LAERE SYNDROME 1,1,SLC52A3
BROWN-VIALETTO-VAN LAERE SYNDROME 2,1,SLC52A2
BRUCK SYNDROME 1,1,FKBP10
BRUCK SYNDROME 2,1,PLOD2
BRUGADA SYNDROME 1,1,SCN5A
BRUGADA SYNDROME 2,1,GPD1L
BRUGADA SYNDROME 3,1,CACNA1C
BRUGADA SYNDROME 4,1,CACNB2
BRUGADA SYNDROME 5,1,SCN1B
BRUGADA SYNDROME 6,1,KCNE3
BRUGADA SYNDROME 7,1,SCN3B
BRUGADA SYNDROME 8,1,HCN4
BRUGADA SYNDROME 9,1,KCND3
BRUNET-WAGNER NEURODEVELOPMENTAL SYNDROME,1,RBL2
BRUNNER SYNDROME,1,MAOA
BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1,1,H3-3A
BUDD-CHIARI SYNDROME,2,"F5, JAK2"
BURATTI-HAREL SYNDROME,1,SIAH1
BURKITT LYMPHOMA,1,MYC
BURN-MCKEOWN SYNDROME,1,TXNL4A
"BURULI ULCER, SUSCEPTIBILITY TO",1,SLC11A1
BUSCHKE-OLLENDORFF SYNDROME,1,LEMD3
BUTYRYLCHOLINESTERASE DEFICIENCY,1,BCHE
C SYNDROME,1,CD96
C1q DEFICIENCY,3,"C1QA, C1QB, C1QC"
C3 GLOMERULOPATHY 3,1,CFHR5
"C3HEX, ABILITY TO SMELL",1,OR2J3
CAFFEY DISEASE,1,COL1A1
CALCIFICATION OF JOINTS AND ARTERIES,1,NT5E
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY,1,SGMS2
CAMPOMELIC DYSPLASIA,1,SOX9
"CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME",1,FGFR3
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME,1,PRG4
"CAMPTOSYNPOLYDACTYLY, COMPLEX",1,BHLHA9
CAMURATI-ENGELMANN DISEASE,1,TGFB1
CANAVAN DISEASE,1,ASPA
"CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA",1,SASH1
"CANDIDIASIS, FAMILIAL, 2",1,CARD9
"CANDIDIASIS, FAMILIAL, 4",1,CLEC7A
"CANDIDIASIS, FAMILIAL, 8",1,TRAF3IP2
"CANDIDIASIS, FAMILIAL, 9",1,IL17RC
CANTU SYNDROME,1,ABCC9
"CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH",1,PIK3CA
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1,1,RASA1
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2,1,EPHB4
"CAPILLARY MALFORMATIONS, CONGENITAL",1,GNAQ
"CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO",1,CPS1
"CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO",1,CA5A
CARBOXYPEPTIDASE N DEFICIENCY,1,CPN1
"CARDIAC ARRHYTHMIA SYNDROME, WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS",1,TRDN
"CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED",1,ANK2
CARDIAC CONDUCTION DEFECT,1,AKAP10
CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY,1,TNNI3K
"CARDIAC VALVULAR DEFECT, DEVELOPMENTAL",1,PLD1
"CARDIAC VALVULAR DYSPLASIA, X-LINKED",1,FLNA
"CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY",1,TRAF7
CARDIAC-UROGENITAL SYNDROME,1,MYRF
CARDIOACROFACIAL DYSPLASIA 1,1,PRKACA
CARDIOACROFACIAL DYSPLASIA 2,1,PRKACB
CARDIOFACIOCUTANEOUS SYNDROME 1,1,BRAF
CARDIOFACIOCUTANEOUS SYNDROME 2,1,KRAS
CARDIOFACIOCUTANEOUS SYNDROME 3,1,MAP2K1
CARDIOFACIOCUTANEOUS SYNDROME 4,1,MAP2K2
CARDIOFACIONEURODEVELOPMENTAL SYNDROME,1,CCDC32
"CARDIOMYOPATHY, DILATED, 1A",1,LMNA
"CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION",1,ACTN2
"CARDIOMYOPATHY, DILATED, 1BB",1,DSG2
"CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION",1,LDB3
"CARDIOMYOPATHY, DILATED, 1CC",1,NEXN
"CARDIOMYOPATHY, DILATED, 1D",1,TNNT2
"CARDIOMYOPATHY, DILATED, 1DD",1,RBM20
"CARDIOMYOPATHY, DILATED, 1E",1,SCN5A
"CARDIOMYOPATHY, DILATED, 1EE",1,MYH6
"CARDIOMYOPATHY, DILATED, 1FF",1,TNNI3
"CARDIOMYOPATHY, DILATED, 1G",1,TTN
"CARDIOMYOPATHY, DILATED, 1GG",1,SDHA
"CARDIOMYOPATHY, DILATED, 1HH",1,BAG3
"CARDIOMYOPATHY, DILATED, 1I",1,DES
"CARDIOMYOPATHY, DILATED, 1II",1,CRYAB
"CARDIOMYOPATHY, DILATED, 1J",1,EYA4
"CARDIOMYOPATHY, DILATED, 1JJ",1,LAMA4
"CARDIOMYOPATHY, DILATED, 1KK",1,MYPN
"CARDIOMYOPATHY, DILATED, 1L",1,SGCD
"CARDIOMYOPATHY, DILATED, 1M",1,CSRP3
"CARDIOMYOPATHY, DILATED, 1NN",1,RAF1
"CARDIOMYOPATHY, DILATED, 1O",1,ABCC9
"CARDIOMYOPATHY, DILATED, 1P",1,PLN
"CARDIOMYOPATHY, DILATED, 1R",1,ACTC1
"CARDIOMYOPATHY, DILATED, 1S",1,MYH7
"CARDIOMYOPATHY, DILATED, 1U",1,PSEN1
"CARDIOMYOPATHY, DILATED, 1V",1,PSEN2
"CARDIOMYOPATHY, DILATED, 1W",1,VCL
"CARDIOMYOPATHY, DILATED, 1X",1,FKTN
"CARDIOMYOPATHY, DILATED, 1Y",1,TPM1
"CARDIOMYOPATHY, DILATED, 1Z",1,TNNC1
"CARDIOMYOPATHY, DILATED, 2A",1,TNNI3
"CARDIOMYOPATHY, DILATED, 2B",1,GATAD1
"CARDIOMYOPATHY, DILATED, 2C",1,PPCS
"CARDIOMYOPATHY, DILATED, 2D",1,RPL3L
"CARDIOMYOPATHY, DILATED, 2E",1,JPH2
"CARDIOMYOPATHY, DILATED, 3B",1,DMD
"CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM",1,LMNA
"CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA",1,DSP
"CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS",1,DSP
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27",1,ALPK3
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1",4,"MYH6, MYH7, MYLK2, CAV3"
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10",1,MYL2
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11",1,ACTC1
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12",1,CSRP3
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13",1,TNNC1
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14",1,MYH6
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15",1,VCL
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16",1,MYOZ2
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17",1,JPH2
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18",1,PLN
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2",1,TNNT2
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20",1,NEXN
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25",1,TCAP
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26",1,FLNC
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 28",1,FHOD3
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3",1,TPM1
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4",1,MYBPC3
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6",1,PRKAG2
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7",1,TNNI3
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8",1,MYL3
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9",1,TTN
"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1",1,TNNI3
"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3",1,TNNT2
"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 6",1,KIF20A
CARDIOSPONDYLOCARPOFACIAL SYNDROME,1,MAP3K7
CARNEY COMPLEX VARIANT,1,MYH8
"CARNEY COMPLEX, TYPE 1",1,PRKAR1A
"CARNITINE DEFICIENCY, SYSTEMIC PRIMARY",1,SLC22A5
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY,1,CPT1A
"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE",1,CPT2
"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL",1,CPT2
"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED",1,CPT2
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY,1,SLC25A20
CAROTID INTIMAL MEDIAL THICKNESS 1,1,PPARG
CARPAL TUNNEL SYNDROME,1,TTR
CARPAL TUNNEL SYNDROME 2,1,COMP
CARPENTER SYNDROME 1,1,RAB23
CARPENTER SYNDROME 2,1,MEGF8
CASPASE 8 DEFICIENCY,1,CASP8
"CATARACT 1, MULTIPLE TYPES",1,GJA8
"CATARACT 10, MULTIPLE TYPES",1,CRYBA1
"CATARACT 11, MULTIPLE TYPES",1,PITX3
"CATARACT 12, MULTIPLE TYPES",1,BFSP2
CATARACT 13 WITH ADULT i PHENOTYPE,1,GCNT2
"CATARACT 14, MULTIPLE TYPES",1,GJA3
"CATARACT 15, MULTIPLE TYPES",1,MIP
"CATARACT 16, MULTIPLE TYPES",1,CRYAB
"CATARACT 17, MULTIPLE TYPES",1,CRYBB1
CATARACT 18,1,FYCO1
"CATARACT 19, MULTIPLE TYPES",1,LIM2
"CATARACT 2, MULTIPLE TYPES",1,CRYGC
"CATARACT 20, MULTIPLE TYPES",1,CRYGS
"CATARACT 21, MULTIPLE TYPES",1,MAF
"CATARACT 22, MULTIPLE TYPES",1,CRYBB3
"CATARACT 23, MULTIPLE TYPES",1,CRYBA4
"CATARACT 3, MULTIPLE TYPES",1,CRYBB2
"CATARACT 30, MULTIPLE TYPES",1,VIM
"CATARACT 31, MULTIPLE TYPES",1,CHMP4B
"CATARACT 33, MULTIPLE TYPES",1,BFSP1
"CATARACT 34, MULTIPLE TYPES",1,FOXE3
CATARACT 36,1,TDRD7
CATARACT 38,1,AGK
"CATARACT 39, MULTIPLE TYPES",1,CRYGB
"CATARACT 4, MULTIPLE TYPES",1,CRYGD
CATARACT 40,1,NHS
CATARACT 41,1,WFS1
CATARACT 42,1,CRYBA2
CATARACT 43,1,UNC45B
CATARACT 44,1,LSS
CATARACT 45,1,SIPA1L3
"CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY",1,LEMD2
CATARACT 47,1,SLC16A12
CATARACT 48,1,DNMBP
CATARACT 49,1,PANK4
"CATARACT 5, MULTIPLE TYPES",1,HSF4
"CATARACT 6, MULTIPLE TYPES",1,EPHA2
"CATARACT 9, MULTIPLE TYPES",1,CRYAA
"CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA",1,IARS2
"CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY",1,FAR1
CATEL-MANZKE SYNDROME,1,TGDS
CATIFA SYNDROME,1,RIC1
CAUDAL DUPLICATION ANOMALY,1,AXIN1
CAVITARY OPTIC DISC ANOMALIES,1,MMP19
"CD8 DEFICIENCY, FAMILIAL",1,CD8A
CEBALID SYNDROME,1,MN1
"CELIAC DISEASE, SUSCEPTIBILITY TO, 1",2,"HLA-DQA1, HLA-DQB1"
"CELIAC DISEASE, SUSCEPTIBILITY TO, 3",1,CTLA4
"CELIAC DISEASE, SUSCEPTIBILITY TO, 4",1,MYO9B
CENANI-LENZ SYNDACTYLY SYNDROME,1,LRP4
CENTRAL CORE DISEASE OF MUSCLE,1,RYR1
"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 1",5,"EDN3, GDNF, ASCL1, RET, PHOX2B"
"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 2, AND AUTONOMIC DYSFUNCTION",1,MYO1H
"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 3",1,LBX1
"CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS",1,ATP1A3
"CEREBELLAR ATAXIA, BRAIN ABNORMALITIES, AND CARDIAC CONDUCTION DEFECTS",1,EXOSC5
"CEREBELLAR ATAXIA, CAYMAN TYPE",1,ATCAY
"CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT",1,DNMT1
"CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1",1,VLDLR
"CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2",1,WDR81
"CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3",1,CA8
"CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4",1,ATP8A2
"CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME",1,RFC1
"CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION",1,CAMTA1
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY,1,CACNA2D2
"CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES",1,KCNMA1
"CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION",1,EMC1
"CEREBELLAR HYPOPLASIA/ATROPHY, EPILEPSY, AND GLOBAL DEVELOPMENTAL DELAY",1,OXR1
"CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME",1,MAB21L1
CEREBELLOFACIODENTAL SYNDROME,1,BRF1
"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED",1,APP
"CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED",1,CST3
"CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1",1,ITM2B
"CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2",1,ITM2B
"CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1",1,NOTCH3
"CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2",1,HTRA1
"CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY",1,HTRA1
CEREBRAL CAVERNOUS MALFORMATIONS,1,KRIT1
CEREBRAL CAVERNOUS MALFORMATIONS 2,1,CCM2
CEREBRAL CAVERNOUS MALFORMATIONS 3,1,PDCD10
CEREBRAL CREATINE DEFICIENCY SYNDROME 1,1,SLC6A8
CEREBRAL CREATINE DEFICIENCY SYNDROME 2,1,GAMT
CEREBRAL CREATINE DEFICIENCY SYNDROME 3,1,GATM
"CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME",1,SNAP29
"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2",1,KANK1
"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3",1,ADD3
CEREBROCOSTOMANDIBULAR SYNDROME,1,SNRPB
CEREBROOCULOFACIOSKELETAL SYNDROME 1,1,ERCC6
CEREBROOCULOFACIOSKELETAL SYNDROME 2,1,ERCC2
CEREBROOCULOFACIOSKELETAL SYNDROME 3,1,ERCC5
CEREBROOCULOFACIOSKELETAL SYNDROME 4,1,ERCC1
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1,1,CTC1
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2,1,STN1
CEREBROTENDINOUS XANTHOMATOSIS,1,CYP27A1
"CEROID LIPOFUSCINOSIS, NEURONAL, 1",1,PPT1
"CEROID LIPOFUSCINOSIS, NEURONAL, 10",1,CTSD
"CEROID LIPOFUSCINOSIS, NEURONAL, 11",1,GRN
"CEROID LIPOFUSCINOSIS, NEURONAL, 13 (KUFS TYPE)",1,CTSF
"CEROID LIPOFUSCINOSIS, NEURONAL, 2",1,TPP1
"CEROID LIPOFUSCINOSIS, NEURONAL, 3",1,CLN3
"CEROID LIPOFUSCINOSIS, NEURONAL, 4 (KUFS TYPE)",1,DNAJC5
"CEROID LIPOFUSCINOSIS, NEURONAL, 5",1,CLN5
"CEROID LIPOFUSCINOSIS, NEURONAL, 6A",1,CLN6
"CEROID LIPOFUSCINOSIS, NEURONAL, 6B (KUFS TYPE)",1,CLN6
"CEROID LIPOFUSCINOSIS, NEURONAL, 7",1,MFSD8
"CEROID LIPOFUSCINOSIS, NEURONAL, 8",1,CLN8
"CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT",1,CLN8
CERVICAL CANCER,1,FGFR3
CHANARIN-DORFMAN SYNDROME,1,ABHD5
CHAND SYNDROME,1,RIPK4
CHAR SYNDROME,1,TFAP2B
CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS,1,PMP22
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A",1,MFN2
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B",1,MFN2
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1",1,KIF1B
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B",1,RAB7A
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1",1,LMNA
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2",2,"PNKP, MED25"
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC",1,NEFH
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D",1,GARS1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD",1,ATP1A1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E",1,NEFL
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE",1,MPV17
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F",1,HSPB1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2FF",1,CADM3
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2GG",1,GBF1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2HH",1,JAG1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I",1,MPZ
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J",1,MPZ
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K",2,"GDAP1, JPH1"
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L",1,HSPB8
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N",1,AARS1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O",1,DYNC1H1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P",1,LRSAM1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q",1,DHTKD1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R",1,TRIM2
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S",1,IGHMBP2
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T",1,MME
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U",1,MARS1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V",1,NAGLU
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W",1,HARS1
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X",1,SPG11
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y",1,VCP
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z",1,MORC2
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE",1,GDAP1
"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A",1,PMP22
"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B",1,MPZ
"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C",1,LITAF
"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D",1,EGR2
"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F",1,NEFL
"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G",1,PMP2
"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F",1,PRX
"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B",1,DNM2
"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C",1,YARS1
"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D",1,MPZ
"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E",1,INF2
"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F",1,GNB4
"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G",1,NEFL
"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A",1,GDAP1
"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B",1,KARS1
"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C",1,PLEKHG5
"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D",1,COX6A1
"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A",1,GDAP1
"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1",1,MTMR2
"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2",1,SBF2
"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3",1,SBF1
"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C",1,SH3TC2
"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D",1,NDRG1
"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H",1,FGD4
"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J",1,FIG4
"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K",1,SURF1
"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1",1,GJB1
"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6",1,PDK3
"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 4, WITH OR WITHOUT CEREBELLAR ATAXIA",1,AIFM1
"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5",1,PRPS1
CHARGE SYNDROME,2,"CHD7, SEMA3E"
CHEDIAK-HIGASHI SYNDROME,1,LYST
CHERUBISM,1,SH3BP2
CHILBLAIN LUPUS 1,1,TREX1
CHILBLAIN LUPUS 2,1,SAMHD1
CHITAYAT SYNDROME,1,ERF
CHITOTRIOSIDASE DEFICIENCY,1,CHIT1
CHOANAL ATRESIA AND LYMPHEDEMA,1,PTPN14
"CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1",1,ATP8B1
"CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2",1,ABCB11
"CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3",1,ABCB4
"CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1",1,ATP8B1
"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1",1,ATP8B1
"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2",1,ABCB11
"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3",1,ABCB4
"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4",1,TJP2
"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5",1,NR1H4
"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6",1,SLC51A
"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 7, WITH OR WITHOUT HEARING LOSS",1,USP53
"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 8",1,KIF12
CHONDROCALCINOSIS 2,1,ANKH
"CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE",1,ARSL
"CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT",1,EBP
"CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE",1,BPNT2
"CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA",1,HDAC6
"CHONDRODYSPLASIA, BLOMSTRAND TYPE",1,PTH1R
CHONDROSARCOMA,1,EXT1
"CHONDROSARCOMA, EXTRASKELETAL MYXOID",2,"NR4A3, TAF15"
CHOPRA-AMIEL-GORDON SYNDROME,1,ANKRD17
CHOPS SYNDROME,1,AFF4
"CHOREA, BENIGN HEREDITARY",1,NKX2-1
"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION",1,GPR88
CHOREOACANTHOCYTOSIS,1,VPS13A
CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION,1,NKX2-1
"CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2",1,PRPH2
"CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1",1,GUCY2D
CHOROIDEREMIA,1,CHM
CHROMOSOME 15q13.3 DELETION SYNDROME,2,"CHRNA7, KLF13"
"CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB",2,"GJA5, GJA8"
CHROMOSOME 20q11-q12 DELETION SYNDROME,1,EPB41L1
CHROMOSOME 2p16.3 DELETION SYNDROME,1,NRXN1
CHROMOSOME 5q DELETION SYNDROME,1,RPS14
CHROMOSOME Xq26.3 DUPLICATION SYNDROME,1,GPR101
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA,1,SGO1
CHUDLEY-MCCULLOUGH SYNDROME,1,GPSM2
CHUNG-JANSEN SYNDROME,1,PHIP
CHYLOMICRON RETENTION DISEASE,1,SAR1B
"CILIARY DYSKINESIA, PRIMARY, 1",1,DNAI1
"CILIARY DYSKINESIA, PRIMARY, 10",1,DNAAF2
"CILIARY DYSKINESIA, PRIMARY, 11",1,RSPH4A
"CILIARY DYSKINESIA, PRIMARY, 12",1,RSPH9
"CILIARY DYSKINESIA, PRIMARY, 13",1,DNAAF1
"CILIARY DYSKINESIA, PRIMARY, 14",1,CCDC39
"CILIARY DYSKINESIA, PRIMARY, 15",1,CCDC40
"CILIARY DYSKINESIA, PRIMARY, 16",1,DNAL1
"CILIARY DYSKINESIA, PRIMARY, 17",1,CCDC103
"CILIARY DYSKINESIA, PRIMARY, 18",1,DNAAF5
"CILIARY DYSKINESIA, PRIMARY, 19",1,DNAAF11
"CILIARY DYSKINESIA, PRIMARY, 2",1,DNAAF3
"CILIARY DYSKINESIA, PRIMARY, 20",1,ODAD1
"CILIARY DYSKINESIA, PRIMARY, 21",1,DRC1
"CILIARY DYSKINESIA, PRIMARY, 22",1,ZMYND10
"CILIARY DYSKINESIA, PRIMARY, 23",1,ODAD2
"CILIARY DYSKINESIA, PRIMARY, 24",1,RSPH1
"CILIARY DYSKINESIA, PRIMARY, 25",1,DNAAF4
"CILIARY DYSKINESIA, PRIMARY, 26",1,CFAP298
"CILIARY DYSKINESIA, PRIMARY, 27",1,CCDC65
"CILIARY DYSKINESIA, PRIMARY, 28",1,SPAG1
"CILIARY DYSKINESIA, PRIMARY, 29",1,CCNO
"CILIARY DYSKINESIA, PRIMARY, 3",1,DNAH5
"CILIARY DYSKINESIA, PRIMARY, 30",2,"ODAD3, ODAD2"
"CILIARY DYSKINESIA, PRIMARY, 32",1,RSPH3
"CILIARY DYSKINESIA, PRIMARY, 33",1,GAS8
"CILIARY DYSKINESIA, PRIMARY, 34",1,DNAJB13
"CILIARY DYSKINESIA, PRIMARY, 35",1,ODAD4
"CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED",1,DNAAF6
"CILIARY DYSKINESIA, PRIMARY, 37",1,DNAH1
"CILIARY DYSKINESIA, PRIMARY, 38",1,CFAP300
"CILIARY DYSKINESIA, PRIMARY, 39",1,LRRC56
"CILIARY DYSKINESIA, PRIMARY, 40",1,DNAH9
"CILIARY DYSKINESIA, PRIMARY, 41",1,GAS2L2
"CILIARY DYSKINESIA, PRIMARY, 42",1,MCIDAS
"CILIARY DYSKINESIA, PRIMARY, 43",1,FOXJ1
"CILIARY DYSKINESIA, PRIMARY, 44",1,NEK10
"CILIARY DYSKINESIA, PRIMARY, 45",1,TTC12
"CILIARY DYSKINESIA, PRIMARY, 46",1,STK36
"CILIARY DYSKINESIA, PRIMARY, 47, AND LISSENCEPHALY",1,TP73
"CILIARY DYSKINESIA, PRIMARY, 5",1,HYDIN
"CILIARY DYSKINESIA, PRIMARY, 6",1,NME8
"CILIARY DYSKINESIA, PRIMARY, 7",1,DNAH11
"CILIARY DYSKINESIA, PRIMARY, 9",1,DNAI2
CIMDAG SYNDROME,1,VPS4A
CINCA SYNDROME,1,NLRP3
"CIRRHOSIS, FAMILIAL",2,"KRT8, KRT18"
"CITRULLINEMIA, CLASSIC",1,ASS1
"CITRULLINEMIA, TYPE II, ADULT-ONSET",1,SLC25A13
"CITRULLINEMIA, TYPE II, NEONATAL-ONSET",1,SLC25A13
CK SYNDROME,1,NSDHL
CLARK-BARAITSER SYNDROME,1,TRIP12
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME,1,NECTIN1
"CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED",1,TBX22
"CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION",1,MEIS2
"CLEFT PALATE, PROLIFERATIVE RETINOPATHY, AND DEVELOPMENTAL DELAY",1,LRRC32
"CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES",1,KDM1A
CLEIDOCRANIAL DYSPLASIA,1,RUNX2
CLOUSTON SYNDROME,1,GJB6
"CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY",1,PITX1
COACH SYNDROME 1,1,TMEM67
COACH SYNDROME 2,1,CC2D2A
COACH SYNDROME 3,1,RPGRIP1L
COCKAYNE SYNDROME A,1,ERCC8
COCKAYNE SYNDROME B,1,ERCC6
CODAS SYNDROME,1,LONP1
"COENZYME Q10 DEFICIENCY, PRIMARY, 1",1,COQ2
"COENZYME Q10 DEFICIENCY, PRIMARY, 2",1,PDSS1
"COENZYME Q10 DEFICIENCY, PRIMARY, 3",1,PDSS2
"COENZYME Q10 DEFICIENCY, PRIMARY, 4",1,COQ8A
"COENZYME Q10 DEFICIENCY, PRIMARY, 5",1,COQ9
"COENZYME Q10 DEFICIENCY, PRIMARY, 6",1,COQ6
"COENZYME Q10 DEFICIENCY, PRIMARY, 7",1,COQ4
"COENZYME Q10 DEFICIENCY, PRIMARY, 8",1,COQ7
"COENZYME Q10 DEFICIENCY, PRIMARY, 9",1,COQ5
COFFIN-SIRIS SYNDROME 1,1,ARID1B
COFFIN-SIRIS SYNDROME 10,1,SOX4
COFFIN-SIRIS SYNDROME 11,1,SMARCD1
COFFIN-SIRIS SYNDROME 12,1,BICRA
COFFIN-SIRIS SYNDROME 2,1,ARID1A
COFFIN-SIRIS SYNDROME 3,1,SMARCB1
COFFIN-SIRIS SYNDROME 4,1,SMARCA4
COFFIN-SIRIS SYNDROME 5,1,SMARCE1
COFFIN-SIRIS SYNDROME 6,1,ARID2
COFFIN-SIRIS SYNDROME 7,1,DPF2
COFFIN-SIRIS SYNDROME 8,1,SMARCC2
COFFIN-SIRIS SYNDROME 9,1,SOX11
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA,1,SCN8A
COHEN SYNDROME,1,VPS13B
COHEN-GIBSON SYNDROME,1,EED
COLCHICINE RESISTANCE,1,ABCB1
COLE DISEASE,1,ENPP1
COLE-CARPENTER SYNDROME 1,1,P4HB
COLE-CARPENTER SYNDROME 2,1,SEC24D
COLOBOMA OF OPTIC NERVE,1,PAX6
"COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME",1,PIGL
"COLOBOMA, OCULAR, AUTOSOMAL DOMINANT",1,PAX6
"COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE",1,SALL2
"COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION",1,YAP1
"COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS",1,MITF
"COLORBLINDNESS, PARTIAL, DEUTAN SERIES",1,OPN1MW
"COLORBLINDNESS, PARTIAL, PROTAN SERIES",1,OPN1LW
COLORECTAL CANCER,28,"DLC1, CHEK2, CTNNB1, DCC, FLCN, EP300, AKT1, FGFR3, RAD54B, MLH3, APC, MCC, NRAS, PDGFRL, PIK3CA, PLA2G2A, PTPN12, PTPRJ, BAX, CCND1, SRC, BRAF, AURKA, BUB1, BUB1B, TLR2, TP53, AXIN2"
"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2",1,MLH1
"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4",1,PMS2
"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5",1,MSH6
"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6",1,TGFBR2
"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7",1,MLH3
"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8",1,EPCAM
"COLORECTAL CANCER, SUSCEPTIBILITY TO, 1",1,GALNT12
"COLORECTAL CANCER, SUSCEPTIBILITY TO, 10",1,POLD1
"COLORECTAL CANCER, SUSCEPTIBILITY TO, 12",1,POLE
"COLORECTAL CANCER, SUSCEPTIBILITY TO, 3",1,SMAD7
COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS,2,"RAG1, RAG2"
COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA,1,SLC25A1
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA,1,MTHFD1
"COMBINED IMMUNODEFICIENCY, X-LINKED",1,IL2RG
COMBINED MALONIC AND METHYLMALONIC ACIDURIA,1,ACSF3
COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1,1,COL1A1
COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2,1,COL1A2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1,1,GFM1
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10,1,MTO1
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11,1,RMND1
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12,1,EARS2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13,1,PNPT1
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14,1,FARS2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15,1,MTFMT
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16,1,MRPL44
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17,1,ELAC2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18,1,SFXN4
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19,1,LYRM4
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2,1,MRPS16
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20,1,VARS2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21,1,TARS2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22,1,ATP5F1A
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23,1,GTPBP3
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24,1,NARS2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25,1,MARS2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26,1,TRMT5
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27,1,CARS2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28,1,SLC25A26
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29,1,TXN2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3,1,TSFM
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30,1,TRMT10C
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31,1,MIPEP
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32,1,MRPS34
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33,1,C1QBP
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34,1,MRPS7
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35,1,TRIT1
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36,1,MRPS2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37,1,MICOS13
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38,1,MRPS14
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39,1,GFM2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4,1,TUFM
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40,1,QRSL1
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41,1,GATB
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42,1,GATC
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 43,1,TIMM22
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44,1,FASTKD2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 45,1,MRPL12
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 46,1,MRPS23
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 47,1,MRPS28
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 48,1,NSUN3
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 49,1,MIEF2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5,1,MRPS22
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 50,1,MRPS25
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 51,1,PTCD3
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52,1,NFS1
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 53,1,C2orf69
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6,1,AIFM1
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7,1,MTRFR
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8,1,AARS2
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9,1,MRPL3
COMBINED SAPOSIN DEFICIENCY,1,PSAP
COMPLEMENT COMPONENT 2 DEFICIENCY,1,C2
"COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE",1,C3
"COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF",1,SERPING1
COMPLEMENT COMPONENT 4A DEFICIENCY,1,C4A
COMPLEMENT COMPONENT 4B DEFICIENCY,1,C4B
COMPLEMENT COMPONENT 5 DEFICIENCY,1,C5
COMPLEMENT COMPONENT 6 DEFICIENCY,1,C6
COMPLEMENT COMPONENT 7 DEFICIENCY,1,C7
"COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I",1,C8A
"COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II",1,C8B
COMPLEMENT COMPONENT 9 DEFICIENCY,1,C9
COMPLEMENT COMPONENT C1s DEFICIENCY,1,C1S
COMPLEMENT FACTOR B DEFICIENCY,1,CFB
COMPLEMENT FACTOR D DEFICIENCY,1,CFD
COMPLEMENT FACTOR H DEFICIENCY,1,CFH
COMPLEMENT FACTOR I DEFICIENCY,1,CFI
"COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY",1,CD55
CONE DYSTROPHY 3,1,GUCA1A
CONE DYSTROPHY 4,1,PDE6C
CONE-ROD DYSTROPHY 10,1,SEMA4A
CONE-ROD DYSTROPHY 11,1,RAX2
CONE-ROD DYSTROPHY 12,1,PROM1
CONE-ROD DYSTROPHY 13,1,RPGRIP1
CONE-ROD DYSTROPHY 15,1,CDHR1
CONE-ROD DYSTROPHY 16,1,CFAP418
CONE-ROD DYSTROPHY 18,1,RAB28
CONE-ROD DYSTROPHY 19,1,TTLL5
CONE-ROD DYSTROPHY 2,1,CRX
CONE-ROD DYSTROPHY 20,1,POC1B
CONE-ROD DYSTROPHY 21,1,DRAM2
CONE-ROD DYSTROPHY 22,1,TLCD3B
CONE-ROD DYSTROPHY 3,1,ABCA4
CONE-ROD DYSTROPHY 5,1,PITPNM3
CONE-ROD DYSTROPHY 6,1,GUCY2D
CONE-ROD DYSTROPHY 7,1,RIMS1
CONE-ROD DYSTROPHY 9,1,ADAM9
CONE-ROD DYSTROPHY AND HEARING LOSS 1,1,CEP78
CONE-ROD DYSTROPHY AND HEARING LOSS 2,1,CEP250
"CONE-ROD DYSTROPHY, X-LINKED, 1",1,RPGR
"CONE-ROD DYSTROPHY, X-LINKED, 3",1,CACNA1F
"CONE-ROD SYNAPTIC DISORDER SYNDROME, CONGENITAL NONPROGRESSIVE",1,RIMS2
"CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE",1,CABP4
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1,1,DSTYK
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2,1,TBX18
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3,1,NRIP1
"CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY",1,PBX1
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE,1,GLE1
"CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY",1,CTDP1
"CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION",1,SLC33A1
"CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY",1,NALCN
CONGENITAL DISORDER OF DEGLYCOSYLATION,1,NGLY1
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1,1,FUT8
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2,1,FCSK
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE 2v",1,EDEM3
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa",1,MGAT2
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb",1,MOGS
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc",1,SLC35C1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId",1,B4GALT1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe",1,COG7
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf",1,SLC35A1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg",1,COG1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh",1,COG8
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi",1,COG5
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj",1,COG4
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk",1,TMEM165
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl",1,COG6
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm",1,SLC35A2
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn",1,SLC39A8
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo",1,CCDC115
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp",1,TMEM199
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq",1,COG2
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr",1,ATP6AP2
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt",1,GALNT2
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIw",1,SLC37A4
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia",1,PMM2
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa",1,NUS1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib",1,MPI
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic",1,ALG6
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc",1,MAGT1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id",1,ALG3
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie",1,DPM1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If",1,MPDU1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig",1,ALG12
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih",1,ALG8
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii",1,ALG2
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij",1,DPAGT1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik",1,ALG1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il",1,ALG9
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im",1,DOLK
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In",1,RFT1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip",1,ALG11
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq",1,SRD5A3
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir",1,DDOST
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It",1,PGM1
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu",1,DPM2
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL DOMINANT",1,STT3A
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL RECESSIVE",1,STT3A
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix",1,STT3B
"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy",1,SSR4
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA,1,PRKD1
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME,1,ABL1
"CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER",1,CDK13
"CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY",1,WDPCP
"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2",1,TAB2
"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4",1,NR2F2
"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5",1,GATA5
"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6",1,GDF1
"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7",1,FLT4
"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 8, WITH OR WITHOUT HETEROTAXY",1,SMAD2
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS,1,NSDHL
"CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES",1,ATN1
"CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI",1,PIK3CA
CONGENITAL SHORT BOWEL SYNDROME,1,CLMP
CONOTRUNCAL HEART MALFORMATIONS,4,"NKX2-6, NKX2-5, GATA6, TBX1"
"CONTRACTURAL ARACHNODACTYLY, CONGENITAL",1,FBN2
"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A",1,MYH3
"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B",1,MYH3
"CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS",1,PRRT2
"COPROPORPHYRIA, HEREDITARY",1,CPOX
"CORNEA PLANA 2, AUTOSOMAL RECESSIVE",1,KERA
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS,1,SLC4A11
"CORNEAL DYSTROPHY, AVELLINO TYPE",1,TGFBI
"CORNEAL DYSTROPHY, CONGENITAL STROMAL",1,DCN
"CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE",1,TGFBI
"CORNEAL DYSTROPHY, FLECK",1,PIKFYVE
"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1",1,COL8A2
"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3",1,TCF4
"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4",1,SLC4A11
"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6",1,ZEB1
"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8",1,AGBL1
"CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE",1,TACSTD2
"CORNEAL DYSTROPHY, GROENOUW TYPE I",1,TGFBI
"CORNEAL DYSTROPHY, LATTICE TYPE I",1,TGFBI
"CORNEAL DYSTROPHY, LATTICE TYPE IIIA",1,TGFBI
"CORNEAL DYSTROPHY, MEESMANN, 1",1,KRT12
"CORNEAL DYSTROPHY, MEESMANN, 2",1,KRT3
"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1",1,OVOL2
"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2",1,COL8A2
"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3",1,ZEB1
"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4",1,GRHL2
"CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE",1,TGFBI
"CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE",1,TGFBI
CORNEAL ENDOTHELIAL DYSTROPHY,1,SLC4A11
CORNELIA DE LANGE SYNDROME 1,1,NIPBL
CORNELIA DE LANGE SYNDROME 2,1,SMC1A
CORNELIA DE LANGE SYNDROME 3 WITH OR WITHOUT MIDLINE BRAIN DEFECTS,1,SMC3
CORNELIA DE LANGE SYNDROME 4 WITH OR WITHOUT MIDLINE BRAIN DEFECTS,1,RAD21
CORNELIA DE LANGE SYNDROME 5,1,HDAC8
"CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2",1,LRP6
"CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1",1,MEF2A
"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1",1,CX3CR1
"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6",1,MMP3
"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7",1,CD36
"CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA",1,ARX
"CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA",1,FRMD4A
"CORPUS CALLOSUM, AGENESIS OF, WITH IMPAIRED INTELLECTUAL DEVELOPMENT, OCULAR COLOBOMA, AND MICROGNATHIA",1,IGBP1
"CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED",1,L1CAM
"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1",1,TUBB3
"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 10",1,APC2
"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2",1,KIF5C
"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3",1,KIF2A
"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4",1,TUBG1
"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5",1,TUBB2A
"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6",1,TUBB
"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7",1,TUBB2B
"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9",1,CTNNA2
"CORTICAL MALFORMATIONS, OCCIPITAL",1,LAMC3
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY,1,SERPINA6
CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY,1,CYP11B2
CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY,1,CYP11B2
CORTISONE REDUCTASE DEFICIENCY 1,1,H6PD
CORTISONE REDUCTASE DEFICIENCY 2,1,HSD11B1
COSTELLO SYNDROME,1,HRAS
COUMARIN RESISTANCE,3,"CYP2A6, CYP2C9, VKORC1"
COUSIN SYNDROME,1,TBX15
COWDEN SYNDROME 1,1,PTEN
COWDEN SYNDROME 5,1,PIK3CA
COWDEN SYNDROME 6,1,AKT1
COWDEN SYNDROME 7,1,SEC23B
"CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT",1,SOST
CRANIOECTODERMAL DYSPLASIA 1,1,IFT122
CRANIOECTODERMAL DYSPLASIA 2,1,WDR35
CRANIOECTODERMAL DYSPLASIA 3,1,IFT43
CRANIOECTODERMAL DYSPLASIA 4,1,WDR19
CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME,1,VSX1
"CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME",1,TMCO1
CRANIOFACIAL-DEAFNESS-HAND SYNDROME,1,PAX3
CRANIOFRONTONASAL SYNDROME,1,EFNB1
CRANIOLENTICULOSUTURAL DYSPLASIA,1,SEC23A
"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT",1,ANKH
"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE",1,GJA1
CRANIOSYNOSTOSIS 1,1,TWIST1
CRANIOSYNOSTOSIS 2,1,MSX2
CRANIOSYNOSTOSIS 3,1,TCF12
CRANIOSYNOSTOSIS 4,1,ERF
"CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO",1,ALX4
CRANIOSYNOSTOSIS 6,1,ZIC1
CRANIOSYNOSTOSIS 7,1,SMAD6
"CRANIOTUBULAR DYSPLASIA, IKEGAWA TYPE",1,TMEM53
"CREATINE PHOSPHOKINASE, ELEVATED SERUM",1,CAV3
CREUTZFELDT-JAKOB DISEASE,2,"HLA-DQB1, PRNP"
"CRIGLER-NAJJAR SYNDROME, TYPE I",1,UGT1A1
"CRIGLER-NAJJAR SYNDROME, TYPE II",1,UGT1A1
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1,1,CRLF1
CRISPONI/COLD-INDUCED SWEATING SYNDROME 2,1,CLCF1
CROUZON SYNDROME,1,FGFR2
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS,1,FGFR3
CRYOHYDROCYTOSIS,1,SLC4A1
"CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED",1,FREM2
"CRYPTORCHIDISM, UNILATERAL OR BILATERAL",1,INSL3
CULLER-JONES SYNDROME,1,GLI2
CURRARINO SYNDROME,1,MNX1
CURRY-JONES SYNDROME,1,SMO
"CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL",1,ATR
"CUTIS LAXA, AUTOSOMAL DOMINANT 1",1,ELN
"CUTIS LAXA, AUTOSOMAL DOMINANT 2",1,FBLN5
"CUTIS LAXA, AUTOSOMAL DOMINANT 3",1,ALDH18A1
"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA",1,FBLN5
"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB",1,EFEMP2
"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC",1,LTBP4
"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA",1,ATP6V0A2
"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB",1,PYCR1
"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC",1,ATP6V1E1
"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID",1,ATP6V1A
"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIE",1,LTBP1
"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA",1,ALDH18A1
"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB",1,PYCR1
"CYANOSIS, TRANSIENT NEONATAL",1,HBG2
CYCLIC NEUTROPENIA,1,ELANE
"CYLINDROMATOSIS, FAMILIAL",1,CYLD
CYSTATHIONINURIA,1,CTH
CYSTIC FIBROSIS,3,"CFTR, FCGR2A, TGFB1"
"CYSTINOSIS, ADULT NONNEPHROPATHIC",1,CTNS
"CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE",1,CTNS
"CYSTINOSIS, NEPHROPATHIC",1,CTNS
CYSTINURIA,2,"SLC7A9, SLC3A1"
CZECH DYSPLASIA,1,COL2A1
D-2-HYDROXYGLUTARIC ACIDURIA 1,1,D2HGDH
D-2-HYDROXYGLUTARIC ACIDURIA 2,1,IDH2
D-BIFUNCTIONAL PROTEIN DEFICIENCY,1,HSD17B4
D-GLYCERIC ACIDURIA,1,GLYCTK
D-LACTIC ACIDURIA WITH GOUT,1,LDHD
DANON DISEASE,1,LAMP2
DARIER-WHITE DISEASE,1,ATP2A2
DE SANCTIS-CACCHIONE SYNDROME,1,ERCC6
DEAFNESS AND MYOPIA,1,SLITRK6
"DEAFNESS, AMINOGLYCOSIDE-INDUCED",1,TRMU
"DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA",1,DIAPH1
"DEAFNESS, AUTOSOMAL DOMINANT 10",1,EYA4
"DEAFNESS, AUTOSOMAL DOMINANT 11",1,MYO7A
"DEAFNESS, AUTOSOMAL DOMINANT 12",1,TECTA
"DEAFNESS, AUTOSOMAL DOMINANT 13",1,COL11A2
"DEAFNESS, AUTOSOMAL DOMINANT 15",1,POU4F3
"DEAFNESS, AUTOSOMAL DOMINANT 17",1,MYH9
"DEAFNESS, AUTOSOMAL DOMINANT 20",1,ACTG1
"DEAFNESS, AUTOSOMAL DOMINANT 22",1,MYO6
"DEAFNESS, AUTOSOMAL DOMINANT 23",1,SIX1
"DEAFNESS, AUTOSOMAL DOMINANT 25",1,SLC17A8
"DEAFNESS, AUTOSOMAL DOMINANT 27",1,REST
"DEAFNESS, AUTOSOMAL DOMINANT 28",1,GRHL2
"DEAFNESS, AUTOSOMAL DOMINANT 2A",1,KCNQ4
"DEAFNESS, AUTOSOMAL DOMINANT 2B",1,GJB3
"DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION",1,NLRP3
"DEAFNESS, AUTOSOMAL DOMINANT 36",1,TMC1
"DEAFNESS, AUTOSOMAL DOMINANT 37",1,COL11A1
"DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1",1,DSPP
"DEAFNESS, AUTOSOMAL DOMINANT 3A",1,GJB2
"DEAFNESS, AUTOSOMAL DOMINANT 3B",1,GJB6
"DEAFNESS, AUTOSOMAL DOMINANT 40",1,CRYM
"DEAFNESS, AUTOSOMAL DOMINANT 41",1,P2RX2
"DEAFNESS, AUTOSOMAL DOMINANT 44",1,CCDC50
"DEAFNESS, AUTOSOMAL DOMINANT 4A",1,MYH14
"DEAFNESS, AUTOSOMAL DOMINANT 4B",1,CEACAM16
"DEAFNESS, AUTOSOMAL DOMINANT 5",1,GSDME
"DEAFNESS, AUTOSOMAL DOMINANT 56",1,TNC
"DEAFNESS, AUTOSOMAL DOMINANT 6",1,WFS1
"DEAFNESS, AUTOSOMAL DOMINANT 64",1,DIABLO
"DEAFNESS, AUTOSOMAL DOMINANT 65",1,TBC1D24
"DEAFNESS, AUTOSOMAL DOMINANT 66",1,CD164
"DEAFNESS, AUTOSOMAL DOMINANT 67",1,OSBPL2
"DEAFNESS, AUTOSOMAL DOMINANT 68",1,HOMER2
"DEAFNESS, AUTOSOMAL DOMINANT 69",1,KITLG
"DEAFNESS, AUTOSOMAL DOMINANT 7",1,LMX1A
"DEAFNESS, AUTOSOMAL DOMINANT 70",1,MCM2
"DEAFNESS, AUTOSOMAL DOMINANT 71",1,DMXL2
"DEAFNESS, AUTOSOMAL DOMINANT 72",1,SLC44A4
"DEAFNESS, AUTOSOMAL DOMINANT 73",1,PTPRQ
"DEAFNESS, AUTOSOMAL DOMINANT 74",1,PDE1C
"DEAFNESS, AUTOSOMAL DOMINANT 75",1,TRRAP
"DEAFNESS, AUTOSOMAL DOMINANT 76",1,PLS1
"DEAFNESS, AUTOSOMAL DOMINANT 77",1,ABCC1
"DEAFNESS, AUTOSOMAL DOMINANT 78",1,SLC12A2
"DEAFNESS, AUTOSOMAL DOMINANT 79",1,SCD5
"DEAFNESS, AUTOSOMAL DOMINANT 80",1,GREB1L
"DEAFNESS, AUTOSOMAL DOMINANT 81",1,ELMOD3
"DEAFNESS, AUTOSOMAL RECESSIVE 100",1,PPIP5K2
"DEAFNESS, AUTOSOMAL RECESSIVE 101",1,GRXCR2
"DEAFNESS, AUTOSOMAL RECESSIVE 102",1,EPS8
"DEAFNESS, AUTOSOMAL RECESSIVE 103",1,CLIC5
"DEAFNESS, AUTOSOMAL RECESSIVE 104",1,RIPOR2
"DEAFNESS, AUTOSOMAL RECESSIVE 106",1,EPS8L2
"DEAFNESS, AUTOSOMAL RECESSIVE 107",1,WBP2
"DEAFNESS, AUTOSOMAL RECESSIVE 108",1,ROR1
"DEAFNESS, AUTOSOMAL RECESSIVE 109",1,ESRP1
"DEAFNESS, AUTOSOMAL RECESSIVE 111",1,MPZL2
"DEAFNESS, AUTOSOMAL RECESSIVE 112",1,BDP1
"DEAFNESS, AUTOSOMAL RECESSIVE 113",1,CEACAM16
"DEAFNESS, AUTOSOMAL RECESSIVE 114",1,GRAP
"DEAFNESS, AUTOSOMAL RECESSIVE 115",1,SPNS2
"DEAFNESS, AUTOSOMAL RECESSIVE 116",1,CLDN9
"DEAFNESS, AUTOSOMAL RECESSIVE 117",1,CLRN2
"DEAFNESS, AUTOSOMAL RECESSIVE 119",1,SPATA5L1
"DEAFNESS, AUTOSOMAL RECESSIVE 12",2,"ATP2B2, CDH23"
"DEAFNESS, AUTOSOMAL RECESSIVE 15",1,GIPC3
"DEAFNESS, AUTOSOMAL RECESSIVE 16",1,STRC
"DEAFNESS, AUTOSOMAL RECESSIVE 18A",1,USH1C
"DEAFNESS, AUTOSOMAL RECESSIVE 18B",1,OTOG
"DEAFNESS, AUTOSOMAL RECESSIVE 1A",3,"GJB6, GJB2, GJB3"
"DEAFNESS, AUTOSOMAL RECESSIVE 1B",1,GJB6
"DEAFNESS, AUTOSOMAL RECESSIVE 2",1,MYO7A
"DEAFNESS, AUTOSOMAL RECESSIVE 21",1,TECTA
"DEAFNESS, AUTOSOMAL RECESSIVE 22",1,OTOA
"DEAFNESS, AUTOSOMAL RECESSIVE 23",1,PCDH15
"DEAFNESS, AUTOSOMAL RECESSIVE 24",1,RDX
"DEAFNESS, AUTOSOMAL RECESSIVE 25",1,GRXCR1
"DEAFNESS, AUTOSOMAL RECESSIVE 26",1,GAB1
"DEAFNESS, AUTOSOMAL RECESSIVE 26, MODIFIER OF",1,METTL13
"DEAFNESS, AUTOSOMAL RECESSIVE 28",1,TRIOBP
"DEAFNESS, AUTOSOMAL RECESSIVE 29",1,CLDN14
"DEAFNESS, AUTOSOMAL RECESSIVE 3",1,MYO15A
"DEAFNESS, AUTOSOMAL RECESSIVE 30",1,MYO3A
"DEAFNESS, AUTOSOMAL RECESSIVE 31",1,WHRN
"DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM",1,CDC14A
"DEAFNESS, AUTOSOMAL RECESSIVE 35",1,ESRRB
"DEAFNESS, AUTOSOMAL RECESSIVE 37",1,MYO6
"DEAFNESS, AUTOSOMAL RECESSIVE 39",1,HGF
"DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT",3,"FOXI1, KCNJ10, SLC26A4"
"DEAFNESS, AUTOSOMAL RECESSIVE 42",1,ILDR1
"DEAFNESS, AUTOSOMAL RECESSIVE 44",1,ADCY1
"DEAFNESS, AUTOSOMAL RECESSIVE 48",1,CIB2
"DEAFNESS, AUTOSOMAL RECESSIVE 49",1,MARVELD2
"DEAFNESS, AUTOSOMAL RECESSIVE 53",1,COL11A2
"DEAFNESS, AUTOSOMAL RECESSIVE 57",1,PDZD7
"DEAFNESS, AUTOSOMAL RECESSIVE 59",1,PJVK
"DEAFNESS, AUTOSOMAL RECESSIVE 6",1,TMIE
"DEAFNESS, AUTOSOMAL RECESSIVE 61",1,SLC26A5
"DEAFNESS, AUTOSOMAL RECESSIVE 63",1,LRTOMT
"DEAFNESS, AUTOSOMAL RECESSIVE 66",1,DCDC2
"DEAFNESS, AUTOSOMAL RECESSIVE 67",1,LHFPL5
"DEAFNESS, AUTOSOMAL RECESSIVE 68",1,S1PR2
"DEAFNESS, AUTOSOMAL RECESSIVE 7",1,TMC1
"DEAFNESS, AUTOSOMAL RECESSIVE 70",1,PNPT1
"DEAFNESS, AUTOSOMAL RECESSIVE 74",1,MSRB3
"DEAFNESS, AUTOSOMAL RECESSIVE 76",1,SYNE4
"DEAFNESS, AUTOSOMAL RECESSIVE 77",1,LOXHD1
"DEAFNESS, AUTOSOMAL RECESSIVE 79",1,TPRN
"DEAFNESS, AUTOSOMAL RECESSIVE 8",1,TMPRSS3
"DEAFNESS, AUTOSOMAL RECESSIVE 84A",1,PTPRQ
"DEAFNESS, AUTOSOMAL RECESSIVE 84B",1,OTOGL
"DEAFNESS, AUTOSOMAL RECESSIVE 86",1,TBC1D24
"DEAFNESS, AUTOSOMAL RECESSIVE 88",1,ELMOD3
"DEAFNESS, AUTOSOMAL RECESSIVE 89",1,KARS1
"DEAFNESS, AUTOSOMAL RECESSIVE 9",1,OTOF
"DEAFNESS, AUTOSOMAL RECESSIVE 91",1,SERPINB6
"DEAFNESS, AUTOSOMAL RECESSIVE 93",1,CABP2
"DEAFNESS, AUTOSOMAL RECESSIVE 94",1,NARS2
"DEAFNESS, AUTOSOMAL RECESSIVE 97",1,MET
"DEAFNESS, AUTOSOMAL RECESSIVE 98",1,TSPEAR
"DEAFNESS, AUTOSOMAL RECESSIVE 99",1,TMEM132E
"DEAFNESS, CATARACT, IMPAIRED INTELLECTUAL DEVELOPMENT, AND POLYNEUROPATHY",1,PSMC3
"DEAFNESS, CONGENITAL HEART DEFECTS, AND POSTERIOR EMBRYOTOXON",1,JAG1
"DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY",1,KARS1
"DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA",1,FGF3
"DEAFNESS, CONGENITAL, WITH ONYCHODYSTROPHY, AUTOSOMAL DOMINANT",1,ATP6V1B2
"DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION",1,BCAP31
"DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME",1,TBC1D24
"DEAFNESS, X-LINKED 1",1,PRPS1
"DEAFNESS, X-LINKED 2",3,"GJB6, GJB2, POU3F4"
"DEAFNESS, X-LINKED 4",1,SMPX
"DEAFNESS, X-LINKED 5, WITH PERIPHERAL NEUROPATHY",1,AIFM1
"DEAFNESS, X-LINKED 6",1,COL4A6
"DEAFNESS, X-LINKED 7",1,GPRASP2
"DEAFNESS, Y-LINKED 2",1,TBL1Y
DEAFNESS-INFERTILITY SYNDROME,2,"CATSPER2, STRC"
DEEAH SYNDROME,1,MADD
DEGCAGS SYNDROME,1,ZNF699
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA,1,PIEZO1
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2,1,KCNN4
"DELAYED PUBERTY, SELF-LIMITED",1,LGR4
"DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO",1,CRY1
DELPIRE-MCNEILL SYNDROME,1,SLC12A2
"DEMENTIA, LEWY BODY",3,"GBA, SNCB, SNCA"
"DENGUE VIRUS, SUSCEPTIBILITY TO",1,CD209
DENT DISEASE 1,1,CLCN5
DENT DISEASE 2,1,OCRL
DENTAL ANOMALIES AND SHORT STATURE,1,LTBP3
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY,1,ATN1
"DENTIN DYSPLASIA, TYPE I",1,SMOC2
"DENTIN DYSPLASIA, TYPE II",1,DSPP
DENTINOGENESIS IMPERFECTA 1,1,DSPP
"DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III",1,DSPP
DENYS-DRASH SYNDROME,1,WT1
DERMATOFIBROSARCOMA PROTUBERANS,1,PDGFB
DERMATOPATHIA PIGMENTOSA RETICULARIS,1,KRT14
DESANTO-SHINAWI SYNDROME,1,WAC
DESBUQUOIS DYSPLASIA 1,1,CANT1
DESBUQUOIS DYSPLASIA 2,1,XYLT1
"DESMOID DISEASE, HEREDITARY",1,APC
DESMOSTEROLOSIS,1,DHCR24
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1,1,ARX
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11,1,SCN2A
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12,1,PLCB1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13,1,SCN8A
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14,1,KCNT1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 15,1,ST3GAL3
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 16,1,TBC1D24
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17,1,GNAO1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18,1,SZT2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19,1,GABRA1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2,1,CDKL5
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21,1,NECAP1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23,1,DOCK7
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 24,1,HCN1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25 WITH AMELOGENESIS IMPERFECTA,1,SLC13A5
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26,1,KCNB1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27,1,GRIN2B
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28,1,WWOX
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29,1,AARS1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3,1,SLC25A22
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30,1,SIK1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31,1,DNM1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32,1,KCNA2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 33,1,EEF1A2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 34,1,SLC12A5
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35,1,ITPA
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36,1,ALG13
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 37,1,FRRS1L
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38,1,ARV1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 39,1,SLC25A12
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4,1,STXBP1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 40,1,GUF1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41,1,SLC1A2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42,1,CACNA1A
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 43,1,GABRB3
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44,1,UBA5
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 45,1,GABRB1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46,1,GRIN2D
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47,1,FGF12
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 48,1,AP3B2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 49,1,DENND5A
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5,1,SPTAN1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50,1,CAD
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51,1,MDH2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52,1,SCN1B
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53,1,SYNJ1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 54,1,HNRNPU
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55,1,PIGP
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 56,1,YWHAG
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57,1,KCNT2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 58,1,NTRK2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 59,1,GABBR2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 60,1,CNPY3
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 61,1,ADAM22
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 62,1,SCN3A
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 63,1,CPLX1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 64,1,RHOBTB2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 65,1,CYFIP2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 66,1,PACS2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 67,1,CUX2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 68,1,TRAK1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 69,1,CACNA1E
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6B,1,SCN1A
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7,1,KCNQ2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 70,1,PHACTR1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 71,1,GLS
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 72,1,NEUROD2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 73,1,RNF13
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 74,1,GABRG2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75,1,PARS2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76,1,ACTL6B
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78,1,GABRA2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79,1,GABRA5
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8,1,ARHGEF9
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80,1,PIGB
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 81,1,DMXL2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82,1,GOT2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83,1,UGP2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84,1,UGDH
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH OR WITHOUT MIDLINE BRAIN DEFECTS,1,SMC1A
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 86,1,DALRD3
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 87,1,CDK19
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 88,1,MDH1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89,1,GAD1
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 9,1,PCDH19
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 90,1,FGF13
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91,1,PPP3CA
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 92,1,GABRB2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 93,1,ATP6V1A
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94,1,CHD2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95,1,PIGS
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96,1,NSF
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 97,1,CELF2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98,1,ATP1A2
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99,1,ATP1A3
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES,1,DHDDS
DEVELOPMENTAL DELAY WITH DYSMORPHIC FACIES AND DENTAL ANOMALIES,1,SATB1
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM,1,TRRAP
DEVELOPMENTAL DELAY WITH OR WITHOUT INTELLECTUAL IMPAIRMENT OR BEHAVIORAL ABNORMALITIES,1,TAOK1
"DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR",1,DPH1
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES,1,TCF20
DEVELOPMENTAL DELAY WITH VARIABLE NEUROLOGIC AND BRAIN ABNORMALITIES,1,LMBRD2
"DEVELOPMENTAL DELAY, HYPOTONIA, MUSCULOSKELETAL DEFECTS, AND BEHAVIORAL ABNORMALITIES",1,SRCAP
"DEVELOPMENTAL DELAY, IMPAIRED GROWTH, DYSMORPHIC FACIES, AND AXONAL NEUROPATHY",1,MORC2
"DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES",1,SPTBN1
"DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL",1,AQP2
"DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED",1,AVPR2
"DIABETES INSIPIDUS, NEUROHYPOPHYSEAL",1,AVP
"DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS",1,INSR
"DIABETES MELLITUS, KETOSIS-PRONE",1,PAX4
"DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM",1,GLIS3
"DIABETES MELLITUS, PERMANENT NEONATAL, 1",5,"GCK, INS, PDX1, KCNJ11, ABCC8"
"DIABETES MELLITUS, PERMANENT NEONATAL, 2",1,KCNJ11
"DIABETES MELLITUS, PERMANENT NEONATAL, 3",1,ABCC8
"DIABETES MELLITUS, PERMANENT NEONATAL, 4",1,INS
"DIABETES MELLITUS, TRANSIENT NEONATAL, 1",1,ZFP57
"DIABETES MELLITUS, TRANSIENT NEONATAL, 2",1,ABCC8
"DIABETES MELLITUS, TRANSIENT NEONATAL, 3",1,KCNJ11
DIAMOND-BLACKFAN ANEMIA 1,1,RPS19
DIAMOND-BLACKFAN ANEMIA 10,1,RPS26
DIAMOND-BLACKFAN ANEMIA 11,1,RPL26
DIAMOND-BLACKFAN ANEMIA 12,1,RPL15
DIAMOND-BLACKFAN ANEMIA 13,1,RPS29
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS,1,TSR2
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS,1,RPS28
DIAMOND-BLACKFAN ANEMIA 16,1,RPL27
DIAMOND-BLACKFAN ANEMIA 17,1,RPS27
DIAMOND-BLACKFAN ANEMIA 18,1,RPL18
DIAMOND-BLACKFAN ANEMIA 19,1,RPL35
DIAMOND-BLACKFAN ANEMIA 20,1,RPS15A
DIAMOND-BLACKFAN ANEMIA 3,1,RPS24
DIAMOND-BLACKFAN ANEMIA 4,1,RPS17
DIAMOND-BLACKFAN ANEMIA 5,1,RPL35A
DIAMOND-BLACKFAN ANEMIA 6,1,RPL5
DIAMOND-BLACKFAN ANEMIA 7,1,RPL11
DIAMOND-BLACKFAN ANEMIA 8,1,RPS7
DIAMOND-BLACKFAN ANEMIA 9,1,RPS10
DIAMOND-BLACKFAN ANEMIA-LIKE,1,EPO
DIAPHANOSPONDYLODYSOSTOSIS,1,BMPER
DIAPHRAGMATIC HERNIA 3,1,ZFPM2
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA,1,MTAP
"DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL",1,SLC26A3
"DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE",1,PLVAP
"DIARRHEA 12, WITH MICROVILLUS ATROPHY",1,STX3
"DIARRHEA 2, WITH MICROVILLUS ATROPHY",1,MYO5B
"DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES",1,SPINT2
"DIARRHEA 4, MALABSORPTIVE, CONGENITAL",1,NEUROG3
"DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL",1,EPCAM
DIARRHEA 6,1,GUCY2C
"DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE",1,DGAT1
"DIARRHEA 8, SECRETORY SODIUM, CONGENITAL",1,SLC9A3
DIARRHEA 9,1,WNT2B
DIASTROPHIC DYSPLASIA,1,SLC26A2
DICARBOXYLIC AMINOACIDURIA,1,SLC1A1
DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 1,1,PCDH12
DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2,1,GSX2
DIETS-JONGMANS SYNDROME,1,KDM3B
DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME,4,"IL1B, IL1RN, KRAS, CDH1"
DIGEORGE SYNDROME,1,TBX1
"DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL",1,TRPV4
"DIGITAL CLUBBING, ISOLATED CONGENITAL",1,HPGD
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY,1,DLD
DIHYDROPYRIMIDINASE DEFICIENCY,1,DPYS
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY,1,DPYD
DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY,1,DMGDH
DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY,1,POR
DONNAI-BARROW SYNDROME,1,LRP2
DONOHUE SYNDROME,1,INSR
DOWLING-DEGOS DISEASE 1,1,KRT5
DOWLING-DEGOS DISEASE 2,1,POFUT1
DOWLING-DEGOS DISEASE 4,1,POGLUT1
DOWN SYNDROME,1,GATA1
DOYNE HONEYCOMB RETINAL DYSTROPHY,1,EFEMP1
DRAVET SYNDROME,1,SCN1A
"DRUG METABOLISM, ALTERED, CES1-RELATED",1,CES1
"DRUG METABOLISM, ALTERED, CYP2C8-RELATED",1,CYP2C8
"DRUG METABOLISM, POOR, CYP2C19-RELATED",1,CYP2C19
"DRUG METABOLISM, POOR, CYP2D6-RELATED",1,CYP2D6
DUANE RETRACTION SYNDROME 2,1,CHN1
DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS,1,MAFB
DUANE-RADIAL RAY SYNDROME,1,SALL4
DUBIN-JOHNSON SYNDROME,1,ABCC2
DYGGVE-MELCHIOR-CLAUSEN DISEASE,1,DYM
DYSCHROMATOSIS SYMMETRICA HEREDITARIA,1,ADAR
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1,1,SASH1
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3,1,ABCB6
"DYSFIBRINOGENEMIA, CONGENITAL",3,"FGA, FGB, FGG"
"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1",2,"TINF2, TERT"
"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2",1,TERT
"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3",1,TINF2
"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6",1,ACD
"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1",2,"NOP10, NHP2"
"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2",1,NHP2
"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3",1,WRAP53
"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5",1,RTEL1
"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6",1,PARN
"DYSKERATOSIS CONGENITA, X-LINKED",1,DKC1
"DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL DOMINANT",1,ADCY5
"DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL RECESSIVE",1,ADCY5
"DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET",1,PDE10A
"DYSLEXIA, SUSCEPTIBILITY TO, 1",1,DNAAF4
"DYSOSTOSIS MULTIPLEX, AIN-NAZ TYPE",1,TMEM251
"DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE",1,HSPG2
"DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT",1,TOR1A
"DYSTONIA 11, MYOCLONIC",1,SGCE
DYSTONIA 12,1,ATP1A3
DYSTONIA 16,1,PRKRA
"DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE",1,HPCA
DYSTONIA 24,1,ANO3
DYSTONIA 25,1,GNAL
"DYSTONIA 26, MYOCLONIC",1,KCTD17
DYSTONIA 27,1,COL6A3
"DYSTONIA 28, CHILDHOOD-ONSET",1,KMT2B
"DYSTONIA 3, TORSION, X-LINKED",1,TAF1
DYSTONIA 30,1,VPS16
DYSTONIA 31,1,AOPEP
DYSTONIA 32,1,VPS11
DYSTONIA 33,1,EIF2AK2
"DYSTONIA 34, MYOCLONIC",1,KCNN2
"DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT",1,TUBB4A
"DYSTONIA 6, TORSION",1,THAP1
DYSTONIA 9,1,SLC2A1
"DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES",1,MECR
"DYSTONIA, DOPA-RESPONSIVE",1,GCH1
"DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY",1,SPR
"DYSTONIA, EARLY-ONSET, AND/OR SPASTIC PARAPLEGIA",1,ATP5MC3
"DYSTONIA, JUVENILE-ONSET",1,ACTB
"ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED",1,EDA
"ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT",2,"EDAR, EDARADD"
"ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",2,"EDAR, EDARADD"
"ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT",1,EDARADD
"ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",1,EDARADD
"ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE",1,KDF1
"ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE",1,KREMEN1
"ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS",1,TSPEAR
"ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE",1,CST6
"ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE",1,KRT85
"ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE",1,KRT74
"ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE",1,HOXC13
ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1,1,IKBKG
ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 2,1,NFKBIA
"ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES",1,RHOA
"ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME",1,CDH3
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1,1,NECTIN4
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME,1,GRHL2
ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME,1,PKP1
"ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT",1,FBN1
"ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE",1,ADAMTSL4
ECTOPIA LENTIS ET PUPILLAE,1,ADAMTSL4
"ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3",1,TP63
"ECULIZUMAB, POOR RESPONSE TO",1,C5
"EFAVIRENZ, POOR METABOLISM OF",1,CYP2B6
"EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1",1,COL1A1
"EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2",1,COL1A2
"EHLERS-DANLOS SYNDROME, CARDIAC VALVULAR TYPE",1,COL1A2
"EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1",1,COL5A1
"EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2",2,"COL5A1, COL5A2"
"EHLERS-DANLOS SYNDROME, CLASSIC-LIKE",1,TNXB
"EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2",1,AEBP1
"EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE",1,ADAMTS2
"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1",1,PLOD1
"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2",1,FKBP14
"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1",1,CHST14
"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2",1,DSE
"EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1",1,C1R
"EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2",1,C1S
"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1",1,B4GALT7
"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2",1,B3GALT6
"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 3",1,SLC39A13
"EHLERS-DANLOS SYNDROME, VASCULAR TYPE",1,COL3A1
EIKEN SYNDROME,1,PTH1R
ELLIPTOCYTOSIS 1,1,EPB41
ELLIPTOCYTOSIS 2,1,SPTA1
ELLIPTOCYTOSIS 3,1,SPTB
ELLIS-VAN CREVELD SYNDROME,2,"EVC2, EVC"
ELSAHY-WATERS SYNDROME,1,CDH11
"EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED",1,EMD
"EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT",1,LMNA
"EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE",1,LMNA
"EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT",1,SYNE2
"EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT",1,TMEM43
"ENCEPHALITIS, ACUTE, INFECTION (VIRAL)-INDUCED, SUSCEPTIBILITY TO, 11",1,DBR1
"ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION",1,MYRF
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS,1,FGFR1
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1,1,DNM1L
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2,1,MFF
"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 1",1,UNC93B1
"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 5",1,TRAF3
"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 6",1,TICAM1
"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7",1,IRF3
"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8",1,TBK1
"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3",1,RANBP2
"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4",1,CPT2
"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9",1,NUP214
"ENCEPHALOPATHY, ETHYLMALONIC",1,ETHE1
"ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES",1,SERPINI1
"ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS",1,MECP2
"ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES",1,LIPT2
"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY",1,TRAPPC12
"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM",1,TBCD
"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1",1,NAXE
"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2",1,NAXD
"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS",1,TRAPPC2L
"ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY",1,TBCE
"ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY",1,BSCL2
ENDOCRINE-CEREBROOSTEODYSPLASIA,1,CILK1
ENDOMETRIAL CANCER,4,"MLH3, MSH6, MSH3, CDH1"
"ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT",1,LRP5
"ENDOVE SYNDROME, LIMB-BRAIN TYPE",1,EN1
ENHANCED S-CONE SYNDROME,1,NR2E3
ENTEROKINASE DEFICIENCY,1,TMPRSS15
EOSINOPHIL PEROXIDASE DEFICIENCY,1,EPX
"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1",1,TMC6
"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 2",1,TMC8
"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3",1,CIB1
"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4",1,RHOH
"EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT",1,COL7A1
"EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE",2,"COL7A1, MMP1"
"EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL",1,COL7A1
EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA,3,"ITGA6, ITGB4, PLEC"
EPIDERMOLYSIS BULLOSA PRURIGINOSA,1,COL7A1
"EPIDERMOLYSIS BULLOSA SIMPLEX 1A, GENERALIZED SEVERE",2,"KRT5, KRT14"
"EPIDERMOLYSIS BULLOSA SIMPLEX 1B, GENERALIZED INTERMEDIATE",2,"KRT5, KRT14"
"EPIDERMOLYSIS BULLOSA SIMPLEX 1C, LOCALIZED",3,"ITGB4, KRT5, KRT14"
"EPIDERMOLYSIS BULLOSA SIMPLEX 1D, GENERALIZED, INTERMEDIATE OR SEVERE, AUTOSOMAL RECESSIVE",2,"KRT5, KRT14"
"EPIDERMOLYSIS BULLOSA SIMPLEX 2A, GENERALIZED SEVERE",1,KRT5
"EPIDERMOLYSIS BULLOSA SIMPLEX 2B, GENERALIZED INTERMEDIATE",1,KRT5
"EPIDERMOLYSIS BULLOSA SIMPLEX 2C, LOCALIZED",1,KRT5
"EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED, INTERMEDIATE OR SEVERE, AUTOSOMAL RECESSIVE",1,KRT5
"EPIDERMOLYSIS BULLOSA SIMPLEX 2E, WITH MIGRATORY CIRCINATE ERYTHEMA",1,KRT5
"EPIDERMOLYSIS BULLOSA SIMPLEX 2F, WITH MOTTLED PIGMENTATION",1,KRT5
"EPIDERMOLYSIS BULLOSA SIMPLEX 3, LOCALIZED OR GENERALIZED INTERMEDIATE, WITH BP230 DEFICIENCY",1,DST
"EPIDERMOLYSIS BULLOSA SIMPLEX 4, LOCALIZED OR GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE",1,EXPH5
"EPIDERMOLYSIS BULLOSA SIMPLEX 5A, OGNA TYPE",1,PLEC
"EPIDERMOLYSIS BULLOSA SIMPLEX 5B, WITH MUSCULAR DYSTROPHY",1,PLEC
"EPIDERMOLYSIS BULLOSA SIMPLEX 5C, WITH PYLORIC ATRESIA",1,PLEC
"EPIDERMOLYSIS BULLOSA SIMPLEX 5D, GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE",1,PLEC
"EPIDERMOLYSIS BULLOSA SIMPLEX 6, GENERALIZED, WITH SCARRING AND HAIR LOSS",1,KLHL24
"EPIDERMOLYSIS BULLOSA SIMPLEX 7, WITH NEPHROPATHY AND DEAFNESS",1,CD151
EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS,1,COL7A1
"EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE",3,"LAMA3, LAMB3, LAMC2"
"EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE",5,"COL17A1, ITGB4, LAMA3, LAMB3, LAMC2"
"EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC",1,DSP
EPIDERMOLYTIC HYPERKERATOSIS,2,"KRT1, KRT10"
"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5",1,GABRB3
"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6",1,CACNA1H
"EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT",1,PLPBP
"EPILEPSY, EARLY-ONSET, WITH OR WITHOUT DEVELOPMENTAL DELAY",1,SETD1A
"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1",1,SAMD12
"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2",1,STARD7
"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3",1,MARCHF6
"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4",1,YEATS2
"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5",1,CNTN2
"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 6",1,TNRC6A
"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 7",1,RAPGEF2
"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1",1,DEPDC5
"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2",1,NPRL2
"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3",1,NPRL3
"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4",1,SCN3A
"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",3,"RELN, MICAL1, LGI1"
"EPILEPSY, FAMILIAL TEMPORAL LOBE, 5",1,CPA6
"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",1,RELN
"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8",1,GAL
"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",1,GRIN2A
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10",1,GABRD
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11",1,CLCN2
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12",1,SLC2A1
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13",1,GABRA1
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14",1,SLC12A5
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15",1,RORB
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 16",1,KCNMA1
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 17",1,HCN2
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 18",1,HCN4
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8",1,CASR
"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9",1,CACNB4
"EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1",1,EFHC1
"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10",1,CILK1
"EPILEPSY, MYOCLONIC JUVENILE",1,EFHC1
"EPILEPSY, NOCTURNAL FRONTAL LOBE, 1",1,CHRNA4
"EPILEPSY, NOCTURNAL FRONTAL LOBE, 3",1,CHRNB2
"EPILEPSY, NOCTURNAL FRONTAL LOBE, 4",1,CHRNA2
"EPILEPSY, NOCTURNAL FRONTAL LOBE, 5",1,KCNT1
"EPILEPSY, PROGRESSIVE MYOCLONIC 7",1,KCNC1
"EPILEPSY, PROGRESSIVE MYOCLONIC, 10",1,PRDM8
"EPILEPSY, PROGRESSIVE MYOCLONIC, 11",1,SEMA6B
"EPILEPSY, PROGRESSIVE MYOCLONIC, 12",1,SLC7A6OS
"EPILEPSY, PROGRESSIVE MYOCLONIC, 1B",1,PRICKLE1
"EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS",1,KCTD7
"EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE",1,SCARB2
"EPILEPSY, PROGRESSIVE MYOCLONIC, 6",1,GOSR2
"EPILEPSY, PROGRESSIVE MYOCLONIC, 8",1,CERS1
"EPILEPSY, PROGRESSIVE MYOCLONIC, 9",1,LMNB2
"EPILEPSY, PYRIDOXINE-DEPENDENT",1,ALDH7A1
"EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP",1,TBC1D24
"EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS",1,SYN1
"EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE",1,NPR2
"EPIPHYSEAL DYSPLASIA, MULTIPLE, 1",1,COMP
"EPIPHYSEAL DYSPLASIA, MULTIPLE, 2",1,COL9A2
"EPIPHYSEAL DYSPLASIA, MULTIPLE, 3",1,COL9A3
"EPIPHYSEAL DYSPLASIA, MULTIPLE, 4",1,SLC26A2
"EPIPHYSEAL DYSPLASIA, MULTIPLE, 5",1,MATN3
"EPIPHYSEAL DYSPLASIA, MULTIPLE, 6",1,COL9A1
"EPIPHYSEAL DYSPLASIA, MULTIPLE, 7",1,CANT1
"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS",1,EIF2AK3
"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS",1,COL2A1
"EPISODIC ATAXIA, TYPE 1",1,KCNA1
"EPISODIC ATAXIA, TYPE 2",1,CACNA1A
"EPISODIC ATAXIA, TYPE 5",1,CACNB4
"EPISODIC ATAXIA, TYPE 6",1,SLC1A3
"EPISODIC ATAXIA, TYPE 9",1,SCN2A
EPISODIC KINESIGENIC DYSKINESIA 1,1,PRRT2
"EPISODIC PAIN SYNDROME, FAMILIAL, 1",1,TRPA1
"EPISODIC PAIN SYNDROME, FAMILIAL, 2",1,SCN10A
"EPISODIC PAIN SYNDROME, FAMILIAL, 3",1,SCN11A
EPITHELIAL RECURRENT EROSION DYSTROPHY,1,COL17A1
"ERYTHERMALGIA, PRIMARY",1,SCN9A
ERYTHROCYTE AMP DEAMINASE DEFICIENCY,1,AMPD3
ERYTHROCYTE LACTATE TRANSPORTER DEFECT,1,SLC16A1
"ERYTHROCYTOSIS, FAMILIAL, 1",3,"SH2B3, EPOR, JAK2"
"ERYTHROCYTOSIS, FAMILIAL, 2",1,VHL
"ERYTHROCYTOSIS, FAMILIAL, 3",1,EGLN1
"ERYTHROCYTOSIS, FAMILIAL, 4",1,EPAS1
"ERYTHROCYTOSIS, FAMILIAL, 5",1,EPO
"ERYTHROCYTOSIS, FAMILIAL, 6",1,HBB
"ERYTHROCYTOSIS, FAMILIAL, 7",1,HBA1
"ERYTHROCYTOSIS, FAMILIAL, 8",1,BPGM
"ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE",1,DSG1
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 1,1,GJB3
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2,1,GJB4
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 3,1,GJA1
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4,1,KDSR
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 5,1,KRT83
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 6,1,TRPM4
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 7,1,PERP
"ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO",1,ERBB3
ESOPHAGEAL CANCER,5,"LZTS1, DCC, WWOX, RNF6, TGFBR2"
ESTROGEN RESISTANCE,1,ESR1
EVEN-PLUS SYNDROME,1,HSPA9
EWING SARCOMA,1,EWSR1
"EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE",1,SLC25A32
EXFOLIATION SYNDROME,1,LOXL1
"EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS",1,COX4I2
"EXOSTOSES, MULTIPLE, TYPE I",1,EXT1
"EXOSTOSES, MULTIPLE, TYPE II",1,EXT2
EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY,1,SELENBP1
EXUDATIVE VITREORETINOPATHY 1,2,"LRP5, FZD4"
"EXUDATIVE VITREORETINOPATHY 2, X-LINKED",1,NDP
EXUDATIVE VITREORETINOPATHY 4,1,LRP5
EXUDATIVE VITREORETINOPATHY 5,1,TSPAN12
EXUDATIVE VITREORETINOPATHY 6,1,ZNF408
EXUDATIVE VITREORETINOPATHY 7,1,CTNNB1
FABRY DISEASE,1,GLA
"FACIAL CLEFTING, OBLIQUE, 1",1,SPECC1L
"FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME",1,KCNK4
"FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE",1,POLE
"FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS",1,ASPH
"FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION",1,TUBB6
"FACIAL PARESIS, HEREDITARY CONGENITAL, 3",1,HOXB1
FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1,1,FRG1
"FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC",1,SMCHD1
"FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 3, DIGENIC",1,LRIF1
"FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 4, DIGENIC",1,DNMT3B
"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1",1,LMAN1
"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2",1,MCFD2
FACTOR V DEFICIENCY,1,F5
FACTOR VII DEFICIENCY,1,F7
FACTOR X DEFICIENCY,1,F10
FACTOR XI DEFICIENCY,1,F11
FACTOR XII DEFICIENCY,1,F12
"FACTOR XIII, A SUBUNIT, DEFICIENCY OF",1,F13A1
"FACTOR XIII, B SUBUNIT, DEFICIENCY OF",1,F13B
"FAILURE OF TOOTH ERUPTION, PRIMARY",1,PTH1R
FAMILIAL ADENOMATOUS POLYPOSIS 1,1,APC
FAMILIAL ADENOMATOUS POLYPOSIS 2,1,MUTYH
FAMILIAL ADENOMATOUS POLYPOSIS 3,1,NTHL1
FAMILIAL ADENOMATOUS POLYPOSIS 4,1,MSH3
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1,1,NLRP3
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2,1,NLRP12
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3,1,PLCG2
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4,1,NLRC4
FAMILIAL EXPANSILE OSTEOLYSIS,1,TNFRSF11A
FAMILIAL MEDITERRANEAN FEVER,1,MEFV
"FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT",1,MEFV
"FANCONI ANEMIA, COMPLEMENTATION GROUP A",1,FANCA
"FANCONI ANEMIA, COMPLEMENTATION GROUP B",1,FANCB
"FANCONI ANEMIA, COMPLEMENTATION GROUP C",1,FANCC
"FANCONI ANEMIA, COMPLEMENTATION GROUP D1",1,BRCA2
"FANCONI ANEMIA, COMPLEMENTATION GROUP D2",1,FANCD2
"FANCONI ANEMIA, COMPLEMENTATION GROUP E",1,FANCE
"FANCONI ANEMIA, COMPLEMENTATION GROUP F",1,FANCF
"FANCONI ANEMIA, COMPLEMENTATION GROUP G",1,FANCG
"FANCONI ANEMIA, COMPLEMENTATION GROUP I",1,FANCI
"FANCONI ANEMIA, COMPLEMENTATION GROUP J",1,BRIP1
"FANCONI ANEMIA, COMPLEMENTATION GROUP L",1,FANCL
"FANCONI ANEMIA, COMPLEMENTATION GROUP N",1,PALB2
"FANCONI ANEMIA, COMPLEMENTATION GROUP O",1,RAD51C
"FANCONI ANEMIA, COMPLEMENTATION GROUP P",1,SLX4
"FANCONI ANEMIA, COMPLEMENTATION GROUP Q",1,ERCC4
"FANCONI ANEMIA, COMPLEMENTATION GROUP R",1,RAD51
"FANCONI ANEMIA, COMPLEMENTATION GROUP S",1,BRCA1
"FANCONI ANEMIA, COMPLEMENTATION GROUP T",1,UBE2T
"FANCONI ANEMIA, COMPLEMENTATION GROUP U",1,XRCC2
"FANCONI ANEMIA, COMPLEMENTATION GROUP V",1,MAD2L2
"FANCONI ANEMIA, COMPLEMENTATION GROUP W",1,RFWD3
FANCONI RENOTUBULAR SYNDROME 1,1,GATM
FANCONI RENOTUBULAR SYNDROME 2,1,SLC34A1
FANCONI RENOTUBULAR SYNDROME 3,1,EHHADH
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG,1,HNF4A
FANCONI RENOTUBULAR SYNDROME 5,1,NDUFAF6
FANCONI-BICKEL SYNDROME,1,SLC2A2
FARBER LIPOGRANULOMATOSIS,1,ASAH1
FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5,1,GCKR
FATAL FAMILIAL INSOMNIA,1,PRNP
FAUNDES-BANKA SYNDROME,1,EIF5A
FAZIO-LONDE DISEASE,1,SLC52A3
"FEBRILE SEIZURES, FAMILIAL, 11",1,CPA6
"FEBRILE SEIZURES, FAMILIAL, 4",1,ADGRV1
"FEBRILE SEIZURES, FAMILIAL, 8",1,GABRG2
FEINGOLD SYNDROME 1,1,MYCN
FERGUSON-BONNI NEURODEVELOPMENTAL SYNDROME,1,ANAPC7
FETAL AKINESIA DEFORMATION SEQUENCE 1,1,MUSK
FETAL AKINESIA DEFORMATION SEQUENCE 2,1,RAPSN
FETAL AKINESIA DEFORMATION SEQUENCE 3,1,DOK7
FETAL AKINESIA DEFORMATION SEQUENCE 4,1,NUP88
"FETAL AKINESIA, RESPIRATORY INSUFFICIENCY, MICROCEPHALY, POLYMICROGYRIA, AND DYSMORPHIC FACIES",1,ATP1A2
FETAL ENCASEMENT SYNDROME,1,CHUK
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1,3,"HBB, HBG1, HBG2"
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6,1,KLF1
FG SYNDROME 2,1,FLNA
FG SYNDROME 4,1,CASK
FIBROCHONDROGENESIS 1,1,COL11A1
FIBROCHONDROGENESIS 2,1,COL11A2
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA,1,ACVR1
"FIBROMATOSIS, GINGIVAL, 1",1,SOS1
"FIBROMATOSIS, GINGIVAL, 5",1,REST
"FIBROMUSCULAR DYSPLASIA, MULTIFOCAL",1,COL5A1
"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1",1,KIF21A
"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2",1,PHOX2A
"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT",1,TUBB3
"FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS",1,NHLRC2
"FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY",1,WNT7A
FILIPPI SYNDROME,1,CKAP2L
FISH-EYE DISEASE,1,LCAT
"FLECK RETINA, FAMILIAL BENIGN",1,PLA2G5
FLOATING-HARBOR SYNDROME,1,SRCAP
"FOCAL CORTICAL DYSPLASIA, TYPE II",3,"MTOR, TSC1, TSC2"
FOCAL DERMAL HYPOPLASIA,1,PORCN
"FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE",1,TWIST2
FOCAL FACIAL DERMAL DYSPLASIA 4,1,CYP26C1
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1,1,ACTN4
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 10,1,LMX1B
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2,1,TRPC6
"FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO",1,CD2AP
"FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO",1,APOL1
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5,1,INF2
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6,1,MYO1E
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7,1,PAX2
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8,1,ANLN
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9,1,CRB2
FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND NEURODEVELOPMENTAL SYNDROME,1,TRIM8
"FOLATE MALABSORPTION, HEREDITARY",1,SLC46A1
FONTAINE PROGEROID SYNDROME,1,SLC25A24
FOVEAL HYPOPLASIA 1,1,PAX6
FOVEAL HYPOPLASIA 2,1,SLC38A8
FRAGILE X SYNDROME,1,FMR1
FRAGILE X TREMOR/ATAXIA SYNDROME,1,FMR1
FRANK-TER HAAR SYNDROME,1,SH3PXD2B
FRASER SYNDROME 1,1,FRAS1
FRASER SYNDROME 2,1,FREM2
FRASER SYNDROME 3,1,GRIP1
FRASIER SYNDROME,1,WT1
FRIEDREICH ATAXIA,1,FXN
FRONTOMETAPHYSEAL DYSPLASIA 1,1,FLNA
FRONTOMETAPHYSEAL DYSPLASIA 2,1,MAP3K7
FRONTONASAL DYSPLASIA 1,1,ALX3
FRONTONASAL DYSPLASIA 2,1,ALX4
FRONTONASAL DYSPLASIA 3,1,ALX1
FRONTOTEMPORAL DEMENTIA,2,"MAPT, PSEN1"
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1,1,C9orf72
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2,1,CHCHD10
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3,1,SQSTM1
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4,1,TBK1
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 5,1,CCNF
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 6,1,VCP
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 7,1,CHMP2B
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 8,1,CYLD
"FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED",1,GRN
"FRUCTOSE INTOLERANCE, HEREDITARY",1,ALDOB
"FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY",1,FBP1
"FRUCTOSURIA, ESSENTIAL",1,KHK
FUCOSIDOSIS,1,FUCA1
FUCOSYLTRANSFERASE 6 DEFICIENCY,1,FUT6
FUMARASE DEFICIENCY,1,FH
FUNDUS ALBIPUNCTATUS,4,"RDH5, PRPH2, RHO, RLBP1"
GABA-TRANSAMINASE DEFICIENCY,1,ABAT
GABRIELE-DE VRIES SYNDROME,1,YY1
GALACTOSEMIA I,1,GALT
GALACTOSEMIA II,1,GALK1
GALACTOSEMIA III,1,GALE
GALACTOSEMIA IV,1,GALM
GALACTOSIALIDOSIS,1,CTSA
GALLBLADDER DISEASE 1,1,ABCB4
GALLBLADDER DISEASE 4,1,ABCG8
GALLOWAY-MOWAT SYNDROME 1,1,WDR73
GALLOWAY-MOWAT SYNDROME 10,1,YRDC
"GALLOWAY-MOWAT SYNDROME 2, X-LINKED",1,LAGE3
GALLOWAY-MOWAT SYNDROME 3,1,OSGEP
GALLOWAY-MOWAT SYNDROME 4,1,TP53RK
GALLOWAY-MOWAT SYNDROME 5,1,TPRKB
GALLOWAY-MOWAT SYNDROME 6,1,WDR4
GALLOWAY-MOWAT SYNDROME 7,1,NUP107
GALLOWAY-MOWAT SYNDROME 8,1,NUP133
GALLOWAY-MOWAT SYNDROME 9,1,GON7
"GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO",1,GCLC
GAND SYNDROME,1,GATAD2B
GAPO SYNDROME,1,ANTXR1
GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH,1,APC
GASTRIC CANCER,11,"KLF6, ERBB2, FGFR2, APC, IL1B, IL1RN, IRF1, KRAS, MUTYH, PIK3CA, CASP10"
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 1,1,TTC7A
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 2,1,PI4KA
GASTROINTESTINAL STROMAL TUMOR,3,"KIT, SDHB, SDHC"
"GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS",1,PLA2G4A
"GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY",1,PSAP
"GAUCHER DISEASE, PERINATAL LETHAL",1,GBA
"GAUCHER DISEASE, TYPE I",1,GBA
"GAUCHER DISEASE, TYPE II",1,GBA
"GAUCHER DISEASE, TYPE III",1,GBA
"GAUCHER DISEASE, TYPE IIIC",1,GBA
"GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 1",1,ROBO3
"GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT",1,DCC
GELEOPHYSIC DYSPLASIA 1,1,ADAMTSL2
GELEOPHYSIC DYSPLASIA 2,1,FBN1
GELEOPHYSIC DYSPLASIA 3,1,LTBP3
"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1",1,SCN1B
"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10",1,HCN1
"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2",1,SCN1A
"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7",1,SCN9A
"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9",1,STX1B
GENITOPATELLAR SYNDROME,1,KAT6B
GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME,1,PPP1R12A
GERODERMA OSTEODYSPLASTICUM,1,GORAB
GERSTMANN-STRAUSSLER DISEASE,1,PRNP
GHOSAL HEMATODIAPHYSEAL DYSPLASIA,1,TBXAS1
"GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE",1,GAN
"GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT",1,DCAF8
GIL BLOOD GROUP,1,AQP3
GILBERT SYNDROME,1,UGT1A1
GILLES DE LA TOURETTE SYNDROME,2,"SLITRK1, HDC"
GILLESPIE SYNDROME,1,ITPR1
GILLESSEN-KAESBACH-NISHIMURA SYNDROME,1,ALG9
GIST-PLUS SYNDROME,1,PDGFRA
GITELMAN SYNDROME,1,SLC12A3
GLANZMANN THROMBASTHENIA 1,2,"ITGA2B, ITGB3"
GLANZMANN THROMBASTHENIA 2,1,ITGB3
GLASS SYNDROME,1,SATB2
"GLAUCOMA 1, OPEN ANGLE, A",1,MYOC
"GLAUCOMA 1, OPEN ANGLE, F",1,ASB10
"GLAUCOMA 1, OPEN ANGLE, G",1,WDR36
"GLAUCOMA 1, OPEN ANGLE, O",1,NTF4
"GLAUCOMA 3, PRIMARY CONGENITAL, A",1,CYP1B1
"GLAUCOMA 3, PRIMARY CONGENITAL, D",1,LTBP2
"GLAUCOMA 3, PRIMARY CONGENITAL, E",1,TEK
"GLAUCOMA 3, PRIMARY INFANTILE, B",3,"CYP1B1, LTBP2, TEK"
"GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO",2,"OPTN, OPA1"
"GLAUCOMA, PRIMARY CLOSED-ANGLE",1,COL18A1
"GLAUCOMA, PRIMARY OPEN ANGLE",1,OPTN
GLIOMA SUSCEPTIBILITY 1,3,"ERBB2, IDH1, TP53"
GLIOMA SUSCEPTIBILITY 2,1,PTEN
GLIOMA SUSCEPTIBILITY 3,1,BRCA2
GLIOMA SUSCEPTIBILITY 9,1,POT1
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT,1,CUX1
GLOBAL DEVELOPMENTAL DELAY WITH SPEECH AND BEHAVIORAL ABNORMALITIES,1,TNRC6B
"GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES",1,ZNF148
"GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR",1,DICER1
"GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE",1,GLS
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2,1,FN1
GLOMUVENOUS MALFORMATIONS,1,GLMN
GLUCOCORTICOID DEFICIENCY 1,1,MC2R
GLUCOCORTICOID DEFICIENCY 2,1,MRAP
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY,1,NNT
GLUCOCORTICOID DEFICIENCY 5,1,TXNRD2
"GLUCOCORTICOID RESISTANCE, GENERALIZED",1,NR3C1
"GLUCOCORTICOID THERAPY, RESPONSE TO",1,GLCCI1
GLUCOSE/GALACTOSE MALABSORPTION,1,SLC5A1
GLUT1 DEFICIENCY SYNDROME 1,1,SLC2A1
GLUT1 DEFICIENCY SYNDROME 2,1,SLC2A1
GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY,1,FTCD
"GLUTAMINE DEFICIENCY, CONGENITAL",1,GLUL
GLUTARIC ACIDEMIA I,1,GCDH
GLUTARIC ACIDURIA III,1,SUGCT
GLUTATHIONE PEROXIDASE DEFICIENCY,1,GPX1
GLUTATHIONE SYNTHETASE DEFICIENCY,1,GSS
"GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO",1,GSS
GLUTATHIONURIA,1,GGT1
GLYCEROL KINASE DEFICIENCY,1,GK
GLYCEROL QUANTITATIVE TRAIT LOCUS,1,AQP7
GLYCINE ENCEPHALOPATHY,3,"GCSH, GLDC, AMT"
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE,1,SLC6A9
GLYCINE N-METHYLTRANSFERASE DEFICIENCY,1,GNMT
"GLYCOGEN STORAGE DISEASE 0, LIVER",1,GYS2
"GLYCOGEN STORAGE DISEASE 0, MUSCLE",1,GYS1
GLYCOGEN STORAGE DISEASE II,1,GAA
GLYCOGEN STORAGE DISEASE III,1,AGL
GLYCOGEN STORAGE DISEASE IV,1,GBE1
GLYCOGEN STORAGE DISEASE IXa1,1,PHKA2
GLYCOGEN STORAGE DISEASE IXb,1,PHKB
GLYCOGEN STORAGE DISEASE IXc,1,PHKG2
GLYCOGEN STORAGE DISEASE Ia,1,G6PC1
GLYCOGEN STORAGE DISEASE Ib,1,SLC37A4
GLYCOGEN STORAGE DISEASE Ic,1,SLC37A4
"GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL",1,PRKAG2
GLYCOGEN STORAGE DISEASE V,1,PYGM
GLYCOGEN STORAGE DISEASE VI,1,PYGL
GLYCOGEN STORAGE DISEASE VII,1,PFKM
GLYCOGEN STORAGE DISEASE X,1,PGAM2
GLYCOGEN STORAGE DISEASE XI,1,LDHA
GLYCOGEN STORAGE DISEASE XII,1,ALDOA
GLYCOGEN STORAGE DISEASE XIII,1,ENO3
GLYCOGEN STORAGE DISEASE XV,1,GYG1
"GLYCOGEN STORAGE DISEASE, TYPE IXd",1,PHKA1
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1,1,PIGM
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11,1,PIGW
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15,1,GPAA1
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16,1,PIGC
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17,1,PIGH
"GM1-GANGLIOSIDOSIS, TYPE I",1,GLB1
"GM1-GANGLIOSIDOSIS, TYPE II",1,GLB1
"GM1-GANGLIOSIDOSIS, TYPE III",1,GLB1
"GM2-GANGLIOSIDOSIS, AB VARIANT",1,GM2A
GNATHODIAPHYSEAL DYSPLASIA,1,ANO5
"GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS",1,DICER1
GOLDBERG-SHPRINTZEN SYNDROME,1,KIFBP
"GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY",1,PPP2R3C
GORDON HOLMES SYNDROME,1,RNF216
GRACILE BONE DYSPLASIA,1,FAM111A
GRACILE SYNDROME,1,BCS1L
GRANGE SYNDROME,1,YY1AP1
"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 1",1,NCF1
"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2",1,NCF2
"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 3",1,NCF4
"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4",1,CYBA
"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 5",1,CYBC1
"GRANULOMATOUS DISEASE, CHRONIC, X-LINKED",1,CYBB
GRAY PLATELET SYNDROME,1,NBEAL2
GREENBERG DYSPLASIA,1,LBR
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME,1,GLI3
"GRISCELLI SYNDROME, TYPE 1",1,MYO5A
"GRISCELLI SYNDROME, TYPE 2",1,RAB27A
"GRISCELLI SYNDROME, TYPE 3",1,MLPH
"GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL",1,GHSR
"GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 1, AUTOSOMAL RECESSIVE",1,STAT5B
"GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 2, AUTOSOMAL DOMINANT",1,STAT5B
"GROWTH HORMONE INSENSITIVITY, PARTIAL",1,GHR
"GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES",1,ZPR1
"GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM",1,FTO
"GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY",1,IARS1
"GUILLAIN-BARRE SYNDROME, FAMILIAL",1,PMP22
GYRATE ATROPHY OF CHOROID AND RETINA,1,OAT
HAIM-MUNK SYNDROME,1,CTSC
HAIR MORPHOLOGY 1,1,EDAR
HALPERIN-BIRK SYNDROME,1,SEC31A
HAMAMY SYNDROME,1,IRX5
HAND-FOOT-GENITAL SYNDROME,1,HOXA13
HAO-FOUNTAIN SYNDROME,1,USP7
HARDEROPORPHYRIA,1,CPOX
HARDIKAR SYNDROME,1,MED12
HAREL-YOON SYNDROME,1,ATAD3A
HARTNUP DISORDER,1,SLC6A19
HARTSFIELD SYNDROME,1,FGFR1
HASHIMOTO THYROIDITIS,1,CTLA4
HAWKINSINURIA,1,HPD
HEART AND BRAIN MALFORMATION SYNDROME,1,SMG9
"HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES",1,GATA6
"HEART-HAND SYNDROME, SLOVENIAN TYPE",1,LMNA
HEIMLER SYNDROME 1,1,PEX1
HEIMLER SYNDROME 2,1,PEX6
HEINZ BODY ANEMIAS,2,"HBA1, HBB"
"HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO",1,IFNGR1
HELIX SYNDROME,1,CLDN10
HELSMOORTEL-VAN DER AA SYNDROME,1,ADNP
"HEMANGIOMA, CAPILLARY INFANTILE",3,"FLT4, KDR, ANTXR1"
"HEMATURIA, BENIGN FAMILIAL",2,"COL4A3, COL4A4"
HEME OXYGENASE 1 DEFICIENCY,1,HMOX1
"HEMOCHROMATOSIS, TYPE 1",2,"HFE, BMP2"
"HEMOCHROMATOSIS, TYPE 2A",1,HJV
"HEMOCHROMATOSIS, TYPE 2B",1,HAMP
"HEMOCHROMATOSIS, TYPE 3",1,TFR2
"HEMOCHROMATOSIS, TYPE 4",1,SLC40A1
"HEMOCHROMATOSIS, TYPE 5",1,FTH1
HEMOGLOBIN H DISEASE,1,HBA1
"HEMOGLOBIN, HIGH ALTITUDE ADAPTATION",1,EGLN1
HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY,1,GSR
"HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY",1,CD59
"HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED",1,ATP11C
"HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY",1,GPI
"HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY",1,HK1
"HEMOLYTIC DISEASE OF FETUS AND NEWBORN, RH-INDUCED",1,RHD
"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1",2,"CFH, CFHR1"
"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2",1,CD46
"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3",1,CFI
"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4",1,CFB
"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5",1,C3
"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6",1,THBD
"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2",1,PRF1
"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3",1,UNC13D
"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4",1,STX11
"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITH OR WITHOUT MICROVILLUS INCLUSION DISEASE",1,STXBP2
HEMOPHILIA A,1,F8
HEMOPHILIA B,1,F9
"HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO",3,"COL4A1, COL4A2, ACE"
"HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS",1,JAM3
HENGEL-MAROOFIAN-SCHOLS SYNDROME,1,BCAS3
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1,1,CCBE1
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2,1,FAT4
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3,1,ADAMTS3
HEPARIN COFACTOR II DEFICIENCY,1,SERPIND1
"HEPATIC ADENOMAS, FAMILIAL",1,HNF1A
HEPATIC LIPASE DEFICIENCY,1,LIPC
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY,1,SP110
"HEPATITIS B VIRUS, SUSCEPTIBILITY TO",3,"IFNAR2, IFNGR1, IL10RB"
"HEPATITIS C VIRUS, SUSCEPTIBILITY TO",4,"CCR5, IFNL3, IFNG, PTPRC"
"HEPATITIS, FULMINANT VIRAL, SUSCEPTIBILITY TO",1,IL18BP
HEPATOCELLULAR CARCINOMA,9,"CTNNB1, APC, IGF2R, MET, PDGFRL, PIK3CA, TP53, AXIN1, CASP8"
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER,1,FH
"HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC",1,TRPV4
HERMANSKY-PUDLAK SYNDROME 1,1,HPS1
HERMANSKY-PUDLAK SYNDROME 10,1,AP3D1
HERMANSKY-PUDLAK SYNDROME 11,1,BLOC1S5
HERMANSKY-PUDLAK SYNDROME 2,1,AP3B1
HERMANSKY-PUDLAK SYNDROME 3,1,HPS3
HERMANSKY-PUDLAK SYNDROME 4,1,HPS4
HERMANSKY-PUDLAK SYNDROME 5,1,HPS5
HERMANSKY-PUDLAK SYNDROME 6,1,HPS6
HERMANSKY-PUDLAK SYNDROME 7,1,DTNBP1
HERMANSKY-PUDLAK SYNDROME 8,1,BLOC1S3
HERMANSKY-PUDLAK SYNDROME 9,1,BLOC1S6
"HETEROTAXY, VISCERAL, 1, X-LINKED",1,ZIC3
"HETEROTAXY, VISCERAL, 10, AUTOSOMAL, WITH MALE INFERTILITY",1,CFAP52
"HETEROTAXY, VISCERAL, 11, AUTOSOMAL, WITH MALE INFERTILITY",1,CFAP45
"HETEROTAXY, VISCERAL, 12, AUTOSOMAL",1,CIROP
"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",1,CFC1
"HETEROTAXY, VISCERAL, 4, AUTOSOMAL",1,ACVR2B
"HETEROTAXY, VISCERAL, 5, AUTOSOMAL",1,NODAL
"HETEROTAXY, VISCERAL, 6, AUTOSOMAL",1,CFAP53
"HETEROTAXY, VISCERAL, 7, AUTOSOMAL",1,MMP21
"HETEROTAXY, VISCERAL, 8, AUTOSOMAL",1,PKD1L1
"HETEROTAXY, VISCERAL, 9, AUTOSOMAL, WITH MALE INFERTILITY",1,MNS1
HEYN-SPROUL-JACKSON SYNDROME,1,DNMT3A
HIATT-NEU-COOPER NEURODEVELOPMENTAL SYNDROME,1,RALA
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12,1,LIPC
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6,1,SCARB1
HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY,1,KNG1
"HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION",1,ECE1
"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1",1,RET
"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2",1,EDNRB
"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3",1,GDNF
"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4",1,EDN3
HISTIDINEMIA,1,HAL
"HISTIOCYTOMA, ANGIOMATOID FIBROUS",1,CREB1
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME,1,SLC29A3
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY,1,HLCS
HOLOPROSENCEPHALY 11,1,CDON
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS,1,CNOT1
"HOLOPROSENCEPHALY 13, X-LINKED",1,STAG2
HOLOPROSENCEPHALY 2,1,SIX3
HOLOPROSENCEPHALY 3,1,SHH
HOLOPROSENCEPHALY 4,1,TGIF1
HOLOPROSENCEPHALY 5,1,ZIC2
HOLOPROSENCEPHALY 7,1,PTCH1
HOLOPROSENCEPHALY 9,1,GLI2
HOLT-ORAM SYNDROME,1,TBX5
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY,1,CBS
"HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY",1,MTHFR
"HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE",1,MTRR
"HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE",1,MTR
HSD10 MITOCHONDRIAL DISEASE,1,HSD17B10
"HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO",14,"CX3CR1, CD209, HLA-C, IFNG, IL4R, CXCR1, KIR3DL1, CCL2, CCL3, CCL3L1, CCL5, CCL11, CXCL12, TLR3"
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY,1,RSPO2
HUNTINGTON DISEASE,1,HTT
HUNTINGTON DISEASE-LIKE 1,1,PRNP
HUNTINGTON DISEASE-LIKE 2,1,JPH3
HURIEZ SYNDROME,1,SMARCAD1
HURLER SYNDROME,1,IDUA
HURLER-SCHEIE SYNDROME,1,IDUA
HUTCHINSON-GILFORD PROGERIA SYNDROME,1,LMNA
HYALINE FIBROMATOSIS SYNDROME,1,ANTXR2
"HYDATIDIFORM MOLE, RECURRENT, 1",1,NLRP7
"HYDATIDIFORM MOLE, RECURRENT, 2",1,KHDC3L
"HYDATIDIFORM MOLE, RECURRENT, 3",1,MEI1
"HYDATIDIFORM MOLE, RECURRENT, 4",1,C11orf80
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS,1,L1CAM
"HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1",1,TRIM71
"HYDROCEPHALUS, CONGENITAL, 1",1,CCDC88C
"HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES",1,MPDZ
"HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES",1,WDR81
"HYDROCEPHALUS, NORMAL-PRESSURE, 1",1,CFAP43
HYDROLETHALUS SYNDROME 1,1,HYLS1
HYDROLETHALUS SYNDROME 2,1,KIF7
"HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA",1,LARS2
HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY,1,HAGH
HYDROXYKYNURENINURIA,1,KYNU
HYPER-IgD SYNDROME,1,MVK
"HYPER-IgE RECURRENT INFECTION SYNDROME 1, AUTOSOMAL DOMINANT",1,STAT3
"HYPER-IgE RECURRENT INFECTION SYNDROME 2, AUTOSOMAL RECESSIVE",1,DOCK8
"HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE",1,ZNF341
"HYPER-IgE RECURRENT INFECTION SYNDROME 4, AUTOSOMAL RECESSIVE",1,IL6ST
"HYPER-IgE RECURRENT INFECTION SYNDROME 5, AUTOSOMAL RECESSIVE",1,IL6R
"HYPERALDOSTERONISM, FAMILIAL, TYPE I",1,CYP11B1
"HYPERALDOSTERONISM, FAMILIAL, TYPE II",1,CLCN2
"HYPERALDOSTERONISM, FAMILIAL, TYPE III",1,KCNJ5
"HYPERALDOSTERONISM, FAMILIAL, TYPE IV",1,CACNA1H
HYPERALPHALIPOPROTEINEMIA 1,1,CETP
"HYPERBILIRUBINEMIA, ROTOR TYPE",2,"SLCO1B1, SLCO1B3"
"HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL",1,UGT1A1
HYPERBILIVERDINEMIA,1,BLVRA
"HYPERCALCEMIA, INFANTILE, 1",1,CYP24A1
"HYPERCALCEMIA, INFANTILE, 2",1,SLC34A1
"HYPERCALCIURIA, ABSORPTIVE, 2",1,ADCY10
"HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT",1,BCO1
"HYPERCHLORHIDROSIS, ISOLATED",1,CA12
"HYPERCHOLANEMIA, FAMILIAL 1",3,"EPHX1, BAAT, TJP2"
"HYPERCHOLANEMIA, FAMILIAL, 2",1,SLC10A1
"HYPERCHOLESTEROLEMIA, FAMILIAL, 1",5,"PPP1R17, EPHX2, GHR, APOA2, LDLR"
"HYPERCHOLESTEROLEMIA, FAMILIAL, 2",1,APOB
"HYPERCHOLESTEROLEMIA, FAMILIAL, 3",1,PCSK9
"HYPERCHOLESTEROLEMIA, FAMILIAL, 4",1,LDLRAP1
HYPEREKPLEXIA 1,2,"GPHN, GLRA1"
HYPEREKPLEXIA 2,1,GLRB
HYPEREKPLEXIA 3,1,SLC6A5
HYPEREKPLEXIA 4,1,ATAD1
"HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC",1,PDGFRA
HYPERFERRITINEMIA WITH OR WITHOUT CATARACT,1,FTL
"HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES",1,LIAS
HYPERGLYCINURIA,3,"SLC36A2, SLC6A19, SLC6A20"
"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1",1,ABCC8
"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2",1,KCNJ11
"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3",1,GCK
"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4",1,HADH
"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5",1,INSR
"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6",1,GLUD1
"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7",1,SLC16A1
HYPERKALEMIC PERIODIC PARALYSIS,1,SCN4A
"HYPERLIPIDEMIA, FAMILIAL COMBINED, 1",1,USF1
"HYPERLIPIDEMIA, FAMILIAL COMBINED, 3",1,LPL
"HYPERLIPOPROTEINEMIA, TYPE I",1,LPL
"HYPERLIPOPROTEINEMIA, TYPE ID",1,GPIHBP1
"HYPERLIPOPROTEINEMIA, TYPE III",1,APOE
"HYPERLIPOPROTEINEMIA, TYPE V",1,APOA5
"HYPERLYSINEMIA, TYPE I",1,AASS
HYPERMANGANESEMIA WITH DYSTONIA 1,1,SLC30A10
HYPERMANGANESEMIA WITH DYSTONIA 2,1,SLC39A14
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY,1,ADK
HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY,1,AHCY
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME,1,SLC25A15
HYPEROSTOSIS CRANIALIS INTERNA,1,SLC39A14
"HYPEROXALURIA, PRIMARY, TYPE I",1,AGXT
"HYPEROXALURIA, PRIMARY, TYPE II",1,GRHPR
"HYPEROXALURIA, PRIMARY, TYPE III",1,HOGA1
HYPERPARATHYROIDISM 1,1,CDC73
HYPERPARATHYROIDISM 2 WITH JAW TUMORS,1,CDC73
HYPERPARATHYROIDISM 4,1,GCM2
"HYPERPARATHYROIDISM, NEONATAL SEVERE",1,CASR
"HYPERPARATHYROIDISM, TRANSIENT NEONATAL",1,TRPV6
"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A",1,PTS
"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B",1,GCH1
"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C",1,QDPR
"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D",1,PCBD1
"HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT",1,DNAJC12
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1,1,PIGV
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2,1,PIGO
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3,1,PGAP2
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4,1,PGAP3
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6,1,PIGY
"HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE",1,KITLG
HYPERPROINSULINEMIA,1,INS
HYPERPROLACTINEMIA,1,PRLR
"HYPERPROLINEMIA, TYPE I",1,PRODH
"HYPERPROLINEMIA, TYPE II",1,ALDH4A1
HYPERTENSION AND BRACHYDACTYLY SYNDROME,1,PDE3A
"HYPERTENSION, DIASTOLIC, RESISTANCE TO",1,KCNMB1
"HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY",1,NR3C2
"HYPERTENSION, ESSENTIAL",10,"ADD1, CYP3A5, AGT, AGTR1, ECE1, GNB3, ATP1B1, NOS3, PTGIS, RGS5"
"HYPERTHYROIDISM, FAMILIAL GESTATIONAL",1,TSHR
"HYPERTHYROIDISM, NONAUTOIMMUNE",1,TSHR
"HYPERTHYROXINEMIA, DYSTRANSTHYRETINEMIC",1,TTR
"HYPERTHYROXINEMIA, FAMILIAL DYSALBUMINEMIC",1,ALB
"HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA",1,ABCA5
HYPERTRIGLYCERIDEMIA 1,1,APOA5
HYPERTRIGLYCERIDEMIA 2,1,CREB3L3
"HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE",1,GPD1
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS,4,"EGR2, MPZ, PMP22, PRX"
"HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT",1,SLCO2A1
"HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1",1,HPGD
"HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2",1,SLCO2A1
HYPERTRYPTOPHANEMIA,1,TDO2
"HYPERURICEMIA, HPRT-RELATED",1,HPRT1
"HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME",1,SARS2
HYPERVALINEMIA AND HYPERLEUCINE-ISOLEUCINEMIA,1,BCAT2
"HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1",1,ABCA1
"HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2",1,APOA1
"HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1",1,APOB
"HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2",1,ANGPTL3
"HYPOCALCEMIA, AUTOSOMAL DOMINANT 1",1,CASR
"HYPOCALCEMIA, AUTOSOMAL DOMINANT 2",1,GNA11
"HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I",1,CASR
"HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II",1,GNA11
"HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III",1,AP2S1
HYPOCHONDROPLASIA,1,FGFR3
"HYPOGLYCEMIA, LEUCINE-INDUCED",1,ABCC8
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA,1,ANOS1
HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA,1,TAC3
HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA,1,TACR3
HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA,1,GNRH1
HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA,1,KISS1
HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA,1,WDR11
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA,1,HS6ST1
HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA,1,SEMA3A
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA,1,SPRY4
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA,1,IL17RD
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA,1,DUSP6
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA,1,FGFR1
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA,1,FGF17
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA,1,FLRT3
HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA,1,FEZF1
HYPOGONADOTROPIC HYPOGONADISM 23 WITH OR WITHOUT ANOSMIA,1,LHB
HYPOGONADOTROPIC HYPOGONADISM 24 WITH OR WITHOUT ANOSMIA,1,FSHB
HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA,1,NDNF
HYPOGONADOTROPIC HYPOGONADISM 26 WITH OR WITHOUT ANOSMIA,1,TCF12
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA,1,PROKR2
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA,1,PROK2
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA,1,CHD7
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA,1,FGF8
HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA,11,"SRA1, DUSP6, GNRH1, GNRHR, CCDC141, FEZF1, WDR11, AXL, SPRY4, FGF17, SEMA3E"
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA,1,KISS1R
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA,1,NSMF
HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY,1,AKT2
"HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1",2,"SCN4A, CACNA1S"
"HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2",1,SCN4A
HYPOKALEMIC TUBULOPATHY AND DEAFNESS,1,KCNJ16
"HYPOMAGNESEMIA 1, INTESTINAL",1,TRPM6
"HYPOMAGNESEMIA 2, RENAL",1,FXYD2
"HYPOMAGNESEMIA 3, RENAL",1,CLDN16
"HYPOMAGNESEMIA 4, RENAL",1,EGF
"HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT",1,CLDN19
"HYPOMAGNESEMIA 6, RENAL",1,CNNM2
"HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 1",1,CNNM2
"HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2",1,ATP1A1
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY,1,DARS1
"HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 1",1,PTH
"HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2",1,GCM2
"HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME",1,GATA3
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME,1,TBCE
"HYPOPHOSPHATASIA, ADULT",1,ALPL
"HYPOPHOSPHATASIA, CHILDHOOD",1,ALPL
"HYPOPHOSPHATASIA, INFANTILE",1,ALPL
"HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY",1,SLC34A3
"HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT",1,FGF23
"HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1",1,DMP1
"HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2",1,ENPP1
"HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT",1,PHEX
"HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE",1,CLCN5
"HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT",1,CLCN7
HYPOPLASTIC LEFT HEART SYNDROME 1,1,GJA1
HYPOPLASTIC LEFT HEART SYNDROME 2,1,NKX2-5
"HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION",1,PANK2
"HYPOSPADIAS 1, X-LINKED",1,AR
"HYPOSPADIAS 2, X-LINKED",1,MAMLD1
HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY,1,SLC6A6
"HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT",1,IGSF1
"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1",1,TSHR
"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2",1,PAX8
"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4",1,TSHB
"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5",1,NKX2-5
"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6",1,THRA
"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7",1,TRHR
"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8",1,TBL1X
"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9",1,IRS4
"HYPOTHYROIDISM, THYROIDAL OR ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE",1,FOXE1
"HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME",1,EBF3
"HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME",1,CTBP1
"HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES",1,P4HTM
"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION",1,CCDC174
"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1",1,NALCN
"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2",1,UNC80
"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3",1,TBCK
HYPOTRICHOSIS 1,1,APCDD1
HYPOTRICHOSIS 11,1,SNRPE
HYPOTRICHOSIS 12,1,RPL21
HYPOTRICHOSIS 13,1,KRT71
HYPOTRICHOSIS 14,1,LSS
HYPOTRICHOSIS 2,1,CDSN
HYPOTRICHOSIS 3,1,KRT74
HYPOTRICHOSIS 4,1,HR
HYPOTRICHOSIS 5,1,EPS8L3
HYPOTRICHOSIS 6,1,DSG4
HYPOTRICHOSIS 7,1,LIPH
HYPOTRICHOSIS 8,1,LPAR6
HYPOTRICHOSIS AND RECURRENT SKIN VESICLES,1,DSC3
"HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY",1,CDH3
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME,1,SOX18
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME,1,SOX18
"HYPOURICEMIA, RENAL, 1",1,SLC22A12
"HYPOURICEMIA, RENAL, 2",1,SLC2A9
ICHTHYOSIS BULLOSA OF SIEMENS,1,KRT2
"ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE",1,KRT1
ICHTHYOSIS PREMATURITY SYNDROME,1,SLC27A4
ICHTHYOSIS WITH CONFETTI,1,KRT10
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1",1,TGM1
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10",1,PNPLA1
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11",1,ST14
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12",1,CASP14
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13",1,SDR9C7
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14",1,SULT2B1
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2",2,"ALOX12B, ALOXE3"
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3",1,ALOXE3
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A",1,ABCA12
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B",1,ABCA12
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5",1,CYP4F22
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6",1,NIPAL4
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8",1,LIPN
"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9",1,CERS3
"ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS",2,"KRT1, KRT10"
"ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS",1,GJB2
"ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT",1,ASPRV1
"ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS",1,CLDN1
"ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION",1,ELOVL4
"ICHTHYOSIS, X-LINKED",1,STS
"ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES",1,ELOVL1
"IFAP SYNDROME 1, WITH OR WITHOUT BRESHECK SYNDROME",1,MBTPS2
IFAP SYNDROME 2,1,SREBF1
IMAGAWA-MATSUMOTO SYNDROME,1,SUZ12
IMERSLUND-GRASBECK SYNDROME 1,1,CUBN
IMERSLUND-GRASBECK SYNDROME 2,1,AMN
IMINOGLYCINURIA,3,"SLC36A2, SLC6A19, SLC6A20"
IMMUNE DYSREGULATION AND SYSTEMIC HYPERINFLAMMATION SYNDROME,1,RC3H1
"IMMUNE DYSREGULATION WITH AUTOIMMUNITY, IMMUNODEFICIENCY, AND LYMPHOPROLIFERATION",1,CTLA4
IMMUNODEFICIENCY 10,1,STIM1
IMMUNODEFICIENCY 11,1,CARD11
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS,1,CARD11
IMMUNODEFICIENCY 12,1,MALT1
IMMUNODEFICIENCY 13,1,UNC119
"IMMUNODEFICIENCY 14A, AUTOSOMAL DOMINANT",1,PIK3CD
"IMMUNODEFICIENCY 14B, AUTOSOMAL RECESSIVE",1,PIK3CD
IMMUNODEFICIENCY 15A,1,IKBKB
IMMUNODEFICIENCY 15B,1,IKBKB
IMMUNODEFICIENCY 16,1,TNFRSF4
IMMUNODEFICIENCY 17,1,CD3G
IMMUNODEFICIENCY 18,1,CD3E
IMMUNODEFICIENCY 19,1,CD3D
IMMUNODEFICIENCY 20,1,FCGR3A
IMMUNODEFICIENCY 21,1,GATA2
IMMUNODEFICIENCY 22,1,LCK
IMMUNODEFICIENCY 23,1,PGM3
IMMUNODEFICIENCY 24,1,CTPS1
IMMUNODEFICIENCY 25,1,CD247
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES,1,PRKDC
IMMUNODEFICIENCY 27A,1,IFNGR1
IMMUNODEFICIENCY 27B,1,IFNGR1
IMMUNODEFICIENCY 28,1,IFNGR2
IMMUNODEFICIENCY 29,1,IL12B
IMMUNODEFICIENCY 30,1,IL12RB1
IMMUNODEFICIENCY 31A,1,STAT1
IMMUNODEFICIENCY 31B,1,STAT1
IMMUNODEFICIENCY 31C,1,STAT1
IMMUNODEFICIENCY 32A,1,IRF8
IMMUNODEFICIENCY 32B,1,IRF8
IMMUNODEFICIENCY 33,1,IKBKG
IMMUNODEFICIENCY 34,1,CYBB
IMMUNODEFICIENCY 35,1,TYK2
IMMUNODEFICIENCY 36,1,PIK3R1
IMMUNODEFICIENCY 37,1,BCL10
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION,1,ISG15
IMMUNODEFICIENCY 39,1,IRF7
IMMUNODEFICIENCY 40,1,DOCK2
IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY,1,IL2RA
IMMUNODEFICIENCY 42,1,RORC
IMMUNODEFICIENCY 43,1,B2M
IMMUNODEFICIENCY 44,1,STAT2
IMMUNODEFICIENCY 45,1,IFNAR2
IMMUNODEFICIENCY 46,1,TFRC
IMMUNODEFICIENCY 47,1,ATP6AP1
IMMUNODEFICIENCY 48,1,ZAP70
IMMUNODEFICIENCY 49,1,BCL11B
IMMUNODEFICIENCY 50,1,MSN
IMMUNODEFICIENCY 51,1,IL17RA
IMMUNODEFICIENCY 52,1,LAT
IMMUNODEFICIENCY 53,1,RELB
IMMUNODEFICIENCY 54,1,MCM4
IMMUNODEFICIENCY 55,1,GINS1
IMMUNODEFICIENCY 56,1,IL21R
IMMUNODEFICIENCY 57 WITH AUTOINFLAMMATION,1,RIPK1
IMMUNODEFICIENCY 58,1,CARMIL2
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA,1,HYOU1
IMMUNODEFICIENCY 60 AND AUTOIMMUNITY,1,BACH2
IMMUNODEFICIENCY 61,1,SH3KBP1
IMMUNODEFICIENCY 62,1,ARHGEF1
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY,1,IL2RB
IMMUNODEFICIENCY 64,1,RASGRP1
"IMMUNODEFICIENCY 65, SUSCEPTIBILITY TO VIRAL INFECTIONS",1,IRF9
IMMUNODEFICIENCY 66,1,MRTFA
IMMUNODEFICIENCY 67,1,IRAK4
IMMUNODEFICIENCY 68,1,MYD88
IMMUNODEFICIENCY 69,1,IFNG
IMMUNODEFICIENCY 7,1,NCOR2
IMMUNODEFICIENCY 70,1,IVNS1ABP
IMMUNODEFICIENCY 71 WITH INFLAMMATORY DISEASE AND CONGENITAL THROMBOCYTOPENIA,1,ARPC1B
IMMUNODEFICIENCY 72 WITH AUTOINFLAMMATION,1,NCKAP1L
IMMUNODEFICIENCY 73A WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LEUKOCYTOSIS,1,RAC2
IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA,1,RAC2
IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA,1,RAC2
"IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED",1,TLR7
IMMUNODEFICIENCY 75,1,TET2
IMMUNODEFICIENCY 76,1,FCHO1
IMMUNODEFICIENCY 77,1,MPEG1
IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY,1,TPP2
IMMUNODEFICIENCY 79,1,CD4
IMMUNODEFICIENCY 8,1,CORO1A
IMMUNODEFICIENCY 80 WITH OR WITHOUT CONGENITAL CARDIOMYOPATHY,1,MCM10
IMMUNODEFICIENCY 81,1,LCP2
IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION,1,SYK
"IMMUNODEFICIENCY 83, SUSCEPTIBILITY TO VIRAL INFECTIONS",1,TLR3
IMMUNODEFICIENCY 84,1,IKZF3
IMMUNODEFICIENCY 85 AND AUTOIMMUNITY,1,TOM1
IMMUNODEFICIENCY 86,1,SPPL2A
IMMUNODEFICIENCY 87 AND AUTOIMMUNITY,1,DEF6
IMMUNODEFICIENCY 88,1,TBX21
IMMUNODEFICIENCY 89 AND AUTOIMMUNITY,1,CARD10
IMMUNODEFICIENCY 9,1,ORAI1
"IMMUNODEFICIENCY 90 WITH ENCEPHALOPATHY, FUNCTIONAL HYPOSPLENIA, AND HEPATIC DYSFUNCTION",1,FADD
IMMUNODEFICIENCY 91 AND HYPERINFLAMMATION,1,ZNFX1
IMMUNODEFICIENCY 92,1,REL
IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY,1,FNIP1
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN,1,LAMTOR2
"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1",1,CD40LG
"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2",1,AICDA
"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3",1,CD40
"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5",1,UNG
"IMMUNODEFICIENCY, COMMON VARIABLE, 1",1,ICOS
"IMMUNODEFICIENCY, COMMON VARIABLE, 10",1,NFKB2
"IMMUNODEFICIENCY, COMMON VARIABLE, 11",1,IL21
"IMMUNODEFICIENCY, COMMON VARIABLE, 12, WITH AUTOIMMUNITY",1,NFKB1
"IMMUNODEFICIENCY, COMMON VARIABLE, 13",1,IKZF1
"IMMUNODEFICIENCY, COMMON VARIABLE, 14",1,IRF2BP2
"IMMUNODEFICIENCY, COMMON VARIABLE, 2",5,"TNFRSF13C, CR2, TNFRSF13B, ICOS, CD19"
"IMMUNODEFICIENCY, COMMON VARIABLE, 3",1,CD19
"IMMUNODEFICIENCY, COMMON VARIABLE, 4",1,TNFRSF13C
"IMMUNODEFICIENCY, COMMON VARIABLE, 5",1,MS4A1
"IMMUNODEFICIENCY, COMMON VARIABLE, 6",1,CD81
"IMMUNODEFICIENCY, COMMON VARIABLE, 7",1,CR2
"IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY",1,LRBA
"IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA",1,NFE2L2
"IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA",1,MAGT1
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1,1,DNMT3B
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2,1,ZBTB24
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3,1,CDCA7
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4,1,HELLS
"IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED",1,FOXP3
IMMUNOGLOBULIN A DEFICIENCY 2,1,TNFRSF13B
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES,1,EXTL3
IMPAIRED INTELLECTUAL DEVELOPMENT AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS,1,MED13L
"IMPDH2 ENZYME ACTIVITY, VARIATION IN",1,IMPDH2
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1,1,VCP
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2,1,HNRNPA2B1
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3,1,HNRNPA1
INCONTINENTIA PIGMENTI,1,IKBKG
"INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC",1,MC1R
"INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE",1,SCN9A
"INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT",1,GLS
INFANTILE CEREBELLAR-RETINAL DEGENERATION,1,ACO2
INFANTILE LIVER FAILURE SYNDROME 1,1,LARS1
INFANTILE LIVER FAILURE SYNDROME 2,1,NBAS
INFANTILE LIVER FAILURE SYNDROME 3,1,RINT1
INFANTILE SIALIC ACID STORAGE DISEASE,1,SLC17A5
INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1,2,"IL6, NOD2"
INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 10,1,ATG16L1
INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 19,1,IRGM
INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 30,1,CARD8
"INFLAMMATORY BOWEL DISEASE (INFANTILE ULCERATIVE COLITIS) 31, AUTOSOMAL RECESSIVE",1,IL37
INFLAMMATORY BOWEL DISEASE 13,1,ABCB1
INFLAMMATORY BOWEL DISEASE 14,1,IRF5
INFLAMMATORY BOWEL DISEASE 17,1,IL23R
"INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE",1,IL10RB
"INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE",1,IL10RA
INFLAMMATORY BOWEL DISEASE 29,1,INAVA
"INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY",1,TGFB1
"INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1",1,ADAM17
"INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2",1,EGFR
"INFLUENZA, SEVERE, SUSCEPTIBILITY TO",1,IFITM3
INOSINE TRIPHOSPHATASE DEFICIENCY,1,ITPA
"INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS",1,NTRK1
INSULIN-LIKE GROWTH FACTOR I DEFICIENCY,1,IGF1
"INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO",1,IGF1R
INSULINOMATOSIS AND DIABETES MELLITUS,1,MAFA
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA,1,SCAPER
"INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE",1,PUS7
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY,1,TBR1
"INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISTIC FEATURES AND LANGUAGE DELAY, WITH OR WITHOUT SEIZURES",1,TANC2
INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES,1,PHF21A
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA,1,GNB5
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES,1,TMEM94
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES,1,FBXO11
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS,1,BRPF1
"INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES",1,OTUD6B
"INTELLECTUAL DEVELOPMENTAL DISORDER WITH EPILEPSY, BEHAVIORAL ABNORMALITIES, AND COARSE FACIES",1,ALG14
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES,1,CCNK
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES,1,CDK8
"INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND DYSMORPHIC FACIES",1,TNPO2
INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES,1,DDX6
"INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY",1,PAK1
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND PONTINE AND CEREBELLAR HYPOPLASIA,1,CASK
"INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES",1,CNOT2
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES,1,SLC45A1
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA,1,RORA
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PAROXYSMAL DYSKINESIA OR SEIZURES,1,PDE2A
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN,1,BCL11A
INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA,1,ABCA2
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEIZURES AND LANGUAGE DELAY,1,SETD1B
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS,1,ACTL6B
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES,1,IQSEC1
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES,1,WIPI2
"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS",1,FBXL3
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY AND AXONAL PERIPHERAL NEUROPATHY,1,NEMF
"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES",1,CNOT3
"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES",1,BCL11B
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 34",1,CERT1
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 39",1,MYT1L
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 42",1,GNB1
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY",1,TRIO
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 50, WITH BEHAVIORAL ABNORMALITIES",1,NAA15
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES",1,NUS1
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 56",1,CLTC
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 59",1,CAMK2G
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 60, WITH SEIZURES",1,AP2M1
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 61",1,MED13
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 62",1,DLG4
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY",1,TRIO
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 64",1,ZNF292
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 65",1,KDM4B
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 12",1,ST3GAL3
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 18, WITH OR WITHOUT EPILEPSY",1,MED23
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 27",1,LINS1
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY",1,CRADD
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 38",1,HERC2
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 39",1,TTI2
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 47",1,FMN2
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 50",1,EDC3
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 52",1,LMAN2L
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 53",1,PIGG
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 54",1,TNIK
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 56",1,ZC3H14
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 57",1,MBOAT7
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6",1,GRIK2
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 66",1,C12orf4
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67",1,EIF3F
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68",1,TRMT1
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69",1,ZBTB11
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70",1,RSRC1
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71",1,ALKBH8
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72",1,METTL5
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 73",1,NAA20
"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 74",1,APC2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 1",1,IQSEC2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 100",1,KIF4A
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 101",1,MID2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 103",1,KLHL15
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 104",1,FRMPD4
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 105",1,USP27X
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 106",1,OGT
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 107",1,STEEP1
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108",1,SLC9A7
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 109",1,AFF2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 12",1,THOC2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21",1,IL1RAPL1
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29",1,ARX
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 30",1,PAK3
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 41",1,GDI1
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 50",1,SYN1
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 58",1,TSPAN7
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 63",1,ACSL4
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 72",1,RAB39B
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 9",1,FTSJ1
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 90",1,DLG3
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 93",1,BRWD3
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 96",1,SYP
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 97",1,ZNF711
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 98",1,NEXMIF
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99",1,USP9X
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED",1,USP9X
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 11",1,RBMX
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13",1,MECP2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 14",1,UPF3B
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 32",1,CLIC2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 33",1,TAF1
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 34",1,NONO
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, 35",1,RPL10
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, ARMFIELD TYPE",1,FAM50A
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BAIN TYPE",1,HNRNPH2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BILLUART TYPE",1,OPHN1
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE",1,CUL4B
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE",1,SLC9A6
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE",1,KDM5C
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE",1,NKAP
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HEDERA TYPE",1,ATP6AP2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HOUGE TYPE",1,CNKSR2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUBS TYPE",1,MECP2
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUJAN-FRYNS TYPE",1,MED12
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, NASCIMENTO TYPE",1,UBE2A
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE",1,ZDHHC9
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SIDERIUS TYPE",1,PHF8
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE",1,DDX3X
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE",1,SMS
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, STOCCO DOS SANTOS TYPE",1,SHROOM4
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, TURNER TYPE",1,HUWE1
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WILSON-TURNER TYPE",1,LAS1L
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WITH PIGMENTARY MOSAICISM AND COARSE FACIES",1,TFE3
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE",1,GRIA3
"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM",1,SOX3
INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME,1,ABCC9
"INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS",1,IL6R
INTERSTITIAL LUNG AND LIVER DISEASE,1,MARS1
INTERSTITIAL LUNG DISEASE 1,1,SFTPA1
INTERSTITIAL LUNG DISEASE 2,4,"SFTPC, TERT, MUC5B, SFTPA2"
"INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL",1,ITGA3
"INTERSTITIAL NEPHRITIS, KARYOMEGALIC",1,FAN1
INTERVERTEBRAL DISC DISEASE,5,"COL9A3, COL11A1, ASPN, THBS2, CILP"
"INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED",1,FLNA
"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES",1,CDKN1C
"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY",1,POLE
INTRINSIC FACTOR DEFICIENCY,1,CBLIF
IRON-REFRACTORY IRON DEFICIENCY ANEMIA,1,TMPRSS6
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION,1,TBX4
ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY,1,ACAD8
"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA",1,GH1
"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB",1,GH1
"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II",1,GH1
"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III, WITH AGAMMAGLOBULINEMIA",1,BTK
"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV",1,GHRHR
ISOVALERIC ACIDEMIA,1,IVD
IVIC SYNDROME,1,SALL4
"IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3",1,SPRY2
"IgE RESPONSIVENESS, ATOPIC",4,"MS4A2, IL4R, IL21R, PLA2G7"
JABERI-ELAHI SYNDROME,1,GTPBP2
JACKSON-WEISS SYNDROME,2,"FGFR1, FGFR2"
JALILI SYNDROME,1,CNNM4
JANSEN-DE VRIES SYNDROME,1,PPM1D
JAWAD SYNDROME,1,RBBP8
JERVELL AND LANGE-NIELSEN SYNDROME 1,1,KCNQ1
JOHANSON-BLIZZARD SYNDROME,1,UBR1
"JOINT LAXITY, SHORT STATURE, AND MYOPIA",1,GZF1
JOUBERT SYNDROME 1,1,INPP5E
JOUBERT SYNDROME 10,1,OFD1
JOUBERT SYNDROME 13,1,TCTN1
JOUBERT SYNDROME 14,1,TMEM237
JOUBERT SYNDROME 15,1,CEP41
JOUBERT SYNDROME 16,1,TMEM138
JOUBERT SYNDROME 17,1,CPLANE1
JOUBERT SYNDROME 18,1,TCTN3
JOUBERT SYNDROME 2,1,TMEM216
JOUBERT SYNDROME 20,1,TMEM231
JOUBERT SYNDROME 21,1,CSPP1
JOUBERT SYNDROME 22,1,PDE6D
JOUBERT SYNDROME 23,1,KIAA0586
JOUBERT SYNDROME 24,1,TCTN2
JOUBERT SYNDROME 25,1,CEP104
JOUBERT SYNDROME 26,1,KATNIP
JOUBERT SYNDROME 27,1,B9D1
JOUBERT SYNDROME 28,1,MKS1
JOUBERT SYNDROME 3,1,AHI1
JOUBERT SYNDROME 30,1,ARMC9
JOUBERT SYNDROME 31,1,CEP120
JOUBERT SYNDROME 32,1,SUFU
JOUBERT SYNDROME 33,1,PIBF1
JOUBERT SYNDROME 35,1,ARL3
JOUBERT SYNDROME 36,1,FAM149B1
JOUBERT SYNDROME 37,1,TOGARAM1
JOUBERT SYNDROME 38,1,KIAA0753
JOUBERT SYNDROME 39,1,TMEM218
JOUBERT SYNDROME 4,1,NPHP1
JOUBERT SYNDROME 40,1,IFT74
JOUBERT SYNDROME 5,1,CEP290
JOUBERT SYNDROME 6,1,TMEM67
JOUBERT SYNDROME 7,1,RPGRIP1L
JOUBERT SYNDROME 8,1,ARL13B
JOUBERT SYNDROME 9,1,CC2D2A
JUBERG-HAYWARD SYNDROME,1,ESCO2
JUVENILE ARTHRITIS,1,LACC1
JUVENILE MYELOMONOCYTIC LEUKEMIA,4,"ARHGAP26, NF1, PTPN11, CBL"
JUVENILE POLYPOSIS SYNDROME,2,"SMAD4, BMPR1A"
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME,1,SMAD4
KABUKI SYNDROME 1,2,"KDM6A, KMT2D"
KABUKI SYNDROME 2,1,KDM6A
KAHRIZI SYNDROME,1,SRD5A3
"KALLIKREIN, DECREASED URINARY ACTIVITY OF",1,KLK1
KANZAKI DISEASE,1,NAGA
"KAPOSI SARCOMA, SUSCEPTIBILITY TO",1,IL6
KAUFMAN OCULOCEREBROFACIAL SYNDROME,1,UBE3B
KAYA-BARAKAT-MASSON SYNDROME,1,YIF1B
KBG SYNDROME,1,ANKRD11
KEIPERT SYNDROME,1,GPC4
"KENNY-CAFFEY SYNDROME, TYPE 1",1,TBCE
"KENNY-CAFFEY SYNDROME, TYPE 2",1,FAM111A
KEPPEN-LUBINSKY SYNDROME,1,KCNJ6
"KERATITIS, HEREDITARY",1,PAX6
"KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT",1,GJB2
"KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE",1,AP1B1
KERATOCONUS 1,1,VSX1
KERATOCONUS 9,1,TUBA3D
"KERATODERMA, PALMOPLANTAR, WITH DEAFNESS",1,GJB2
KERATOENDOTHELIITIS FUGAX HEREDITARIA,1,NLRP3
KERATOLYTIC WINTER ERYTHEMA,1,CTSB
"KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED",1,MBTPS2
KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA,1,POMP
KERATOSIS PALMOPLANTARIS STRIATA II,1,DSP
KERATOSIS PALMOPLANTARIS STRIATA III,1,KRT1
KERATOSIS PILARIS ATROPHICANS,1,LRP1
"KERATOSIS, SEBORRHEIC",1,PIK3CA
KEUTEL SYNDROME,1,MGP
KHAN-KHAN-KATSANIS SYNDROME,1,NCAPG2
KILQUIST SYNDROME,1,SLC12A2
KINDLER SYNDROME,1,FERMT1
KING-DENBOROUGH SYNDROME,1,RYR1
KINSSHIP SYNDROME,1,AFF3
KLEEFSTRA SYNDROME 1,1,EHMT1
KLEEFSTRA SYNDROME 2,1,KMT2C
"KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT",1,GDF6
"KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE",1,MEOX1
"KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT",1,GDF3
"KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM",1,MYO18B
KNIEST DYSPLASIA,1,COL2A1
KNOBLOCH SYNDROME 1,1,COL18A1
KNOPS BLOOD GROUP SYSTEM,1,CR1
KOHLSCHUTTER-TONZ SYNDROME,1,ROGDI
KOHLSCHUTTER-TONZ SYNDROME-LIKE,1,SATB1
KOOLEN-DE VRIES SYNDROME,1,KANSL1
KOSAKI OVERGROWTH SYNDROME,1,PDGFRB
KOWARSKI SYNDROME,1,GH1
KRABBE DISEASE,1,GALC
"KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY",1,PSAP
KUFOR-RAKEB SYNDROME,1,ATP13A2
"KURU, SUSCEPTIBILITY TO",1,PRNP
L-2-HYDROXYGLUTARIC ACIDURIA,1,L2HGDH
L-FERRITIN DEFICIENCY,1,FTL
LACRIMAL DUCT DEFECT,1,IGSF3
LACRIMOAURICULODENTODIGITAL SYNDROME,3,"FGF10, FGFR3, FGFR2"
"LACTASE DEFICIENCY, CONGENITAL",1,LCT
LACTATE DEHYDROGENASE B DEFICIENCY,1,LDHB
"LACTOSE INTOLERANCE, ADULT TYPE",1,MCM6
LAMB-SHAFFER SYNDROME,1,SOX5
LANGER MESOMELIC DYSPLASIA,1,SHOX
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA,1,GNB5
LARON SYNDROME,1,GHR
LARSEN SYNDROME,1,FLNB
LARYNGOONYCHOCUTANEOUS SYNDROME,1,LAMA3
LATE-ONSET RETINAL DEGENERATION,1,C1QTNF5
LATERAL MENINGOCELE SYNDROME,1,NOTCH3
LATHOSTEROLOSIS,1,SC5D
LAURENCE-MOON SYNDROME,1,PNPLA6
LAURIN-SANDROW SYNDROME,1,LMBR1
LEBER CONGENITAL AMAUROSIS 1,1,GUCY2D
LEBER CONGENITAL AMAUROSIS 10,1,CEP290
LEBER CONGENITAL AMAUROSIS 11,1,IMPDH1
LEBER CONGENITAL AMAUROSIS 12,1,RD3
LEBER CONGENITAL AMAUROSIS 13,1,RDH12
LEBER CONGENITAL AMAUROSIS 14,1,LRAT
LEBER CONGENITAL AMAUROSIS 15,1,TULP1
LEBER CONGENITAL AMAUROSIS 16,1,KCNJ13
LEBER CONGENITAL AMAUROSIS 17,1,GDF6
LEBER CONGENITAL AMAUROSIS 19,1,USP45
LEBER CONGENITAL AMAUROSIS 2,1,RPE65
LEBER CONGENITAL AMAUROSIS 3,1,SPATA7
LEBER CONGENITAL AMAUROSIS 4,1,AIPL1
LEBER CONGENITAL AMAUROSIS 5,1,LCA5
LEBER CONGENITAL AMAUROSIS 6,1,RPGRIP1
LEBER CONGENITAL AMAUROSIS 7,1,CRX
LEBER CONGENITAL AMAUROSIS 8,1,CRB1
LEBER CONGENITAL AMAUROSIS 9,1,NMNAT1
LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS,1,TUBB4B
"LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE",1,DNAJC30
"LEBER HEREDITARY OPTIC NEUROPATHY, MODIFIER OF",1,PRICKLE3
LEBER OPTIC ATROPHY,9,"MT-ATP6, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND4, MT-ND4L, MT-ND5, MT-ND6"
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY,1,LCAT
LEFT VENTRICULAR NONCOMPACTION 1,1,DTNA
LEFT VENTRICULAR NONCOMPACTION 10,1,MYBPC3
LEFT VENTRICULAR NONCOMPACTION 7,1,MIB1
LEFT VENTRICULAR NONCOMPACTION 8,1,PRDM16
LEGG-CALVE-PERTHES DISEASE,1,COL2A1
"LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO",1,TLR5
LEGIUS SYNDROME,1,SPRED1
LEIGH SYNDROME,1,SDHA
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM,1,PTDSS1
LEOPARD SYNDROME 1,1,PTPN11
LEOPARD SYNDROME 2,1,RAF1
LEOPARD SYNDROME 3,1,BRAF
"LEPROSY, SUSCEPTIBILITY TO, 3",1,TLR2
"LEPROSY, SUSCEPTIBILITY TO, 4",1,LTA
"LEPROSY, SUSCEPTIBILITY TO, 5",1,TLR1
LEPTIN DEFICIENCY OR DYSFUNCTION,1,LEP
LEPTIN RECEPTOR DEFICIENCY,1,LEPR
LERI-WEILL DYSCHONDROSTEOSIS,1,SHOX
LESCH-NYHAN SYNDROME,1,HPRT1
LESSEL-KREIENKAMP SYNDROME,1,AGO2
LESSEL-KUBISCH SYNDROME,1,MDM2
LETHAL CONGENITAL CONTRACTURE SYNDROME 1,1,GLE1
LETHAL CONGENITAL CONTRACTURE SYNDROME 10,1,NEK9
LETHAL CONGENITAL CONTRACTURE SYNDROME 11,1,GLDN
LETHAL CONGENITAL CONTRACTURE SYNDROME 2,1,ERBB3
LETHAL CONGENITAL CONTRACTURE SYNDROME 3,1,PIP5K1C
LETHAL CONGENITAL CONTRACTURE SYNDROME 4,1,MYBPC1
LETHAL CONGENITAL CONTRACTURE SYNDROME 5,1,DNM2
LETHAL CONGENITAL CONTRACTURE SYNDROME 6,1,ZBTB42
LETHAL CONGENITAL CONTRACTURE SYNDROME 7,1,CNTNAP1
LETHAL CONGENITAL CONTRACTURE SYNDROME 8,1,ADCY6
LETHAL CONGENITAL CONTRACTURE SYNDROME 9,1,ADGRG6
"LEUKEMIA, ACUTE LYMPHOBLASTIC",8,"FLT3, GNB1, NBN, BAX, BCR, TAL1, TAL2, NUP214"
"LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3",1,PAX5
"LEUKEMIA, ACUTE MYELOID",18,"CEBPA, DNMT3A, ETV6, FLT3, GATA2, CHIC2, JAK2, KIT, KRAS, LPP, NPM1, SH3GL1, TERT, NUP214, MLLT10, PICALM, RUNX1, CBFB"
"LEUKEMIA, CHRONIC MYELOID",2,"ABL1, BCR"
"LEUKOCYTE ADHESION DEFICIENCY, TYPE I",1,ITGB2
"LEUKOCYTE ADHESION DEFICIENCY, TYPE III",1,FERMT3
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA,1,PLEKHG2
"LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT",1,LMNB1
"LEUKODYSTROPHY, HYPOMYELINATING, 10",1,PYCR2
"LEUKODYSTROPHY, HYPOMYELINATING, 11",1,POLR1C
"LEUKODYSTROPHY, HYPOMYELINATING, 12",1,VPS11
"LEUKODYSTROPHY, HYPOMYELINATING, 13",1,HIKESHI
"LEUKODYSTROPHY, HYPOMYELINATING, 14",1,UFM1
"LEUKODYSTROPHY, HYPOMYELINATING, 15",1,EPRS1
"LEUKODYSTROPHY, HYPOMYELINATING, 16",1,TMEM106B
"LEUKODYSTROPHY, HYPOMYELINATING, 17",1,AIMP2
"LEUKODYSTROPHY, HYPOMYELINATING, 18",1,DEGS1
"LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE",1,TMEM63A
"LEUKODYSTROPHY, HYPOMYELINATING, 2",1,GJC2
"LEUKODYSTROPHY, HYPOMYELINATING, 20",1,CNP
"LEUKODYSTROPHY, HYPOMYELINATING, 21",1,POLR3K
"LEUKODYSTROPHY, HYPOMYELINATING, 22",1,CLDN11
"LEUKODYSTROPHY, HYPOMYELINATING, 23, WITH ATAXIA, DEAFNESS, LIVER DYSFUNCTION, AND DILATED CARDIOMYOPATHY",1,RNF220
"LEUKODYSTROPHY, HYPOMYELINATING, 3",1,AIMP1
"LEUKODYSTROPHY, HYPOMYELINATING, 4",1,HSPD1
"LEUKODYSTROPHY, HYPOMYELINATING, 5",1,FAM126A
"LEUKODYSTROPHY, HYPOMYELINATING, 6",1,TUBB4A
"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM",2,"POLR3A, POLR3B"
"LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM",1,POLR3B
"LEUKODYSTROPHY, HYPOMYELINATING, 9",1,RARS1
"LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET",1,ACER3
LEUKOENCEPHALOPATHY WITH ATAXIA,1,CLCN2
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION,1,DARS2
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY,1,SCP2
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER,5,"EIF2B1, EIF2B4, EIF2B3, EIF2B2, EIF2B5"
"LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE",1,SLC13A3
"LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY",1,RNASET2
"LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME",1,EIF2AK2
"LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 1",1,CSF1R
"LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2",1,AARS1
"LEUKOENCEPHALOPATHY, MOTOR DELAY, SPASTICITY, AND DYSARTHRIA SYNDROME",1,EIF2AK1
"LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS",1,KARS1
"LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE",1,AARS2
LEUKOTRIENE C4 SYNTHASE DEFICIENCY,1,LTC4S
"LEYDIG CELL HYPOPLASIA, TYPE I",1,LHCGR
LI-CAMPEAU SYNDROME,1,UBR7
LI-FRAUMENI SYNDROME,1,TP53
LI-FRAUMENI SYNDROME 2,1,CHEK2
LI-GHORBANI-WEISZ-HUBSHMAN SYNDROME,1,KAT8
LIANG-WANG SYNDROME,1,KCNMA1
LIBERFARB SYNDROME,1,PISD
LICHTENSTEIN-KNORR SYNDROME,1,SLC9A1
LIDDLE SYNDROME 1,1,SCNN1B
LIDDLE SYNDROME 2,1,SCNN1G
LIDDLE SYNDROME 3,1,SCNN1A
LIEBENBERG SYNDROME,1,PITX1
LIG4 SYNDROME,1,LIG4
LIMB-MAMMARY SYNDROME,1,TP63
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1,3,"COX7B, HCCS, NDUFB11"
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2,1,COX7B
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3,1,NDUFB11
"LIPASE DEFICIENCY, COMBINED",1,LMF1
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY,1,FLAD1
"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1",1,AGPAT2
"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2",1,BSCL2
"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3",1,CAV1
"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4",1,CAVIN1
"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2",1,LMNA
"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3",1,PPARG
"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4",1,PLIN1
"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5",1,CIDEC
"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6",1,LIPE
"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7",1,CAV1
"LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO",1,LMNB2
LIPOID CONGENITAL ADRENAL HYPERPLASIA,1,STAR
LIPOID PROTEINOSIS OF URBACH AND WIETHE,1,ECM1
LIPOPROTEIN GLOMERULOPATHY,1,APOE
LIPOPROTEIN(a) QUANTITATIVE TRAIT LOCUS,1,LPA
LIPOYLTRANSFERASE 1 DEFICIENCY,1,LIPT1
LISSENCEPHALY 1,1,PAFAH1B1
LISSENCEPHALY 10,1,CEP85L
LISSENCEPHALY 2,1,RELN
LISSENCEPHALY 3,1,TUBA1A
LISSENCEPHALY 4,1,NDE1
LISSENCEPHALY 5,1,LAMB1
LISSENCEPHALY 6 WITH MICROCEPHALY,1,KATNB1
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA,1,CDK5
LISSENCEPHALY 8,1,TMTC3
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION,1,MACF1
"LISSENCEPHALY, X-LINKED, 2",1,ARX
"LIVER FAILURE, INFANTILE, TRANSIENT",1,TRMU
LOEYS-DIETZ SYNDROME 1,1,TGFBR1
LOEYS-DIETZ SYNDROME 2,1,TGFBR2
LOEYS-DIETZ SYNDROME 3,1,SMAD3
LOEYS-DIETZ SYNDROME 4,1,TGFB2
LOEYS-DIETZ SYNDROME 5,1,TGFB3
LOEYS-DIETZ SYNDROME 6,1,SMAD2
LONG QT SYNDROME 1,1,KCNQ1
LONG QT SYNDROME 10,1,SCN4B
LONG QT SYNDROME 11,1,AKAP9
LONG QT SYNDROME 12,1,SNTA1
LONG QT SYNDROME 13,1,KCNJ5
LONG QT SYNDROME 14,1,CALM1
LONG QT SYNDROME 15,1,CALM2
LONG QT SYNDROME 16,1,CALM3
LONG QT SYNDROME 2,2,"ALG10B, KCNH2"
LONG QT SYNDROME 3,1,SCN5A
LONG QT SYNDROME 6,1,KCNE2
LONG QT SYNDROME 8,1,CACNA1C
LONG QT SYNDROME 9,1,CAV3
LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY,1,HADHA
LOPES-MACIEL-RODAN SYNDROME,1,HTT
LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6,1,SORT1
LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7,1,NPC1L1
LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 8,1,LIMA1
LOWE OCULOCEREBRORENAL SYNDROME,1,OCRL
"LOWER URINARY TRACT OBSTRUCTION, CONGENITAL",1,BNC2
LUNG CANCER,14,"MAP3K8, CYP2A6, EGFR, ERBB2, ERCC6, FASLG, IRF1, KRAS, SLC22A18, PRKN, PIK3CA, PPP2R1B, BRAF, CASP8"
"LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME",1,NSMCE3
LUO-SCHOCH-YAMAMOTO SYNDROME,1,RNF2
LUSCAN-LUMISH SYNDROME,1,SETD2
LUTHERAN NULL,1,BCAM
LYMPHANGIOLEIOMYOMATOSIS,2,"TSC1, TSC2"
LYMPHATIC MALFORMATION 1,1,FLT4
LYMPHATIC MALFORMATION 10,1,ANGPT2
LYMPHATIC MALFORMATION 11,1,TIE1
LYMPHATIC MALFORMATION 3,1,GJC2
LYMPHATIC MALFORMATION 4,1,VEGFC
LYMPHATIC MALFORMATION 6,1,PIEZO1
LYMPHATIC MALFORMATION 7,1,EPHB4
LYMPHATIC MALFORMATION 8,1,CALCRL
LYMPHATIC MALFORMATION 9,1,CELSR1
"LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA",1,GATA2
LYMPHEDEMA-DISTICHIASIS SYNDROME,1,FOXC2
"LYMPHOMA, HODGKIN, CLASSIC",1,KLHDC8B
"LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TYPE",1,BCL10
"LYMPHOMA, NON-HODGKIN, FAMILIAL",5,"RAD54B, PRF1, CASP10, RAD54L, BCL10"
LYMPHOPROLIFERATIVE SYNDROME 1,1,ITK
LYMPHOPROLIFERATIVE SYNDROME 2,1,CD27
LYMPHOPROLIFERATIVE SYNDROME 3,1,CD70
"LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1",2,"XIAP, SH2D1A"
"LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2",1,XIAP
LYNCH SYNDROME I,2,"MSH2, PMS1"
LYSINURIC PROTEIN INTOLERANCE,1,SLC7A7
LYSOSOMAL ACID LIPASE DEFICIENCY,1,LIPA
MACHADO-JOSEPH DISEASE,1,ATXN3
"MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT",1,NFIB
"MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION",1,HERC1
MACROCEPHALY/AUTISM SYNDROME,1,PTEN
"MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE",1,TBC1D7
MACRODACTYLY,1,PIK3CA
"MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1",1,MYD88
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS,1,MYH9
"MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED",1,TUBB1
MACS SYNDROME,1,RIN2
"MACULAR DEGENERATION, AGE-RELATED, 1",3,"CFHR1, APOE, HMCN1"
"MACULAR DEGENERATION, AGE-RELATED, 11",1,CST3
"MACULAR DEGENERATION, AGE-RELATED, 12",1,CX3CR1
"MACULAR DEGENERATION, AGE-RELATED, 13",1,CFI
"MACULAR DEGENERATION, AGE-RELATED, 14",2,"CFB, C2"
"MACULAR DEGENERATION, AGE-RELATED, 15",1,C9
"MACULAR DEGENERATION, AGE-RELATED, 2",1,ABCA4
"MACULAR DEGENERATION, AGE-RELATED, 4",1,CFH
"MACULAR DEGENERATION, AGE-RELATED, 5",1,ERCC6
"MACULAR DEGENERATION, AGE-RELATED, 6",1,RAX2
"MACULAR DEGENERATION, AGE-RELATED, 7",1,HTRA1
"MACULAR DEGENERATION, AGE-RELATED, 9",1,C3
"MACULAR DEGENERATION, EARLY-ONSET",1,FBN2
"MACULAR DEGENERATION, X-LINKED ATROPHIC",1,RPGR
MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT,1,MFSD8
"MACULAR DYSTROPHY, CORNEAL",1,CHST6
"MACULAR DYSTROPHY, PATTERNED, 1",1,PRPH2
"MACULAR DYSTROPHY, PATTERNED, 2",1,CTNNA1
"MACULAR DYSTROPHY, PATTERNED, 3",1,MAPKAPK3
"MACULAR DYSTROPHY, RETINAL, 2",1,PROM1
"MACULAR DYSTROPHY, VITELLIFORM, 2",1,BEST1
"MACULAR DYSTROPHY, VITELLIFORM, 3",1,PRPH2
"MACULAR DYSTROPHY, VITELLIFORM, 4",1,IMPG1
"MACULAR DYSTROPHY, VITELLIFORM, 5",1,IMPG2
MAHVASH DISEASE,1,GCGR
MAJEED SYNDROME,1,LPIN2
MAJOR AFFECTIVE DISORDER 7,1,XBP1
MAJOR DEPRESSIVE DISORDER,3,"TPH2, FKBP5, HTR2A"
MAL DE MELEDA,1,SLURP1
MALAN SYNDROME,1,NFIX
"MALARIA, MILD, SUSCEPTIBILITY TO",1,NCR3
"MALARIA, SUSCEPTIBILITY TO",16,"TIRAP, CISH, CR1, FCGR2A, FCGR2B, ACKR1, G6PD, GYPA, GYPB, GYPC, HBB, ICAM1, NOS2, SLC4A1, TNF, CD36"
MALEYLACETOACETATE ISOMERASE DEFICIENCY,1,GSTZ1
"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1",1,RYR1
"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5",1,CACNA1S
MALONYL-CoA DECARBOXYLASE DEFICIENCY,1,MLYCD
"MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME",1,POLD1
MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME,1,MTX2
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY,1,LMNA
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY,1,ZMPSTE24
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA,1,EDNRA
"MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE",1,EFTUD2
MANITOBA OCULOTRICHOANAL SYNDROME,1,FREM1
"MANNOSIDOSIS, ALPHA B, LYSOSOMAL",1,MAN2B1
"MANNOSIDOSIS, BETA A, LYSOSOMAL",1,MANBA
MAPLE SYRUP URINE DISEASE,3,"DBT, BCKDHA, BCKDHB"
"MAPLE SYRUP URINE DISEASE, MILD VARIANT",1,PPM1K
MARBACH-RUSTAD PROGEROID SYNDROME,1,LEMD2
MARBACH-SCHAAF NEURODEVELOPMENTAL SYNDROME,1,PRKAR1B
MARDEN-WALKER SYNDROME,1,PIEZO2
MARFAN SYNDROME,1,FBN1
MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME,1,FBN1
MARINESCO-SJOGREN SYNDROME,1,SIL1
MARSHALL SYNDROME,1,COL11A1
MARSHALL-SMITH SYNDROME,1,NFIX
MARSILI SYNDROME,1,ZFHX2
MARTSOLF SYNDROME 1,1,RAB3GAP2
MARTSOLF SYNDROME 2,1,RAB3GAP1
MASA SYNDROME,1,L1CAM
MASP2 DEFICIENCY,1,MASP2
MASS SYNDROME,1,FBN1
MAST SYNDROME,1,SPG21
"MASTOCYTOSIS, CUTANEOUS",1,KIT
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1",1,HNF4A
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10",1,INS
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11",1,BLK
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13",1,KCNJ11
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14",1,APPL1
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2",1,GCK
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3",1,HNF1A
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4",1,PDX1
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6",1,NEUROD1
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7",1,KLF11
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION",1,CEL
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9",1,PAX4
MCCUNE-ALBRIGHT SYNDROME,1,GNAS
MCKUSICK-KAUFMAN SYNDROME,1,MKKS
MCLEOD SYNDROME,1,XK
MEACHAM SYNDROME,1,WT1
MECKEL SYNDROME 12,1,KIF14
MECKEL SYNDROME 13,1,TMEM107
"MECKEL SYNDROME, TYPE 1",1,MKS1
"MECKEL SYNDROME, TYPE 10",1,B9D2
"MECKEL SYNDROME, TYPE 11",1,TMEM231
"MECKEL SYNDROME, TYPE 2",1,TMEM216
"MECKEL SYNDROME, TYPE 3",1,TMEM67
"MECKEL SYNDROME, TYPE 4",1,CEP290
"MECKEL SYNDROME, TYPE 5",1,RPGRIP1L
"MECKEL SYNDROME, TYPE 6",1,CC2D2A
"MECKEL SYNDROME, TYPE 7",1,NPHP3
"MECKEL SYNDROME, TYPE 8",1,TCTN2
"MECKEL SYNDROME, TYPE 9",1,B9D1
MECONIUM ILEUS,1,GUCY2C
MEDULLOBLASTOMA,5,"CTNNB1, SUFU, BRCA2, ELP1, PTCH2"
MEESTER-LOEYS SYNDROME,1,BGN
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS,1,MAST1
"MEGABLADDER, CONGENITAL",1,MYOCD
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 1,1,MYLK
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2,1,MYH11
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 3,1,LMOD1
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4,1,MYL9
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5,1,ACTG2
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1,2,"HEPACAM, MLC1"
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A,1,HEPACAM
"MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION",1,HEPACAM
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME,1,PIK3CA
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1,1,PIK3R2
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2,1,AKT3
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3,1,CCND2
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY,1,DHFR
"MEGALOBLASTIC ANEMIA, FOLATE-RESPONSIVE",1,SLC19A1
MEGALOCORNEA,1,CHRDL1
MEHMO SYNDROME,1,EIF2S3
MEIER-GORLIN SYNDROME 1,1,ORC1
MEIER-GORLIN SYNDROME 2,1,ORC4
MEIER-GORLIN SYNDROME 3,1,ORC6
MEIER-GORLIN SYNDROME 4,1,CDT1
MEIER-GORLIN SYNDROME 5,1,CDC6
MEIER-GORLIN SYNDROME 6,1,GMNN
MEIER-GORLIN SYNDROME 7,1,CDC45
MEIER-GORLIN SYNDROME 8,1,MCM5
"MELANOCYTIC NEVUS SYNDROME, CONGENITAL",2,"HRAS, NRAS"
"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1",2,"BRAF, STK11"
"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10",1,POT1
"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2",1,CDKN2A
"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3",1,CDK4
"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5",1,MC1R
"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6",1,XRCC3
"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8",1,MITF
"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9",1,TERT
MELANOMA-ASTROCYTOMA SYNDROME,1,CDKN2A
MELANOMA-PANCREATIC CANCER SYNDROME,1,CDKN2A
"MELANOSIS, NEUROCUTANEOUS",1,NRAS
"MELIOIDOSIS, SUSCEPTIBILITY TO",1,TLR5
MELNICK-NEEDLES SYNDROME,1,FLNA
"MELORHEOSTOSIS, ISOLATED",1,MAP2K1
MEMORY QUANTITATIVE TRAIT LOCUS,1,WWC1
MEND SYNDROME,1,EBP
"MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO",6,"MN1, NF2, PDGFB, SUFU, PTEN, SMARCE1"
MENKE-HENNEKAM SYNDROME 1,1,CREBBP
MENKE-HENNEKAM SYNDROME 2,1,EP300
MENKES DISEASE,1,ATP7A
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES,1,FOXP1
"MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS",1,SOBP
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 1",1,MBD5
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 10",1,CACNG2
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 13",1,DYNC1H1
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 21",1,CTCF
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 22",1,ZBTB18
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 23",1,SETD5
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 26",1,AUTS2
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 29",1,SETBP1
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 3",1,CDH15
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 30",1,ZMYND11
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 33",1,DPP6
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 35",1,PPP2R5D
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 36",1,PPP2R1A
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 38",1,EEF1A2
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 40",1,CHAMP1
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 41",1,TBL1XR1
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 43",1,HIVEP2
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 45",1,CIC
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 46",1,KCNQ5
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47",1,STAG1
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 48",1,RAC1
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 5",1,SYNGAP1
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 51",1,KMT5B
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 52",1,ASH1L
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 53",1,CAMK2A
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 54",1,CAMK2B
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 57",1,TLK2
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 58",1,SET
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES",1,GRIN2B
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 7",1,DYRK1A
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1",1,PRSS12
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13",1,TRAPPC9
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14",1,TECR
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2",1,CRBN
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3",1,CC2D1A
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37",1,ANK3
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40",1,TAF2
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41",1,KPTN
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43",1,WASHC4
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44",1,METTL23
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45",1,FBXO31
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46",1,NDST1
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48",1,SLC6A17
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5",1,NSUN2
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58",1,ELP2
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59",1,IMPA1
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60",1,TAF13
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61",1,RUSC2
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63",1,CAMK2A
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64",1,LINGO1
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65",1,KDM5B
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7",1,TUSC3
"MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA",1,AP1S1
"MENTAL RETARDATION, FRA12A TYPE",1,DIP2B
"MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME",1,INPP5E
"MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1",1,ATRX
"MESOTHELIOMA, MALIGNANT",2,"WT1, BCL10"
"METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION",1,TANGO2
"METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION",1,SLC25A42
METACARPAL 4-5 FUSION,1,FGF16
METACHONDROMATOSIS,1,PTPN11
METACHROMATIC LEUKODYSTROPHY,1,ARSA
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY,1,PSAP
METAPHYSEAL ANADYSPLASIA 2,1,MMP9
"METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE",1,PTH1R
"METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE",1,COL10A1
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY,1,RUNX2
"METAPHYSEAL DYSPLASIA, SPAHR TYPE",1,MMP13
METATROPIC DYSPLASIA,1,TRPV4
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA,1,CYB5A
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE,1,CYB5R3
"METHEMOGLOBINEMIA, ALPHA TYPE",1,HBA1
"METHEMOGLOBINEMIA, BETA TYPE",1,HBB
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY,1,MAT1A
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY,1,ALDH6A1
"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE",2,"MMACHC, PRDX1"
"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE",1,MMADHC
"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE",1,LMBRD1
"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE",1,ABCD4
"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblX TYPE",1,HCFC1
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY,1,MMUT
"METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT",1,CD320
"METHYLMALONIC ACIDURIA, cblA TYPE",1,MMAA
"METHYLMALONIC ACIDURIA, cblB TYPE",1,MMAB
METHYLMALONYL-CoA EPIMERASE DEFICIENCY,1,MCEE
MEVALONIC ACIDURIA,1,MVK
"MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT",1,COL4A1
"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II",1,PCNT
"MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE",1,MCPH1
"MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE",1,ZNF335
"MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE",1,PHC1
"MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE",1,CDK6
"MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE",1,CENPE
"MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE",1,SASS6
"MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE",1,ANKLE2
"MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE",1,CIT
"MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT",1,WDFY3
"MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE",1,COPB2
"MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS",1,WDR62
"MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE",1,KIF14
"MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE",1,NCAPD2
"MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE",1,NCAPD3
"MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE",1,NCAPH
"MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE",1,NUP37
"MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE",1,TRAPPC14
"MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT",1,LMNB1
"MICROCEPHALY 27, PRIMARY, AUTOSOMAL DOMINANT",1,LMNB2
"MICROCEPHALY 28, PRIMARY, AUTOSOMAL RECESSIVE",1,RRP7A
"MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE",1,CDK5RAP2
"MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE",1,KNL1
"MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE",1,ASPM
"MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE",1,CENPJ
"MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE",1,STIL
"MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE",1,CEP135
"MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE",1,CEP152
"MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1",1,TUBGCP6
"MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2",1,PLK4
"MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3",1,TUBGCP4
"MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION",1,KIF11
"MICROCEPHALY, AMISH TYPE",1,SLC25A19
"MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM",1,KCNA4
"MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS",1,MSMO1
"MICROCEPHALY, DEVELOPMENTAL DELAY, AND BRITTLE HAIR SYNDROME",1,CARS1
"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1",1,IER3IP1
"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 2",1,YIPF5
"MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME",1,CTU2
"MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS",1,WDR4
"MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2",1,TOP3A
"MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY",1,MED17
"MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY",1,QARS1
"MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY",1,PNKP
"MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1",1,TRMT10A
"MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2",1,PPP1R15B
"MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES",1,DONSON
"MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES",1,RTTN
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME,1,STAMBP
MICROCEPHALY-MICROMELIA SYNDROME,1,DONSON
"MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS",1,ADAMTS18
"MICROCORNEA, ROD-CONE DYSTROPHY, CATARACT, AND POSTERIOR STAPHYLOMA 1",1,ARL2
MICROHYDRANENCEPHALY,1,NDE1
MICROPHTHALMIA WITH LIMB ANOMALIES,1,SMOC1
"MICROPHTHALMIA, ISOLATED 2",1,VSX2
"MICROPHTHALMIA, ISOLATED 3",1,RAX
"MICROPHTHALMIA, ISOLATED 4",1,GDF6
"MICROPHTHALMIA, ISOLATED 5",1,MFRP
"MICROPHTHALMIA, ISOLATED 6",1,PRSS56
"MICROPHTHALMIA, ISOLATED 7",1,GDF3
"MICROPHTHALMIA, ISOLATED 8",1,ALDH1A3
"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10",1,RBP4
"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3",1,VSX2
"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5",1,SHH
"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6",2,"GDF6, GDF3"
"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7",1,ABCB6
"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9",1,TENM3
"MICROPHTHALMIA, SYNDROMIC 1",2,"BCOR, NAA10"
"MICROPHTHALMIA, SYNDROMIC 11",1,VAX1
"MICROPHTHALMIA, SYNDROMIC 12",1,RARB
"MICROPHTHALMIA, SYNDROMIC 13",1,HMGB3
"MICROPHTHALMIA, SYNDROMIC 2",1,BCOR
"MICROPHTHALMIA, SYNDROMIC 3",2,"SIX6, SOX2"
"MICROPHTHALMIA, SYNDROMIC 5",1,OTX2
"MICROPHTHALMIA, SYNDROMIC 6",1,BMP4
"MICROPHTHALMIA, SYNDROMIC 9",1,STRA6
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME,1,MAB21L2
"MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA",1,LTBP2
"MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE",1,HOXA2
"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1",1,VEGFA
"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2",1,EPO
"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3",1,ACE
"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4",1,IL1RN
"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5",1,PON1
"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6",1,SOD2
"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7",1,HFE
"MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS",1,AMMECR1
"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1",3,"EDNRA, ESR1, TNF"
"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13",1,KCNK18
"MIGRAINE, FAMILIAL HEMIPLEGIC, 1",1,CACNA1A
"MIGRAINE, FAMILIAL HEMIPLEGIC, 2",1,ATP1A2
"MIGRAINE, FAMILIAL HEMIPLEGIC, 3",1,SCN1A
MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA,1,RYR1
MIRAGE SYNDROME,1,SAMD9
MIRROR MOVEMENTS 1,1,DCC
MIRROR MOVEMENTS 2,1,RAD51
MIRROR MOVEMENTS 3,1,DNAL4
MIRROR MOVEMENTS 4,1,NTN1
MISMATCH REPAIR CANCER SYNDROME 1,1,MLH1
MISMATCH REPAIR CANCER SYNDROME 2,1,MSH2
MISMATCH REPAIR CANCER SYNDROME 3,1,MSH6
MISMATCH REPAIR CANCER SYNDROME 4,1,PMS2
MITCHELL SYNDROME,1,ACOX1
MITCHELL-RILEY SYNDROME,1,RFX6
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1",1,NDUFS4
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10",1,NDUFAF2
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11",1,NDUFAF1
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12",1,NDUFA1
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13",1,NDUFA2
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14",1,NDUFA11
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15",1,NDUFAF4
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16",1,NDUFAF5
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17",1,NDUFAF6
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18",1,NDUFAF3
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19",1,FOXRED1
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2",1,NDUFS8
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20",1,ACAD9
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21",1,NUBPL
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22",1,NDUFA10
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23",1,NDUFA12
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24",1,NDUFB9
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25",1,NDUFB3
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26",1,NDUFA9
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27",1,MTFMT
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28",1,NDUFA13
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29",1,TMEM126B
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3",1,NDUFS7
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30",1,NDUFB11
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31",1,TIMMDC1
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32",1,NDUFB8
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33",1,NDUFA6
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34",1,NDUFAF8
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 35",1,NDUFB10
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36",1,NDUFC2
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37",1,NDUFA8
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4",1,NDUFV1
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5",1,NDUFS1
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6",1,NDUFS2
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7",1,NDUFV2
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8",1,NDUFS3
"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9",1,NDUFS6
"MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1",3,"SDHA, SDHD, SDHAF1"
"MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 2",1,SDHAF1
"MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3",1,SDHD
"MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 4",1,SDHB
"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1",1,BCS1L
"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10",1,UQCRFS1
"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2",1,TTC19
"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3",1,UQCRB
"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4",1,UQCRQ
"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5",1,UQCRC2
"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6",1,CYC1
"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7",1,UQCC2
"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8",1,LYRM7
"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9",1,UQCC3
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1",1,SURF1
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 10",1,COX14
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 11",1,COX20
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12",1,PET100
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 13",1,COA6
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 14",1,COA3
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15",1,COX8A
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16",1,COX4I1
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17",1,COA8
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18",1,COX6A2
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19",1,PET117
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 2",1,SCO2
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20",1,COX5A
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21",1,NDUFA4
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22",1,COX16
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3",1,COX10
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4",1,SCO1
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5",1,LRPPRC
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6",1,COX15
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7",1,COX6B1
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 8",1,TACO1
"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 9",1,COA5
"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1",1,ATPAF2
"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2",1,TMEM70
"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3",1,ATP5F1E
"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4",1,ATP5F1A
"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5",1,ATP5F1D
"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6",1,ATP5MK
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE),2,"TYMP, POLG"
MITOCHONDRIAL DNA DEPLETION SYNDROME 11,1,MGME1
"MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT",1,SLC25A4
"MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE",1,SLC25A4
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE),1,FBXL4
MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE),1,OPA1
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE),1,TFAM
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE),1,POLG2
MITOCHONDRIAL DNA DEPLETION SYNDROME 16B (NEUROOPHTHALMIC TYPE),1,POLG2
MITOCHONDRIAL DNA DEPLETION SYNDROME 17,1,MRM2
MITOCHONDRIAL DNA DEPLETION SYNDROME 18,1,SLC25A21
MITOCHONDRIAL DNA DEPLETION SYNDROME 19,1,SLC25A10
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE),1,TK2
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE),1,DGUOK
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE),1,POLG
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE),1,POLG
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA),1,SUCLA2
MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE),1,MPV17
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE),1,TWNK
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY),1,RRM2B
MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA),1,SUCLG1
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS,1,PNPLA8
"MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES",7,"MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND5, MT-ND6"
"MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY",1,FDX2
MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY,1,SLC25A3
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY,1,MPC1
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY,1,ECHS1
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY,2,"HADHA, HADHB"
MITRAL VALVE PROLAPSE 2,1,DCHS1
MITRAL VALVE PROLAPSE 3,1,DZIP1
MIYOSHI MUSCULAR DYSTROPHY 1,1,DYSF
MIYOSHI MUSCULAR DYSTROPHY 3,1,ANO5
MOHR-TRANEBJAERG SYNDROME,1,TIMM8A
"MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A",1,MOCS1
"MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B",1,MOCS2
"MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C",1,GPHN
MONILETHRIX,3,"KRT81, KRT83, KRT86"
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY,1,SLC16A1
"MONONEUROPATHY OF THE MEDIAN NERVE, MILD",1,SH3TC2
MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 1,1,SAMD9L
MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 2,1,SAMD9
MORBID OBESITY AND SPERMATOGENIC FAILURE,1,CEP19
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1,1,BUB1B
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2,1,CEP57
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3,1,TRIP13
MOWAT-WILSON SYNDROME,1,ZEB2
MOYAMOYA DISEASE 2,1,RNF213
MOYAMOYA DISEASE 5,1,ACTA2
MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA,1,GUCY1A1
MUCKLE-WELLS SYNDROME,1,NLRP3
"MUCOCUTANEOUS ULCERATION, CHRONIC",1,RELA
"MUCOEPITHELIAL DYSPLASIA, HEREDITARY",1,SREBF1
MUCOLIPIDOSIS II ALPHA/BETA,1,GNPTAB
MUCOLIPIDOSIS III ALPHA/BETA,1,GNPTAB
MUCOLIPIDOSIS III GAMMA,1,GNPTG
MUCOLIPIDOSIS IV,1,MCOLN1
"MUCOPOLYSACCHARIDOSIS, TYPE II",1,IDS
"MUCOPOLYSACCHARIDOSIS, TYPE IIIA",1,SGSH
"MUCOPOLYSACCHARIDOSIS, TYPE IIIB",1,NAGLU
"MUCOPOLYSACCHARIDOSIS, TYPE IIIC",1,HGSNAT
"MUCOPOLYSACCHARIDOSIS, TYPE IIID",1,GNS
"MUCOPOLYSACCHARIDOSIS, TYPE IVA",1,GALNS
"MUCOPOLYSACCHARIDOSIS, TYPE IVB",1,GLB1
"MUCOPOLYSACCHARIDOSIS, TYPE IX",1,HYAL1
"MUCOPOLYSACCHARIDOSIS, TYPE VI",1,ARSB
"MUCOPOLYSACCHARIDOSIS, TYPE VII",1,GUSB
"MUCOPOLYSACCHARIDOSIS, TYPE X",1,ARSK
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME,1,VPS33A
MUENKE SYNDROME,1,FGFR3
MUIR-TORRE SYNDROME,2,"MLH1, MSH2"
MULIBREY NANISM,1,TRIM37
MULLEGAMA-KLEIN-MARTINEZ SYNDROME,1,STAG2
MULLERIAN APLASIA AND HYPERANDROGENISM,1,WNT4
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME,1,MAFB
"MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY",1,MMP2
"MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY",1,CEP55
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY,3,"ETFA, ETFB, ETFDH"
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1,1,PIGN
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2,1,PIGA
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3,1,PIGT
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4,1,PIGQ
"MULTIPLE CONGENITAL ANOMALIES-NEURODEVELOPMENTAL SYNDROME, X-LINKED",1,OTUD5
"MULTIPLE ENDOCRINE NEOPLASIA, TYPE I",1,MEN1
"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA",1,RET
"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB",1,RET
"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV",1,CDKN1B
MULTIPLE FIBROADENOMAS OF THE BREAST,1,PRLR
"MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS",2,"B3GAT3, CHST3"
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1,1,NFU1
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA,1,BOLA3
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3,1,IBA57
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4,1,ISCA2
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5,1,ISCA1
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6,1,PMPCB
"MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT",1,CHRNG
"MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE",3,"CHRNA1, CHRND, CHRNG"
"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO",3,"HLA-DQB1, HLA-DRB1, PDCD1"
"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5",1,TNFRSF1A
"MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO",1,TGFBR1
MULTIPLE SULFATASE DEFICIENCY,1,SUMF1
MULTIPLE SYNOSTOSES SYNDROME 1,1,NOG
MULTIPLE SYNOSTOSES SYNDROME 2,1,GDF5
MULTIPLE SYNOSTOSES SYNDROME 3,1,FGF9
MULTIPLE SYNOSTOSES SYNDROME 4,1,GDF6
"MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO",1,COQ2
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME,1,ACTA2
MUNGAN SYNDROME,1,RAD21
MUSCLE HYPERTROPHY,1,MSTN
"MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE",1,LIMS2
"MUSCULAR DYSTROPHY, BECKER TYPE",1,DMD
"MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME",1,GGPS1
"MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A",1,LAMA2
"MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE",1,TRIP4
"MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY",1,ITGA7
"MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED",1,LMNA
"MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE",1,CHKB
"MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY",1,INPP5K
"MUSCULAR DYSTROPHY, DUCHENNE TYPE",1,DMD
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1",1,DNAJB6
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2",1,TNPO3
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 3",1,HNRNPDL
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4",1,CAPN3
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1",1,CAPN3
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10",1,TTN
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12",1,ANO5
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17",1,PLEC
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18",1,TRAPPC11
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2",1,DYSF
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21",1,POGLUT1
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23",1,LAMA2
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25",1,BVES
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 26",1,POPDC3
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 27",1,JAG2
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3",1,SGCA
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4",1,SGCB
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5",1,SGCG
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6",1,SGCD
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 7",1,TCAP
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 8",1,TRIM32
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1",4,"FKTN, POMT2, FKRP, LARGE1"
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10",1,RXYLT1
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11",1,B3GALNT2
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12",1,POMK
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13",1,B4GAT1
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14",1,GMPPB
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2",1,POMT2
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3",1,POMGNT1
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4",1,FKTN
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5",1,FKRP
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6",1,LARGE1
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7",1,CRPPA
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8",1,POMGNT2
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9",1,DAG1
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14",1,GMPPB
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 15",1,DPM3
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2",1,POMT2
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 3",1,POMGNT1
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6",1,LARGE1
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5",1,FKRP
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 4",1,FKTN
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12",1,POMK
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14",1,GMPPB
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15",1,DPM3
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2",1,POMT2
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3",1,POMGNT1
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4",1,FKTN
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5",1,FKRP
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7",1,CRPPA
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8",1,POMGNT2
"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9",1,DAG1
"MYASTHENIC SYNDROME, CONGENITAL, 10",1,DOK7
"MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY",1,RAPSN
"MYASTHENIC SYNDROME, CONGENITAL, 12",1,GFPT1
"MYASTHENIC SYNDROME, CONGENITAL, 13",1,DPAGT1
"MYASTHENIC SYNDROME, CONGENITAL, 14",1,ALG2
"MYASTHENIC SYNDROME, CONGENITAL, 15",1,ALG14
"MYASTHENIC SYNDROME, CONGENITAL, 16",1,SCN4A
"MYASTHENIC SYNDROME, CONGENITAL, 17",1,LRP4
"MYASTHENIC SYNDROME, CONGENITAL, 18",1,SNAP25
"MYASTHENIC SYNDROME, CONGENITAL, 19",1,COL13A1
"MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL",1,CHRNA1
"MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL",1,CHRNA1
"MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC",1,SLC5A7
"MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC",1,SLC18A3
"MYASTHENIC SYNDROME, CONGENITAL, 22",1,PREPL
"MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC",1,SLC25A1
"MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC",1,MYO9A
"MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC",1,VAMP1
"MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL",1,CHRNB1
"MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY",1,CHRNB1
"MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL",1,CHRND
"MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL",1,CHRND
"MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY",1,CHRND
"MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL",1,CHRNE
"MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL",1,CHRNE
"MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY",2,"CHRNE, GFPT1"
"MYASTHENIC SYNDROME, CONGENITAL, 5",1,COLQ
"MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC",1,CHAT
"MYASTHENIC SYNDROME, CONGENITAL, 7A, PRESYNAPTIC, AND DISTAL MOTOR NEUROPATHY, AUTOSOMAL DOMINANT",1,SYT2
"MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE",1,SYT2
"MYASTHENIC SYNDROME, CONGENITAL, 8",1,AGRN
"MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY",1,MUSK
"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",10,"TIRAP, CISH, CD209, SP110, IRGM, IFNG, IFNGR1, CCL2, SLC11A1, TLR2"
MYELODYSPLASTIC SYNDROME,5,"ASXL1, SF3B1, GATA2, GNB1, TET2"
MYELOFIBROSIS,4,"SH2B3, JAK2, MPL, CALR"
"MYELOMA, MULTIPLE",2,"LIG4, CCND1"
MYELOPEROXIDASE DEFICIENCY,1,MPO
"MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA",1,PDGFRB
"MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO",1,DDX41
MYHRE SYNDROME,1,SMAD4
"MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO",12,"ESR1, F7, F13A1, GCLC, GCLM, ITGB3, LGALS2, LTA, OLR1, PSMA6, TNFSF4, LRP8"
MYOCLONIC EPILEPSY OF LAFORA,1,NHLRC1
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG,1,CSTB
"MYOCLONIC EPILEPSY, FAMILIAL INFANTILE",1,TBC1D24
MYOCLONIC-ATONIC EPILEPSY,1,SLC6A1
"MYOCLONUS, FAMILIAL, 1",1,NOL3
"MYOCLONUS, FAMILIAL, 2",1,SCN8A
"MYOCLONUS, INTRACTABLE, NEONATAL",1,KIF5A
MYOFIBRILLAR MYOPATHY 10,1,SVIL
MYOFIBRILLAR MYOPATHY 11,1,UNC45B
"MYOFIBROMATOSIS, INFANTILE, 1",1,PDGFRB
"MYOFIBROMATOSIS, INFANTILE, 2",1,NOTCH3
"MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE",1,LPIN1
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY,1,AMPD1
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS,1,MICU1
"MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY",1,ISCU
"MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET",1,MEGF10
"MYOPATHY, AUTOSOMAL RECESSIVE, WITH RIGID SPINE AND DISTAL JOINT CONTRACTURES",1,TOR1AIP1
"MYOPATHY, CENTRONUCLEAR, 1",2,"DNM2, MTMR14"
"MYOPATHY, CENTRONUCLEAR, 2",1,BIN1
"MYOPATHY, CENTRONUCLEAR, 4",1,CCDC78
"MYOPATHY, CENTRONUCLEAR, 5",1,SPEG
"MYOPATHY, CENTRONUCLEAR, X-LINKED",1,MTM1
"MYOPATHY, CONGENITAL PROXIMAL, WITH MINICORE LESIONS",1,FXR1
"MYOPATHY, CONGENITAL, BAILEY-BLOCH",1,STAC3
"MYOPATHY, CONGENITAL, COMPTON-NORTH",1,CNTN1
"MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS",1,PAX7
"MYOPATHY, CONGENITAL, WITH DIAPHRAGMATIC DEFECTS, RESPIRATORY INSUFFICIENCY, AND DYSMORPHIC FACIES",1,MYOD1
"MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY",1,MYL1
"MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION",6,"MYH7, SELENON, ACTA1, RYR1, TPM2, TPM3"
"MYOPATHY, CONGENITAL, WITH RESPIRATORY INSUFFICIENCY AND BONE FRACTURES",1,FXR1
"MYOPATHY, CONGENITAL, WITH STRUCTURED CORES AND Z-LINE ABNORMALITIES",1,ACTN2
"MYOPATHY, CONGENITAL, WITH TREMOR",1,MYBPC1
"MYOPATHY, DISTAL, 1",1,MYH7
"MYOPATHY, DISTAL, 4",1,FLNC
"MYOPATHY, DISTAL, 5",1,ADSS1
"MYOPATHY, DISTAL, 6, ADULT-ONSET, AUTOSOMAL DOMINANT",1,ACTN2
"MYOPATHY, DISTAL, TATEYAMA TYPE",1,CAV3
"MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET",1,DYSF
"MYOPATHY, DISTAL, WITH RIMMED VACUOLES",1,SQSTM1
"MYOPATHY, EPILEPSY, AND PROGRESSIVE CEREBRAL ATROPHY",1,ALG14
"MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT",1,CHCHD10
"MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1",1,PUS1
"MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2",1,YARS2
"MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT AND DEVELOPMENTAL DELAY",1,GFER
"MYOPATHY, MITOCHONDRIAL, AND ATAXIA",1,MSTO1
"MYOPATHY, MYOFIBRILLAR, 1",1,DES
"MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY",1,MYL2
"MYOPATHY, MYOFIBRILLAR, 2",1,CRYAB
"MYOPATHY, MYOFIBRILLAR, 3",1,MYOT
"MYOPATHY, MYOFIBRILLAR, 4",1,LDB3
"MYOPATHY, MYOFIBRILLAR, 5",1,FLNC
"MYOPATHY, MYOFIBRILLAR, 6",1,BAG3
"MYOPATHY, MYOFIBRILLAR, 7",1,KY
"MYOPATHY, MYOFIBRILLAR, 8",1,PYROXD1
"MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE",1,TTN
"MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED",1,CRYAB
"MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT",1,MYH7
"MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE",1,MYH7
"MYOPATHY, PROXIMAL, WITH OPHTHALMOPLEGIA",1,MYH2
"MYOPATHY, SCAPULOHUMEROPERONEAL",1,ACTA1
"MYOPATHY, SPHEROID BODY",1,MYOT
"MYOPATHY, TUBULAR AGGREGATE, 1",1,STIM1
"MYOPATHY, TUBULAR AGGREGATE, 2",1,ORAI1
"MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES",1,CASQ1
"MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY",1,VMA21
"MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY",1,FHL1
"MYOPIA 21, AUTOSOMAL DOMINANT",1,ZNF644
"MYOPIA 22, AUTOSOMAL DOMINANT",1,PRIMPOL
"MYOPIA 23, AUTOSOMAL RECESSIVE",1,LRPAP1
"MYOPIA 24, AUTOSOMAL DOMINANT",1,SLC39A5
"MYOPIA 25, AUTOSOMAL DOMINANT",1,P4HA2
"MYOPIA 26, X-LINKED, FEMALE-LIMITED",1,ARR3
MYOPIA 27,1,CPSF1
MYOPIA 6,1,SCO2
"MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION",1,P3H2
"MYOSCLEROSIS, AUTOSOMAL RECESSIVE",1,COL6A2
"MYOTONIA CONGENITA, AUTOSOMAL DOMINANT",1,CLCN1
"MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE",1,CLCN1
"MYOTONIA, POTASSIUM-AGGRAVATED",1,SCN4A
MYOTONIC DYSTROPHY 1,1,DMPK
MYOTONIC DYSTROPHY 2,1,CNBP
"MYXOMA, INTRACARDIAC",1,PRKAR1A
N-ACETYLASPARTATE DEFICIENCY,1,NAT8L
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY,1,NAGS
"NABAIS SA-DE VRIES SYNDROME, TYPE 1",1,SPOP
"NABAIS SA-DE VRIES SYNDROME, TYPE 2",1,SPOP
NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME,1,KRT14
"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1",1,FZD6
"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3",1,PLCD1
"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4",1,RSPO4
"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8",1,COL7A1
NAIL-PATELLA SYNDROME,1,LMX1B
NANCE-HORAN SYNDROME,1,NHS
NANOPHTHALMOS 2,1,MFRP
NANOPHTHALMOS 4,1,TMEM98
NARCOLEPSY 1,1,HCRT
NARCOLEPSY 7,1,MOG
NASOPHARYNGEAL CARCINOMA,1,TP53
"NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3",1,MST1R
NAXOS DISEASE,1,JUP
NEMALINE MYOPATHY 1,1,TPM3
NEMALINE MYOPATHY 10,1,LMOD3
"NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE",1,MYPN
NEMALINE MYOPATHY 2,1,NEB
NEMALINE MYOPATHY 3,1,ACTA1
NEMALINE MYOPATHY 4,1,TPM2
NEMALINE MYOPATHY 5,1,TNNT1
NEMALINE MYOPATHY 6,1,KBTBD13
NEMALINE MYOPATHY 7,1,CFL2
NEMALINE MYOPATHY 8,1,KLHL40
NEMALINE MYOPATHY 9,1,KLHL41
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS,1,AVPR2
"NEPHROLITHIASIS, CALCIUM OXALATE",1,SLC26A1
"NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO",1,ZNF365
"NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE",1,CLCN5
"NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1",1,SLC34A1
"NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2",1,SLC9A3R1
NEPHRONOPHTHISIS 1,1,NPHP1
NEPHRONOPHTHISIS 11,1,TMEM67
NEPHRONOPHTHISIS 12,1,TTC21B
NEPHRONOPHTHISIS 13,1,WDR19
NEPHRONOPHTHISIS 14,1,ZNF423
NEPHRONOPHTHISIS 15,1,CEP164
NEPHRONOPHTHISIS 16,1,ANKS6
NEPHRONOPHTHISIS 18,1,CEP83
NEPHRONOPHTHISIS 19,1,DCDC2
NEPHRONOPHTHISIS 2,1,INVS
NEPHRONOPHTHISIS 20,1,MAPKBP1
NEPHRONOPHTHISIS 3,1,NPHP3
NEPHRONOPHTHISIS 4,1,NPHP4
NEPHRONOPHTHISIS 7,1,GLIS2
NEPHRONOPHTHISIS 9,1,NEK8
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1,1,XPNPEP3
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 2,1,SLC41A1
"NEPHROTIC SYNDROME, TYPE 1",1,NPHS1
"NEPHROTIC SYNDROME, TYPE 10",1,EMP2
"NEPHROTIC SYNDROME, TYPE 11",1,NUP107
"NEPHROTIC SYNDROME, TYPE 12",1,NUP93
"NEPHROTIC SYNDROME, TYPE 13",1,NUP205
"NEPHROTIC SYNDROME, TYPE 14",1,SGPL1
"NEPHROTIC SYNDROME, TYPE 15",1,MAGI2
"NEPHROTIC SYNDROME, TYPE 16",1,KANK2
"NEPHROTIC SYNDROME, TYPE 17",1,NUP85
"NEPHROTIC SYNDROME, TYPE 18",1,NUP133
"NEPHROTIC SYNDROME, TYPE 19",1,NUP160
"NEPHROTIC SYNDROME, TYPE 2",1,NPHS2
"NEPHROTIC SYNDROME, TYPE 20",1,TBC1D8B
"NEPHROTIC SYNDROME, TYPE 21",1,AVIL
"NEPHROTIC SYNDROME, TYPE 22",1,NOS1AP
"NEPHROTIC SYNDROME, TYPE 23",1,KIRREL1
"NEPHROTIC SYNDROME, TYPE 24",1,DAAM2
"NEPHROTIC SYNDROME, TYPE 3",1,PLCE1
"NEPHROTIC SYNDROME, TYPE 4",1,WT1
"NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES",1,LAMB2
"NEPHROTIC SYNDROME, TYPE 6",1,PTPRO
"NEPHROTIC SYNDROME, TYPE 7",1,DGKE
"NEPHROTIC SYNDROME, TYPE 8",1,ARHGDIA
"NEPHROTIC SYNDROME, TYPE 9",1,COQ8B
NESCAV SYNDROME,1,KIF1A
NEU-LAXOVA SYNDROME 1,1,PHGDH
NEU-LAXOVA SYNDROME 2,1,PSAT1
"NEURAL TUBE DEFECTS, FOLATE-SENSITIVE",4,"MTHFD1, MTHFR, MTR, MTRR"
"NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO",5,"VANGL2, CCL2, TBXT, FUZ, VANGL1"
NEURAMINIDASE DEFICIENCY,1,NEU1
"NEUROBLASTOMA, SUSCEPTIBILITY TO, 1",1,KIF1B
"NEUROBLASTOMA, SUSCEPTIBILITY TO, 2",1,PHOX2B
"NEUROBLASTOMA, SUSCEPTIBILITY TO, 3",1,ALK
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY,1,FOLR1
NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY,1,SDHA
"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",1,SQSTM1
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1,1,PANK2
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A,1,PLA2G6
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B,1,PLA2G6
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3,1,FTL
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4,1,C19orf12
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5,1,WDR45
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6,1,COASY
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7,1,REPS1
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8,1,CRAT
"NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES",1,ADPRS
"NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE",1,SLC44A1
"NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY",1,UBTF
"NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY",1,AGTPBP1
"NEURODEGENERATION, CHILDHOOD-ONSET, WITH HYPOTONIA, RESPIRATORY INSUFFICIENCY, AND BRAIN IMAGING ABNORMALITIES",1,CLCN6
"NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA",1,IREB2
"NEURODEGENERATION, INFANTILE-ONSET, BIOTIN-RESPONSIVE",1,SLC5A6
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES,1,PPP2CA
NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY,1,PTPN23
NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES,1,WASF1
"NEURODEVELOPMENTAL DISORDER WITH ATAXIA, HYPOTONIA, AND MICROCEPHALY",1,SVBP
"NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER",1,RAB11B
"NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA",1,NTNG2
"NEURODEVELOPMENTAL DISORDER WITH BRAIN ABNORMALITIES, POOR GROWTH, AND DYSMORPHIC FACIES",1,ADAT3
NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES,1,DHX37
"NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS",1,PIGU
"NEURODEVELOPMENTAL DISORDER WITH CARDIOMYOPATHY, SPASTICITY, AND BRAIN ABNORMALITIES",1,SHMT2
"NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES",1,INTS1
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION,1,NFASC
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND MOTOR DYSFUNCTION,1,GEMIN5
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES,1,BRAT1
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR HYPOPLASIA AND SPASTICITY,1,INTS8
NEURODEVELOPMENTAL DISORDER WITH CEREBRAL ATROPHY AND VARIABLE FACIAL DYSMORPHISM,1,TTC5
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES,1,KDM6B
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND CEREBELLAR HYPOPLASIA,1,EXOC2
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES,1,BPTF
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES,1,ZMIZ1
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM,1,SUPT16H
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND VARIABLE SEIZURES,1,EMC10
"NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, IMPAIRED SPEECH, AND HYPOTONIA",1,MADD
"NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES",1,KAT5
"NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FEATURES, SPASTICITY, AND BRAIN ABNORMALITIES",1,PGAP1
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM,1,LNPK
"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION",1,NACC1
"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY",1,TRAPPC4
NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY,1,SPATA5L1
"NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS, SEIZURES, AND BRAIN ABNORMALITIES",1,SPATA5
NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND DYSKINESIA,1,ADCY5
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS,1,VAMP2
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND BRAIN ABNORMALITIES,1,CLCN3
"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CEREBELLAR ATROPHY, WITH OR WITHOUT SEIZURES",1,PIGK
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES,1,GNB2
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND GROSS MOTOR AND SPEECH DELAY,1,UBE4A
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES,1,DEAF1
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES,1,POLR2A
"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, CRANIOFACIAL ABNORMALITIES, AND SEIZURES",1,SNIP1
"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, FACIAL DYSMORPHISM, AND BRAIN ABNORMALITIES",1,PPP1R21
"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES",1,ADARB1
"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION",1,RALGAPA1
"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS",1,SPTBN4
"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE",1,HECW2
"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, STEREOTYPIC HAND MOVEMENTS, AND IMPAIRED LANGUAGE",1,MEF2C
"NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA",1,DOCK3
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES,1,GRIK2
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS,1,ZNF142
NEURODEVELOPMENTAL DISORDER WITH INFANTILE EPILEPTIC SPASMS,1,NCDN
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS,1,GNAO1
NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES,1,GRIA2
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND GRAY SCLERAE,1,PUS3
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES,1,DYNC1I2
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES",1,SMPD4
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES",1,SARS1
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES",1,GEMIN4
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY",1,TMX2
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY",1,TRAPPC6B
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION",1,MTHFS
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES",1,PRUNE1
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES",1,NARS1
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES",1,NARS1
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND BRAIN ATROPHY",1,EXOC8
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY",1,VARS1
"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND NEONATAL CHOLESTASIS",1,VPS50
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS,1,ARHGEF2
NEURODEVELOPMENTAL DISORDER WITH MOTOR AND SPEECH DELAY AND BEHAVIORAL ABNORMALITIES,1,TMEM222
"NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES",1,ZSWIM6
"NEURODEVELOPMENTAL DISORDER WITH NEONATAL RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND FEEDING DIFFICULTIES",1,PURA
NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES,1,DLL1
"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART",1,RERE
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISM OR SEIZURES,1,CUL3
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISTIC FEATURES AND/OR STRUCTURAL BRAIN ABNORMALITIES,1,NOVA2
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT EARLY-ONSET GENERALIZED EPILEPSY,1,NBEA
"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT",1,GRIN1
"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE",1,GRIN1
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES,1,GRIA4
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES,1,MAPK8IP3
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE MOVEMENT OR BEHAVIORAL ABNORMALITIES,1,KCNN2
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS,1,GABBR2
"NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES",1,PLAA
"NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN IMAGING ABNORMALITIES",1,MFSD2A
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES,1,HPDL
"NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES",1,IRF2BPL
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ABNORMALITIES,1,CLCN3
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ATROPHY,1,EXOC7
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND GINGIVAL OVERGROWTH,1,TBC1D2B
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS,1,CACNA1B
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT,1,DHPS
"NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES",1,GRM7
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE,1,DHX30
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS,1,CTNNB1
NEURODEVELOPMENTAL DISORDER WITH SPASTIC PARAPLEGIA AND MICROCEPHALY,1,GPT2
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES,1,WDR45B
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH,1,UFC1
"NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, CATARACTS, AND CEREBELLAR HYPOPLASIA",1,MED27
"NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, HYPOMYELINATING LEUKODYSTROPHY, AND BRAIN ABNORMALITIES",1,PI4KA
NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND DYSMORPHIC FACIES,1,SETD1A
NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES,1,RAC3
NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES,1,HK1
"NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES",1,WARS2
"NEURODEVELOPMENTAL DISORDER, NONPROGRESSIVE, WITH SPASTICITY AND TRANSIENT OPISTHOTONUS",1,TNR
"NEURODEVELOPMENTAL, JAW, EYE, AND DIGITAL SYNDROME",1,FBXW11
NEURODEVELOPMENTAL-CRANIOFACIAL SYNDROME WITH VARIABLE RENAL AND CARDIAC ABNORMALITIES,1,ZMYM2
NEUROFACIOSKELETAL SYNDROME WITH OR WITHOUT RENAL AGENESIS,1,HS2ST1
"NEUROFIBROMATOSIS, FAMILIAL SPINAL",1,NF1
"NEUROFIBROMATOSIS, TYPE I",1,NF1
"NEUROFIBROMATOSIS, TYPE II",1,NF2
NEUROFIBROMATOSIS-NOONAN SYNDROME,1,NF1
"NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 1",1,PTRH2
"NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2",1,YARS1
NEUROMUSCULAR OCULOAUDITORY SYNDROME,1,DHX16
"NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE",1,HINT1
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA",1,HSPB8
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB",1,HSPB1
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC",1,HSPB3
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID",1,FBXO38
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX",1,WARS1
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA",2,"GARS1, BSCL2"
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB",1,REEP1
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VC",1,BSCL2
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA",1,SLC5A7
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB",1,DCTN1
"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII",1,TRPV4
NEUROOCULAR SYNDROME,1,PRR12
NEUROOCULOCARDIOGENITOURINARY SYNDROME,1,WDR37
"NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA",1,MT-ATP6
"NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE",1,EGR2
"NEUROPATHY, CONGENITAL HYPOMYELINATING, 2",1,MPZ
"NEUROPATHY, CONGENITAL HYPOMYELINATING, 3",1,CNTNAP1
"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE",1,TFG
"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE",1,HK1
"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA, WITH OPTIC ATROPHY",1,MFN2
"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, WITH OPTIC ATROPHY",1,SLC25A46
"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY",1,PDXK
"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA",1,SPTLC1
"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC",1,SPTLC2
"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA",4,"RETREG1, KIF1A, SCN9A, WNK1"
"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB",1,RETREG1
"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III",1,ELP1
"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY",1,TECPR2
"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V",1,NGF
"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI",1,DST
"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII",1,SCN11A
"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII",1,PRDM12
"NEUROPATHY, HEREDITARY SENSORY, TYPE ID",1,ATL1
"NEUROPATHY, HEREDITARY SENSORY, TYPE IE",1,DNMT1
"NEUROPATHY, HEREDITARY SENSORY, TYPE IF",1,ATL3
"NEUROPATHY, HEREDITARY SENSORY, TYPE IIC",1,KIF1A
"NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE",1,CCT5
"NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES",1,PMP22
"NEUROPATHY, HEREDITARY, WITH OR WITHOUT AGE-RELATED MACULAR DEGENERATION",1,FBLN5
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY,1,PNPLA2
"NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS",1,GFI1
"NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT",1,ELANE
"NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT",1,GFI1
"NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE",1,HAX1
"NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE",1,G6PC3
"NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE",1,VPS45
"NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE",1,JAGN1
"NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE",1,CSF3R
"NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT",1,SRP54
"NEUTROPENIA, SEVERE CONGENITAL, X-LINKED",1,WAS
"NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE",1,MEFV
NEVUS COMEDONICUS,1,NEK9
"NEVUS, EPIDERMAL",4,"FGFR3, HRAS, NRAS, PIK3CA"
NEWFOUNDLAND ROD-CONE DYSTROPHY,1,RLBP1
NICOLAIDES-BARAITSER SYNDROME,1,SMARCA2
"NIEMANN-PICK DISEASE, TYPE A",1,SMPD1
"NIEMANN-PICK DISEASE, TYPE B",1,SMPD1
"NIEMANN-PICK DISEASE, TYPE C1",1,NPC1
"NIEMANN-PICK DISEASE, TYPE C2",1,NPC2
"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1",1,RHO
"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2",1,PDE6B
"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3",1,GNAT1
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A",1,NYX
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B",1,GRM6
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C",1,TRPM1
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D",1,SLC24A1
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E",1,GPR179
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F",1,LRIT3
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G",1,GNAT1
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H",1,GNB3
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A",1,CACNA1F
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE1I",1,GUCY2D
NIJMEGEN BREAKAGE SYNDROME,1,NBN
NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER,1,RAD50
NIVELON-NIVELON-MABILLE SYNDROME,1,HHAT
NIZON-ISIDOR SYNDROME,1,MED12L
NONAKA MYOPATHY,1,GNE
"NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO",1,GP1BA
NOONAN SYNDROME 1,3,"MAP2K1, PTPN11, BRAF"
NOONAN SYNDROME 10,1,LZTR1
NOONAN SYNDROME 11,1,MRAS
NOONAN SYNDROME 12,1,RRAS2
NOONAN SYNDROME 13,1,MAPK1
NOONAN SYNDROME 2,1,LZTR1
NOONAN SYNDROME 3,1,KRAS
NOONAN SYNDROME 4,1,SOS1
NOONAN SYNDROME 5,1,RAF1
NOONAN SYNDROME 6,1,NRAS
NOONAN SYNDROME 7,1,BRAF
NOONAN SYNDROME 8,1,RIT1
NOONAN SYNDROME 9,1,SOS2
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1,1,SHOC2
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2,1,PPP1CB
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA,1,CBL
NORRIE DISEASE,1,NDP
"NYSTAGMUS 1, CONGENITAL, X-LINKED",1,FRMD7
"NYSTAGMUS 6, CONGENITAL, X-LINKED",1,GPR143
O'DONNELL-LURIA-RODAN SYNDROME,1,KMT2E
OBESITY,11,"ADRB2, ADRB3, AGRP, ENPP1, GHRL, POMC, PPARG, UCP3, NR0B2, CARTPT, SDC3"
"OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR",1,POMC
"OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY",1,NTRK2
OBSESSIVE-COMPULSIVE DISORDER,2,"HTR2A, SLC6A4"
OCCIPITAL HORN SYNDROME,1,ATP7A
OCCULT MACULAR DYSTROPHY,1,RP1L1
OCULOAURICULAR SYNDROME,1,HMX1
"OCULOCUTANEOUS ALBINISM, TYPE VIII",1,DCT
OCULODENTODIGITAL DYSPLASIA,1,GJA1
"OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE",1,GJA1
OCULOECTODERMAL SYNDROME,1,KRAS
OCULOGASTROINTESTINAL NEURODEVELOPMENTAL SYNDROME,1,CAPN15
OCULOMOTOR-ABDUCENS SYNKINESIS,1,ACKR3
OCULOPHARYNGEAL MUSCULAR DYSTROPHY,1,PABPN1
OCULOPHARYNGODISTAL MYOPATHY 1,1,LRP12
OCULOPHARYNGODISTAL MYOPATHY 2,1,GIPC1
OCULOSKELETODENTAL SYNDROME,1,PIK3C2A
ODONTOCHONDRODYSPLASIA 1,1,TRIP11
ODONTOCHONDRODYSPLASIA 2 WITH HEARING LOSS AND DIABETES,1,MIA3
ODONTOONYCHODERMAL DYSPLASIA,1,WNT10A
OGDEN SYNDROME,1,NAA10
OGUCHI DISEASE 1,1,SAG
OGUCHI DISEASE 2,1,GRK1
"OHDO SYNDROME, SBBYS VARIANT",1,KAT6B
"OHDO SYNDROME, X-LINKED",1,MED12
OKT4 EPITOPE DEFICIENCY,1,CD4
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME,1,CSNK2A1
OLIGODONTIA-COLORECTAL CANCER SYNDROME,1,AXIN2
OLIVER-MCFARLANE SYNDROME,1,PNPLA6
OLMSTED SYNDROME 1,1,TRPV3
OLMSTED SYNDROME 2,1,PERP
"OLMSTED SYNDROME, X-LINKED",1,MBTPS2
OMENN SYNDROME,3,"RAG1, RAG2, DCLRE1C"
OMODYSPLASIA 1,1,GPC6
OMODYSPLASIA 2,1,FZD2
"ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME",1,PIGF
OOCYTE MATURATION DEFECT 1,1,ZP1
OOCYTE MATURATION DEFECT 10,1,REC114
OOCYTE MATURATION DEFECT 11,1,ASTL
OOCYTE MATURATION DEFECT 12,1,FBXO43
OOCYTE MATURATION DEFECT 2,1,TUBB8
OOCYTE MATURATION DEFECT 3,1,ZP3
OOCYTE MATURATION DEFECT 4,1,PATL2
OOCYTE MATURATION DEFECT 5,1,WEE2
OOCYTE MATURATION DEFECT 6,1,ZP2
OOCYTE MATURATION DEFECT 7,1,PANX1
OOCYTE MATURATION DEFECT 8,1,BTG4
OOCYTE MATURATION DEFECT 9,1,TRIP13
"OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES",1,MYF5
"OPITZ GBBB SYNDROME, TYPE I",1,MID1
"OPITZ GBBB SYNDROME, TYPE II",1,SPECC1L
OPITZ-KAVEGGIA SYNDROME,1,MED12
OPSISMODYSPLASIA,1,INPPL1
OPTIC ATROPHY 1,1,OPA1
"OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES",1,RTN4IP1
OPTIC ATROPHY 11,1,YME1L1
OPTIC ATROPHY 12,1,AFG3L2
OPTIC ATROPHY 13 WITH RETINAL AND FOVEAL ABNORMALITIES,1,SSBP1
"OPTIC ATROPHY 3, AUTOSOMAL DOMINANT",1,OPA3
OPTIC ATROPHY 5,1,DNM1L
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY,1,TMEM126A
OPTIC ATROPHY 9,1,ACO2
"OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY",1,OPA1
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY,1,SIX6
"OPTIC NERVE HYPOPLASIA, BILATERAL",1,PAX6
"ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO",1,OTC
OROFACIAL CLEFT 10,1,SUMO1
OROFACIAL CLEFT 11,1,BMP4
OROFACIAL CLEFT 15,1,DLX4
OROFACIAL CLEFT 5,1,MSX1
"OROFACIAL CLEFT 6, SUSCEPTIBILITY TO",1,IRF6
OROFACIAL CLEFT 8,1,TP63
OROFACIODIGITAL SYNDROME I,1,OFD1
OROFACIODIGITAL SYNDROME IV,1,TCTN3
OROFACIODIGITAL SYNDROME V,1,DDX59
OROFACIODIGITAL SYNDROME VI,1,CPLANE1
OROFACIODIGITAL SYNDROME XIV,1,C2CD3
OROFACIODIGITAL SYNDROME XV,1,KIAA0753
OROFACIODIGITAL SYNDROME XVI,1,TMEM107
OROFACIODIGITAL SYNDROME XVII,1,INTU
OROFACIODIGITAL SYNDROME XVIII,1,IFT57
OROTIC ACIDURIA,1,UMPS
ORTHOSTATIC HYPOTENSION 1,1,DBH
ORTHOSTATIC HYPOTENSION 2,1,CYB561
ORTHOSTATIC INTOLERANCE,1,SLC6A2
"OSSEOUS HETEROPLASIA, PROGRESSIVE",1,GNAS
OSTEOARTHRITIS SUSCEPTIBILITY 1,1,FRZB
OSTEOARTHRITIS SUSCEPTIBILITY 2,1,MATN3
OSTEOARTHRITIS SUSCEPTIBILITY 3,1,ASPN
OSTEOARTHRITIS SUSCEPTIBILITY 5,1,GDF5
OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA,1,COL2A1
"OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS",1,CHST11
"OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE",1,TAPT1
"OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO",1,MET
"OSTEOGENESIS IMPERFECTA, TYPE I",1,COL1A1
"OSTEOGENESIS IMPERFECTA, TYPE II",2,"COL1A1, COL1A2"
"OSTEOGENESIS IMPERFECTA, TYPE III",2,"COL1A1, COL1A2"
"OSTEOGENESIS IMPERFECTA, TYPE IV",2,"COL1A1, COL1A2"
"OSTEOGENESIS IMPERFECTA, TYPE IX",1,PPIB
"OSTEOGENESIS IMPERFECTA, TYPE V",1,IFITM5
"OSTEOGENESIS IMPERFECTA, TYPE VI",1,SERPINF1
"OSTEOGENESIS IMPERFECTA, TYPE VII",1,CRTAP
"OSTEOGENESIS IMPERFECTA, TYPE VIII",1,P3H1
"OSTEOGENESIS IMPERFECTA, TYPE X",1,SERPINH1
"OSTEOGENESIS IMPERFECTA, TYPE XI",1,FKBP10
"OSTEOGENESIS IMPERFECTA, TYPE XII",1,SP7
"OSTEOGENESIS IMPERFECTA, TYPE XIII",1,BMP1
"OSTEOGENESIS IMPERFECTA, TYPE XIV",1,TMEM38B
"OSTEOGENESIS IMPERFECTA, TYPE XIX",1,MBTPS2
"OSTEOGENESIS IMPERFECTA, TYPE XV",1,WNT1
"OSTEOGENESIS IMPERFECTA, TYPE XVI",1,CREB3L1
"OSTEOGENESIS IMPERFECTA, TYPE XVII",1,SPARC
"OSTEOGENESIS IMPERFECTA, TYPE XVIII",1,TENT5A
"OSTEOGENESIS IMPERFECTA, TYPE XX",1,MESD
"OSTEOGENESIS IMPERFECTA, TYPE XXI",1,KDELR2
OSTEOGENIC SARCOMA,3,"CHEK2, RB1, TP53"
OSTEOGLOPHONIC DYSPLASIA,1,FGFR1
"OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS",1,IL1RN
OSTEOOTOHEPATOENTERIC SYNDROME,1,UNC45A
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS,1,AMER1
"OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4",1,CLCN7
"OSTEOPETROSIS, AUTOSOMAL DOMINANT 1",1,LRP5
"OSTEOPETROSIS, AUTOSOMAL DOMINANT 2",1,CLCN7
"OSTEOPETROSIS, AUTOSOMAL DOMINANT 3",1,PLEKHM1
"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1",1,TCIRG1
"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2",1,TNFSF11
"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3",1,CA2
"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5",1,OSTM1
"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6",1,PLEKHM1
"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7",1,TNFRSF11A
"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8",1,SNX10
OSTEOPOROSIS,5,"COL1A1, COL1A2, LRP5, CALCR, PDLIM4"
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME,1,LRP5
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA,1,LRRK1
"OTITIS MEDIA, SUSCEPTIBILITY TO",1,A2ML1
OTOFACIOCERVICAL SYNDROME 1,1,EYA1
"OTOFACIOCERVICAL SYNDROME 2, WITH T-CELL DEFICIENCY",1,PAX1
"OTOPALATODIGITAL SYNDROME, TYPE I",1,FLNA
"OTOPALATODIGITAL SYNDROME, TYPE II",1,FLNA
"OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT",1,COL11A2
"OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE",1,COL11A2
"OVALOCYTOSIS, SOUTHEAST ASIAN",1,SLC4A1
OVARIAN CANCER,7,"CTNNB1, ERBB2, AKT1, OPCML, PRKN, PIK3CA, CDH1"
OVARIAN DYSGENESIS 1,1,FSHR
OVARIAN DYSGENESIS 2,1,BMP15
OVARIAN DYSGENESIS 3,1,PSMC3IP
OVARIAN DYSGENESIS 4,1,MCM9
OVARIAN DYSGENESIS 5,1,SOHLH1
OVARIAN DYSGENESIS 6,1,NUP107
OVARIAN DYSGENESIS 7,1,MRPS22
OVARIAN DYSGENESIS 8,1,ESR2
OVARIAN DYSGENESIS 9,1,SPIDR
OVARIAN HYPERSTIMULATION SYNDROME,1,FSHR
OVERHYDRATED HEREDITARY STOMATOCYTOSIS,1,RHAG
OXOGLUTARATE DEHYDROGENASE DEFICIENCY,1,OGDH
"PACHYGYRIA, MICROCEPHALY, DEVELOPMENTAL DELAY, AND DYSMORPHIC FACIES, WITH OR WITHOUT SEIZURES",1,TUBGCP2
PACHYONYCHIA CONGENITA 1,1,KRT16
PACHYONYCHIA CONGENITA 2,1,KRT17
PACHYONYCHIA CONGENITA 3,1,KRT6A
PACHYONYCHIA CONGENITA 4,1,KRT6B
PAGANINI-MIOZZO SYNDROME,1,HS6ST2
"PAGET DISEASE OF BONE 2, EARLY-ONSET",1,TNFRSF11A
PAGET DISEASE OF BONE 3,1,SQSTM1
"PAGET DISEASE OF BONE 5, JUVENILE-ONSET",1,TNFRSF11B
PAGET DISEASE OF BONE 6,1,ZNF687
PALLISTER-HALL SYNDROME,1,GLI3
PALLISTER-HALL-LIKE SYNDROME,2,"GLI3, SMO"
"PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING",1,NLRP1
"PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL",1,RSPO1
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1,1,GJA1
PALMOPLANTAR KERATODERMA AND WOOLLY HAIR,1,KANK2
"PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE",1,DSG1
"PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE",1,AQP5
"PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC",2,"KRT1, KRT9"
"PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE",1,SERPINB7
"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC",1,KRT1
"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1",1,KRT16
"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2",1,TRPV3
"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE",1,KRT6C
"PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA",1,AAGAB
PANCREATIC AGENESIS 1,1,PDX1
PANCREATIC AGENESIS 2,1,PTF1A
PANCREATIC AND CEREBELLAR AGENESIS,1,PTF1A
PANCREATIC CANCER,4,"KRAS, SMAD4, STK11, TP53"
"PANCREATIC CANCER, SUSCEPTIBILITY TO, 2",1,BRCA2
"PANCREATIC CANCER, SUSCEPTIBILITY TO, 3",1,PALB2
"PANCREATIC CANCER, SUSCEPTIBILITY TO, 4",1,BRCA1
"PANCREATIC CANCER, SUSCEPTIBILITY TO, 5",1,RABL3
PANCREATIC LIPASE DEFICIENCY,1,PNLIP
"PANCREATITIS, HEREDITARY",5,"CFTR, CTRC, PRSS1, PRSS2, SPINK1"
"PANHYPOPITUITARISM, X-LINKED",1,SOX3
PANIC DISORDER 1,1,COMT
PAPILLOMA OF CHOROID PLEXUS,1,TP53
PAPILLON-LEFEVRE SYNDROME,1,CTSC
PAPILLORENAL SYNDROME,1,PAX2
PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,3,"SDHB, SDHC, SDHD"
PARAGANGLIOMAS 1,1,SDHD
PARAGANGLIOMAS 2,1,SDHAF2
PARAGANGLIOMAS 3,1,SDHC
PARAGANGLIOMAS 4,1,SDHB
PARAGANGLIOMAS 5,1,SDHA
PARAGANGLIOMAS 6,1,SLC25A11
PARAGANGLIOMAS 7,1,DLST
PARAMYOTONIA CONGENITA OF VON EULENBURG,1,SCN4A
PARASTREMMATIC DWARFISM,1,TRPV4
PARATHYROID CARCINOMA,1,CDC73
PARIETAL FORAMINA 1,1,MSX2
PARIETAL FORAMINA 2,1,ALX4
PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA,1,MSX2
"PARKINSON DISEASE 1, AUTOSOMAL DOMINANT",1,SNCA
"PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO",1,GIGYF2
"PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO",1,HTRA2
"PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE",1,PLA2G6
"PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET",1,FBXO7
PARKINSON DISEASE 17,1,VPS35
"PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO",1,EIF4G1
"PARKINSON DISEASE 19A, JUVENILE-ONSET",1,DNAJC6
"PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE",1,PRKN
"PARKINSON DISEASE 20, EARLY-ONSET",1,SYNJ1
"PARKINSON DISEASE 22, AUTOSOMAL DOMINANT",1,CHCHD2
"PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET",1,VPS13C
"PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO",1,PSAP
"PARKINSON DISEASE 4, AUTOSOMAL DOMINANT",1,SNCA
"PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO",1,UCHL1
"PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET",1,PINK1
"PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET",1,PARK7
"PARKINSON DISEASE 8, AUTOSOMAL DOMINANT",1,LRRK2
"PARKINSON DISEASE, LATE-ONSET",8,"ADH1C, GBA, GLUD2, MAPT, NR4A2, ATXN2, TBP, SNCAIP"
PARKINSON-DEMENTIA SYNDROME,1,MAPT
PARKINSONISM WITH POLYNEUROPATHY,1,UQCRC1
"PARKINSONISM WITH SPASTICITY, X-LINKED",1,ATP6AP2
"PARKINSONISM-DYSTONIA, INFANTILE, 1",1,SLC6A3
"PARKINSONISM-DYSTONIA, INFANTILE, 2",1,SLC18A2
PAROXYSMAL EXTREME PAIN DISORDER,1,SCN9A
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1,1,PIGA
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2,1,PIGT
PAROXYSMAL NONKINESIGENIC DYSKINESIA 1,1,PNKD
"PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY",1,KCNMA1
PARTINGTON SYNDROME,1,ARX
PATENT DUCTUS ARTERIOSUS 2,1,TFAP2B
PATENT DUCTUS ARTERIOSUS 3,1,PRDM6
PEELING SKIN SYNDROME 1,1,CDSN
PEELING SKIN SYNDROME 2,1,TGM5
PEELING SKIN SYNDROME 3,1,CHST8
PEELING SKIN SYNDROME 4,1,CSTA
PEELING SKIN SYNDROME 5,1,SERPINB8
PEELING SKIN SYNDROME 6,1,FLG2
"PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS",1,CAST
PEHO SYNDROME,1,ZNHIT3
PEHO-LIKE SYNDROME,1,CCDC88A
PELGER-HUET ANOMALY,1,LBR
PELIZAEUS-MERZBACHER DISEASE,1,PLP1
PENDRED SYNDROME,3,"FOXI1, KCNJ10, SLC26A4"
PENTOSURIA,1,DCXR
PERCHING SYNDROME,1,KLHL7
"PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT",1,TNFRSF1A
"PERIODIC FEVER, IMMUNODEFICIENCY, AND THROMBOCYTOPENIA SYNDROME",1,WDR1
"PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT",1,HTR1A
"PERIODONTITIS, AGGRESSIVE, 1",1,CTSC
"PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE",1,SOX10
"PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",1,MCM3AP
"PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS",1,MYH14
"PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE",1,ARFGEF2
PERIVENTRICULAR NODULAR HETEROTOPIA 1,1,FLNA
PERIVENTRICULAR NODULAR HETEROTOPIA 6,1,ERMARD
PERIVENTRICULAR NODULAR HETEROTOPIA 7,1,NEDD4L
PERIVENTRICULAR NODULAR HETEROTOPIA 8,1,ARF1
PERIVENTRICULAR NODULAR HETEROTOPIA 9,1,MAP1B
PERLMAN SYNDROME,1,DIS3L2
PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY,1,ACOX1
PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER,1,FAR1
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER),1,PEX3
PEROXISOME BIOGENESIS DISORDER 10B,1,PEX3
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER),1,PEX13
PEROXISOME BIOGENESIS DISORDER 11B,1,PEX13
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER),1,PEX19
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER),1,PEX14
PEROXISOME BIOGENESIS DISORDER 14B,1,PEX11B
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER),1,PEX1
PEROXISOME BIOGENESIS DISORDER 1B,1,PEX1
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER),1,PEX5
PEROXISOME BIOGENESIS DISORDER 2B,1,PEX5
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER),1,PEX12
PEROXISOME BIOGENESIS DISORDER 3B,1,PEX12
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER),1,PEX6
PEROXISOME BIOGENESIS DISORDER 4B,1,PEX6
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER),1,PEX10
PEROXISOME BIOGENESIS DISORDER 6B,1,PEX10
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER),1,PEX26
PEROXISOME BIOGENESIS DISORDER 7B,1,PEX26
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER),1,PEX16
PEROXISOME BIOGENESIS DISORDER 8B,1,PEX16
PEROXISOME BIOGENESIS DISORDER 9B,1,PEX7
PERRAULT SYNDROME 1,1,HSD17B4
PERRAULT SYNDROME 2,1,HARS2
PERRAULT SYNDROME 3,1,CLPP
PERRAULT SYNDROME 4,1,LARS2
PERRAULT SYNDROME 5,1,TWNK
PERRAULT SYNDROME 6,1,ERAL1
PERRY SYNDROME,1,DCTN1
"PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE",1,ATOH7
"PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II",2,"AMH, AMHR2"
PETERS-PLUS SYNDROME,1,B3GLCT
PETTIGREW SYNDROME,1,AP1S2
PEUTZ-JEGHERS SYNDROME,1,STK11
PFEIFFER SYNDROME,2,"FGFR1, FGFR2"
PHELAN-MCDERMID SYNDROME,1,SHANK3
PHENYLKETONURIA,1,PAH
PHEOCHROMOCYTOMA,8,"KIF1B, GDNF, MAX, TMEM127, RET, SDHB, SDHD, VHL"
"PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC",1,PCK1
"PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL",1,PCK2
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY,1,PHGDH
PHOSPHOGLYCERATE KINASE 1 DEFICIENCY,1,PGK1
PHOSPHOHYDROXYLYSINURIA,1,PHYKPL
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY,1,PRPS1
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY,1,PSAT1
PHOSPHOSERINE PHOSPHATASE DEFICIENCY,1,PSPH
PICK DISEASE OF BRAIN,2,"MAPT, PSEN1"
PIEBALD TRAIT,2,"KIT, SNAI2"
PIERPONT SYNDROME,1,TBL1XR1
PIERSON SYNDROME,1,LAMB2
"PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED",1,POLA1
"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1",1,PRKAR1A
"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2",1,PDE11A
"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3",1,PDE8B
"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4",1,PRKACA
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY,1,CRB1
PILAROWSKI-BJORNSSON SYNDROME,1,CHD1
PILOMATRIXOMA,1,CTNNB1
"PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES",1,INSR
PITT-HOPKINS SYNDROME,1,TCF4
PITT-HOPKINS-LIKE SYNDROME 1,1,CNTNAP2
PITT-HOPKINS-LIKE SYNDROME 2,1,NRXN1
"PITUITARY ADENOMA 1, MULTIPLE TYPES",1,AIP
"PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING",1,GPR101
"PITUITARY ADENOMA 3, MULTIPLE TYPES",1,GNAS
"PITUITARY ADENOMA 4, ACTH-SECRETING",2,"AIP, USP8"
"PITUITARY ADENOMA 5, MULTIPLE TYPES",1,CDH23
"PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 1",1,POU1F1
"PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 7",1,RNPC3
"PITUITARY HORMONE DEFICIENCY, COMBINED, 2",1,PROP1
"PITUITARY HORMONE DEFICIENCY, COMBINED, 3",1,LHX3
"PITUITARY HORMONE DEFICIENCY, COMBINED, 4",1,LHX4
"PITUITARY HORMONE DEFICIENCY, COMBINED, 6",1,OTX2
PITYRIASIS RUBRA PILARIS,1,CARD14
PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS,1,ANGPTL4
PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY,1,SERPINE1
"PLASMINOGEN DEFICIENCY, TYPE I",1,PLG
"PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY",1,RUNX1
PLATELET GLYCOPROTEIN IV DEFICIENCY,1,CD36
PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY,1,PLA2G7
"PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE",1,COL2A1
PLEUROPULMONARY BLASTOMA,1,DICER1
"PNEUMOTHORAX, PRIMARY SPONTANEOUS",1,FLCN
POIKILODERMA WITH NEUTROPENIA,1,USB1
"POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS",1,FAM111B
POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME,1,CSNK2B
POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE,1,PKD2
POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE,1,GANAB
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE,1,PKHD1
POLYCYSTIC KIDNEY DISEASE 5,1,DZIP1L
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE,1,DNAJB11
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 1,1,TYROBP
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2,1,TREM2
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS,1,PRKCSH
POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS,1,SEC63
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS,1,ALG8
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS,1,LRP5
POLYCYTHEMIA VERA,1,JAK2
"POLYDACTYLY, POSTAXIAL, TYPE A1",1,GLI3
"POLYDACTYLY, POSTAXIAL, TYPE A10",1,KIAA0825
"POLYDACTYLY, POSTAXIAL, TYPE A6",1,ZNF141
"POLYDACTYLY, POSTAXIAL, TYPE A7",1,IQCE
"POLYDACTYLY, POSTAXIAL, TYPE A8",1,GLI1
"POLYDACTYLY, POSTAXIAL, TYPE A9",1,CIBAR1
"POLYDACTYLY, PREAXIAL I",1,GLI1
"POLYDACTYLY, PREAXIAL II",1,LMBR1
"POLYDACTYLY, PREAXIAL IV",1,GLI3
POLYENDOCRINE-POLYNEUROPATHY SYNDROME,1,DMXL2
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY,1,RBCK1
POLYGLUCOSAN BODY MYOPATHY 2,1,GYG1
"POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM",1,GBE1
"POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY",1,STRADA
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME,1,COL3A1
"POLYMICROGYRIA, BILATERAL FRONTOPARIETAL",1,ADGRG1
"POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE",1,ADGRG1
"POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL",1,FIG4
"POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT",1,ABHD12
"POLYPOSIS SYNDROME, HEREDITARY MIXED, 2",1,BMPR1A
"POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO",1,FAAH
"PONTOCEREBELLAR HYPOPLASIA, HYPOTONIA, AND RESPIRATORY INSUFFICIENCY SYNDROME, NEONATAL LETHAL",1,ATAD3A
"PONTOCEREBELLAR HYPOPLASIA, TYPE 10",1,CLP1
"PONTOCEREBELLAR HYPOPLASIA, TYPE 11",1,TBC1D23
"PONTOCEREBELLAR HYPOPLASIA, TYPE 12",1,COASY
"PONTOCEREBELLAR HYPOPLASIA, TYPE 13",1,VPS51
"PONTOCEREBELLAR HYPOPLASIA, TYPE 14",1,PPIL1
"PONTOCEREBELLAR HYPOPLASIA, TYPE 15",1,CDC40
"PONTOCEREBELLAR HYPOPLASIA, TYPE 16",1,MINPP1
"PONTOCEREBELLAR HYPOPLASIA, TYPE 1A",1,VRK1
"PONTOCEREBELLAR HYPOPLASIA, TYPE 1B",1,EXOSC3
"PONTOCEREBELLAR HYPOPLASIA, TYPE 1C",1,EXOSC8
"PONTOCEREBELLAR HYPOPLASIA, TYPE 1D",1,EXOSC9
"PONTOCEREBELLAR HYPOPLASIA, TYPE 1E",1,SLC25A46
"PONTOCEREBELLAR HYPOPLASIA, TYPE 1F",1,EXOSC1
"PONTOCEREBELLAR HYPOPLASIA, TYPE 2A",1,TSEN54
"PONTOCEREBELLAR HYPOPLASIA, TYPE 2B",1,TSEN2
"PONTOCEREBELLAR HYPOPLASIA, TYPE 2C",1,TSEN34
"PONTOCEREBELLAR HYPOPLASIA, TYPE 2D",1,SEPSECS
"PONTOCEREBELLAR HYPOPLASIA, TYPE 2E",1,VPS53
"PONTOCEREBELLAR HYPOPLASIA, TYPE 2F",1,TSEN15
"PONTOCEREBELLAR HYPOPLASIA, TYPE 3",1,PCLO
"PONTOCEREBELLAR HYPOPLASIA, TYPE 4",1,TSEN54
"PONTOCEREBELLAR HYPOPLASIA, TYPE 5",1,TSEN54
"PONTOCEREBELLAR HYPOPLASIA, TYPE 6",1,RARS2
"PONTOCEREBELLAR HYPOPLASIA, TYPE 7",1,TOE1
"PONTOCEREBELLAR HYPOPLASIA, TYPE 8",1,CHMP1A
"PONTOCEREBELLAR HYPOPLASIA, TYPE 9",1,AMPD2
POPLITEAL PTERYGIUM SYNDROME,1,IRF6
PORETTI-BOLTSHAUSER SYNDROME,1,LAMA1
"POROKERATOSIS 1, MULTIPLE TYPES",1,PMVK
"POROKERATOSIS 3, MULTIPLE TYPES",1,MVK
"POROKERATOSIS 7, MULTIPLE TYPES",1,MVD
"POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE",1,SLC17A9
"POROKERATOSIS 9, MULTIPLE TYPES",1,FDPS
PORPHYRIA CUTANEA TARDA,2,"HFE, UROD"
"PORPHYRIA, ACUTE HEPATIC",1,ALAD
"PORPHYRIA, ACUTE INTERMITTENT",1,HMBS
"PORPHYRIA, CONGENITAL ERYTHROPOIETIC",1,UROS
"PORTAL HYPERTENSION, NONCIRRHOTIC, 1",1,DGUOK
"PORTAL HYPERTENSION, NONCIRRHOTIC, 2",1,GIMAP5
POSTAXIAL ACROFACIAL DYSOSTOSIS,1,DHODH
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA,1,FLVCR1
POTOCKI-LUPSKI SYNDROME,1,FLCN
PRADER-WILLI SYNDROME,6,"NPAP1, NDN, MAGEL2, SNRPN, MKRN3, HERC2"
"PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS",1,HOXA13
"PRECOCIOUS PUBERTY, CENTRAL, 1",1,KISS1R
"PRECOCIOUS PUBERTY, CENTRAL, 2",1,MKRN3
"PRECOCIOUS PUBERTY, MALE-LIMITED",1,LHCGR
PREECLAMPSIA/ECLAMPSIA 1,1,NOS3
PREECLAMPSIA/ECLAMPSIA 4,1,STOX1
PREECLAMPSIA/ECLAMPSIA 5,1,CORIN
"PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1",1,F5
"PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2",1,F2
"PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3",1,ANXA5
PREIMPLANTATION EMBRYONIC LETHALITY 1,1,TLE6
PREIMPLANTATION EMBRYONIC LETHALITY 2,1,PADI6
PREKALLIKREIN DEFICIENCY,1,KLKB1
"PREMATURE AGING SYNDROME, PENTTINEN TYPE",1,PDGFRB
PREMATURE CHROMATID SEPARATION TRAIT,1,BUB1B
PREMATURE OVARIAN FAILURE 1,1,FMR1
PREMATURE OVARIAN FAILURE 10,1,MCM8
PREMATURE OVARIAN FAILURE 11,1,ERCC6
PREMATURE OVARIAN FAILURE 12,1,SYCE1
PREMATURE OVARIAN FAILURE 13,1,MSH5
PREMATURE OVARIAN FAILURE 14,1,GDF9
PREMATURE OVARIAN FAILURE 15,1,FANCM
PREMATURE OVARIAN FAILURE 16,1,BNC1
PREMATURE OVARIAN FAILURE 17,1,XRCC2
PREMATURE OVARIAN FAILURE 18,1,C14orf39
PREMATURE OVARIAN FAILURE 19,1,HSF2BP
PREMATURE OVARIAN FAILURE 2A,1,DIAPH2
PREMATURE OVARIAN FAILURE 2B,1,POF1B
PREMATURE OVARIAN FAILURE 3,1,FOXL2
PREMATURE OVARIAN FAILURE 5,1,NOBOX
PREMATURE OVARIAN FAILURE 6,1,FIGLA
PREMATURE OVARIAN FAILURE 7,1,NR5A1
PREMATURE OVARIAN FAILURE 8,1,STAG3
PREMATURE OVARIAN FAILURE 9,1,HFM1
PRETERM PREMATURE RUPTURE OF THE MEMBRANES,1,SERPINH1
"PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES",1,CACNA1D
"PRIMARY LATERAL SCLEROSIS, JUVENILE",1,ALS2
PRIMROSE SYNDROME,1,ZBTB20
PROGESTERONE RESISTANCE,1,PGR
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1",1,POLG
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2",1,SLC25A4
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3",1,TWNK
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4",1,POLG2
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5",1,RRM2B
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6",1,DNA2
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1",1,POLG
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2",1,RNASEH1
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3",1,TK2
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4",1,DGUOK
"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5",1,TOP3A
"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA",1,SCN5A
"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB",1,TRPM4
PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA,1,CCN6
PROLIDASE DEFICIENCY,1,PEPD
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME,1,FLVCR2
PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION,2,"RGS9BP, RGS9"
"PROPERDIN DEFICIENCY, X-LINKED",1,CFP
PROPIONIC ACIDEMIA,2,"PCCA, PCCB"
PROPROTEIN CONVERTASE 1/3 DEFICIENCY,1,PCSK1
PROSTATE CANCER,9,"CHEK2, KLF6, AR, MXI1, ZFHX3, PTEN, BRCA2, MAD1L1, CDH1"
"PROSTATE CANCER, HEREDITARY, 1",1,RNASEL
"PROSTATE CANCER, HEREDITARY, 12",1,EHBP1
"PROSTATE CANCER, HEREDITARY, 13",1,MSMB
"PROSTATE CANCER, HEREDITARY, 2",1,ELAC2
"PROSTATE CANCER, HEREDITARY, 9",1,HOXB13
PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY,1,EPHB2
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1,1,PSMB8
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2,1,POMP
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3,2,"PSMB4, PSMB9"
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4,1,PSMG2
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5,1,PSMB10
PROTEIN Z DEFICIENCY,1,PROZ
"PROTEINURIA, CHRONIC BENIGN",1,CUBN
"PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS",1,CLCN5
PROTEUS SYNDROME,1,AKT1
"PROTHROMBIN DEFICIENCY, CONGENITAL",1,F2
"PROTOPORPHYRIA, ERYTHROPOIETIC, 1",1,FECH
"PROTOPORPHYRIA, ERYTHROPOIETIC, 2",1,CLPX
"PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED",1,ALAS2
PRUNE BELLY SYNDROME,1,CHRM3
PSEUDO-TORCH SYNDROME 1,1,OCLN
PSEUDO-TORCH SYNDROME 2,1,USP18
PSEUDO-TORCH SYNDROME 3,1,STAT2
PSEUDO-VON WILLEBRAND DISEASE,1,GP1BA
PSEUDOACHONDROPLASIA,1,COMP
PSEUDOFOLLICULITIS BARBAE,1,KRT75
"PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK",1,ABCB6
"PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT",1,NR3C2
"PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE",3,"SCNN1A, SCNN1B, SCNN1G"
"PSEUDOHYPOALDOSTERONISM, TYPE IIB",1,WNK4
"PSEUDOHYPOALDOSTERONISM, TYPE IIC",1,WNK1
"PSEUDOHYPOALDOSTERONISM, TYPE IID",1,KLHL3
"PSEUDOHYPOALDOSTERONISM, TYPE IIE",1,CUL3
"PSEUDOHYPOPARATHYROIDISM, TYPE IA",1,GNAS
"PSEUDOHYPOPARATHYROIDISM, TYPE IB",2,"GNAS, STX16"
"PSEUDOHYPOPARATHYROIDISM, TYPE IC",1,GNAS
PSEUDOPSEUDOHYPOPARATHYROIDISM,1,GNAS
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS,1,SRD5A2
PSEUDOXANTHOMA ELASTICUM,3,"ABCC6, XYLT1, XYLT2"
"PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE",1,ABCC6
PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY,1,GGCX
"PSORIASIS 1, SUSCEPTIBILITY TO",1,HLA-C
"PSORIASIS 13, SUSCEPTIBILITY TO",1,TRAF3IP2
"PSORIASIS 14, PUSTULAR",1,IL36RN
"PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO",1,AP1S3
PSORIASIS 2,1,CARD14
"PSORIASIS 7, SUSCEPTIBILITY TO",1,IL23R
"PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO",1,LTA
"PTOSIS, HEREDITARY CONGENITAL 1",1,ZFHX4
PULMONARY ALVEOLAR MICROLITHIASIS,1,SLC34A2
"PULMONARY DISEASE, CHRONIC OBSTRUCTIVE",2,"HMOX1, MMP1"
"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1",1,TERT
"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3",1,RTEL1
"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4",1,PARN
"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 5",1,ZCCHC8
"PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO",1,CPS1
"PULMONARY HYPERTENSION, PRIMARY, 1",1,BMPR2
"PULMONARY HYPERTENSION, PRIMARY, 2",1,SMAD9
"PULMONARY HYPERTENSION, PRIMARY, 3",1,CAV1
"PULMONARY HYPERTENSION, PRIMARY, 4",1,KCNK3
"PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT",1,BMPR2
"PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE",1,EIF2AK4
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY,1,PNP
PYCNODYSOSTOSIS,1,CTSK
PYLE DISEASE,1,SFRP4
"PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE",1,PSTPIP1
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY,1,PNPO
"PYROPOIKILOCYTOSIS, HEREDITARY",1,SPTA1
PYRUVATE CARBOXYLASE DEFICIENCY,1,PC
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY,1,PDHA1
PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY,1,PDHB
PYRUVATE DEHYDROGENASE E2 DEFICIENCY,1,DLAT
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY,1,PDHX
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY,1,PDP1
PYRUVATE KINASE DEFICIENCY OF RED CELLS,1,PKLR
QUEBEC PLATELET DISORDER,1,PLAU
"QUESTION MARK EARS, ISOLATED",1,EDN1
RADIN BLOOD GROUP ANTIGEN,1,ERMAP
RADIO-TARTAGLIA SYNDROME,1,SPEN
RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES,1,CYP26B1
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1,1,HOXA11
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2,1,MECOM
"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO",1,SMAD6
RAFIQ SYNDROME,1,MAN1B1
RAHMAN SYNDROME,1,H1-4
RAINE SYNDROME,1,FAM20C
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1,1,FARSB
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2,1,FARSA
RAPADILINO SYNDROME,1,RECQL4
RAPH BLOOD GROUP SYSTEM,1,CD151
RAPP-HODGKIN SYNDROME,1,TP63
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER,2,"KRAS, NRAS"
RAUCH-STEINDL SYNDROME,1,NSD2
RAYNAUD-CLAES SYNDROME,1,CLCN4
RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1,1,RNF212
"REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET",1,FHL1
"REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET",1,FHL1
"REFSUM DISEASE, CLASSIC",2,"PEX7, PHYH"
"RENAL CELL CARCINOMA, NONPAPILLARY",7,"RNF139, FLCN, OGG1, PBRM1, HNF1A, HNF1B, VHL"
"RENAL CELL CARCINOMA, PAPILLARY, 1",2,"MET, PRCC"
"RENAL CELL CARCINOMA, Xp11-ASSOCIATED",1,TFE3
RENAL CYSTS AND DIABETES SYNDROME,1,HNF1B
"RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO",1,BICC1
RENAL GLUCOSURIA,1,SLC5A2
RENAL HYPODYSPLASIA/APLASIA 1,1,ITGA8
RENAL HYPODYSPLASIA/APLASIA 2,1,FGF20
RENAL HYPODYSPLASIA/APLASIA 3,1,GREB1L
"RENAL TUBULAR ACIDOSIS, DISTAL, 1",1,SLC4A1
"RENAL TUBULAR ACIDOSIS, DISTAL, 2, WITH PROGRESSIVE SENSORINEURAL HEARING LOSS",1,ATP6V1B1
"RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS",1,ATP6V0A4
"RENAL TUBULAR ACIDOSIS, DISTAL, 4, WITH HEMOLYTIC ANEMIA",1,SLC4A1
"RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION",1,SLC4A4
RENAL TUBULAR DYSGENESIS,4,"ACE, AGT, AGTR1, REN"
RENAL-HEPATIC-PANCREATIC DYSPLASIA 1,1,NPHP3
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2,1,NEK8
RENPENNING SYNDROME 1,1,PQBP1
"RESPIRATORY PAPILLOMATOSIS, JUVENILE RECURRENT, CONGENITAL",1,NLRP1
"RESTING HEART RATE, VARIATION IN",1,ADRB1
"RESTRICTIVE DERMOPATHY, LETHAL",2,"ZMPSTE24, LMNA"
RETICULAR DYSGENESIS,1,AK2
RETICULATE ACROPIGMENTATION OF KITAMURA,1,ADAM10
RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS,1,IGFBP7
"RETINAL ARTERIES, TORTUOSITY OF",1,COL4A1
RETINAL CONE DYSTROPHY 3A,1,PDE6H
RETINAL CONE DYSTROPHY 3B,1,KCNV2
RETINAL CONE DYSTROPHY 4,1,CACNA2D4
RETINAL DYSTROPHY AND MICROVILLUS INCLUSION DISEASE,1,STX3
RETINAL DYSTROPHY AND OBESITY,1,TUB
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES,1,ITM2B
RETINAL DYSTROPHY WITH LEUKODYSTROPHY,1,ACBD5
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES,1,RCBTB1
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA,1,CFAP410
"RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME",1,RBP4
"RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME",1,RDH11
"RETINAL DYSTROPHY, OPTIC NERVE EDEMA, SPLENOMEGALY, ANHIDROSIS, AND MIGRAINE HEADACHE SYNDROME",1,ALPK1
RETINITIS PIGMENTOSA,10,"CNGA1, CRX, CFAP418, AIPL1, PDE6G, RBP3, ROM1, CLRN1, ARL6, LRAT"
RETINITIS PIGMENTOSA 10,1,IMPDH1
RETINITIS PIGMENTOSA 11,1,PRPF31
RETINITIS PIGMENTOSA 12,1,CRB1
RETINITIS PIGMENTOSA 13,1,PRPF8
RETINITIS PIGMENTOSA 14,1,TULP1
RETINITIS PIGMENTOSA 17,1,CA4
RETINITIS PIGMENTOSA 18,1,PRPF3
RETINITIS PIGMENTOSA 19,1,ABCA4
RETINITIS PIGMENTOSA 2,1,RP2
RETINITIS PIGMENTOSA 20,1,RPE65
RETINITIS PIGMENTOSA 23,1,OFD1
RETINITIS PIGMENTOSA 25,1,EYS
RETINITIS PIGMENTOSA 26,1,CERKL
RETINITIS PIGMENTOSA 27,1,NRL
RETINITIS PIGMENTOSA 28,1,FAM161A
RETINITIS PIGMENTOSA 3,1,RPGR
RETINITIS PIGMENTOSA 30,1,FSCN2
RETINITIS PIGMENTOSA 31,1,TOPORS
RETINITIS PIGMENTOSA 32,1,CLCC1
RETINITIS PIGMENTOSA 33,1,SNRNP200
RETINITIS PIGMENTOSA 35,1,SEMA4A
RETINITIS PIGMENTOSA 36,1,PRCD
RETINITIS PIGMENTOSA 37,1,NR2E3
RETINITIS PIGMENTOSA 38,1,MERTK
RETINITIS PIGMENTOSA 39,1,USH2A
RETINITIS PIGMENTOSA 4,1,RHO
RETINITIS PIGMENTOSA 40,1,PDE6B
RETINITIS PIGMENTOSA 41,1,PROM1
RETINITIS PIGMENTOSA 42,1,KLHL7
RETINITIS PIGMENTOSA 43,1,PDE6A
RETINITIS PIGMENTOSA 44,1,RGR
RETINITIS PIGMENTOSA 45,1,CNGB1
RETINITIS PIGMENTOSA 46,1,IDH3B
RETINITIS PIGMENTOSA 47,1,SAG
RETINITIS PIGMENTOSA 48,1,GUCA1B
RETINITIS PIGMENTOSA 49,1,CNGA1
RETINITIS PIGMENTOSA 50,1,BEST1
RETINITIS PIGMENTOSA 51,1,TTC8
RETINITIS PIGMENTOSA 54,1,PCARE
RETINITIS PIGMENTOSA 55,1,ARL6
RETINITIS PIGMENTOSA 56,1,IMPG2
RETINITIS PIGMENTOSA 57,1,PDE6G
RETINITIS PIGMENTOSA 58,1,ZNF513
RETINITIS PIGMENTOSA 59,1,DHDDS
RETINITIS PIGMENTOSA 60,1,PRPF6
RETINITIS PIGMENTOSA 61,1,CLRN1
RETINITIS PIGMENTOSA 62,1,MAK
RETINITIS PIGMENTOSA 66,1,RBP3
RETINITIS PIGMENTOSA 67,1,NEK2
RETINITIS PIGMENTOSA 68,1,SLC7A14
RETINITIS PIGMENTOSA 69,1,KIZ
RETINITIS PIGMENTOSA 7,2,"PRPH2, ROM1"
RETINITIS PIGMENTOSA 70,1,PRPF4
RETINITIS PIGMENTOSA 71,1,IFT172
RETINITIS PIGMENTOSA 72,1,ZNF408
RETINITIS PIGMENTOSA 73,1,HGSNAT
RETINITIS PIGMENTOSA 74,1,BBS2
RETINITIS PIGMENTOSA 75,1,AGBL5
RETINITIS PIGMENTOSA 76,1,POMGNT1
RETINITIS PIGMENTOSA 77,1,REEP6
RETINITIS PIGMENTOSA 78,1,ARHGEF18
RETINITIS PIGMENTOSA 79,1,HK1
RETINITIS PIGMENTOSA 80,1,IFT140
RETINITIS PIGMENTOSA 81,1,IFT43
RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS,1,ARL2BP
RETINITIS PIGMENTOSA 83,1,ARL3
RETINITIS PIGMENTOSA 84,1,DHX38
RETINITIS PIGMENTOSA 85,1,AHR
RETINITIS PIGMENTOSA 86,1,KIAA1549
RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT,1,RPE65
RETINITIS PIGMENTOSA 88,1,RP1L1
RETINITIS PIGMENTOSA 89,1,KIF3B
RETINITIS PIGMENTOSA 9,1,RP9
RETINITIS PIGMENTOSA 90,1,IDH3A
RETINITIS PIGMENTOSA 91,1,IMPG1
RETINITIS PIGMENTOSA 92,1,HKDC1
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS,1,TRNT1
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES,1,CWC27
"RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS",1,RPGR
RETINOBLASTOMA,1,RB1
"RETINOSCHISIS 1, X-LINKED, JUVENILE",1,RS1
RETT SYNDROME,1,MECP2
"RETT SYNDROME, CONGENITAL VARIANT",1,FOXG1
REVESZ SYNDROME,1,TINF2
REYNOLDS SYNDROME,1,LBR
"RH-NULL, AMORPH TYPE",1,RHCE
"RH-NULL, REGULATOR TYPE",1,RHAG
RHABDOID TUMOR PREDISPOSITION SYNDROME 1,1,SMARCB1
RHABDOID TUMOR PREDISPOSITION SYNDROME 2,1,SMARCA4
RHABDOMYOSARCOMA 2,3,"FOXO1, PAX3, PAX7"
"RHABDOMYOSARCOMA, EMBRYONAL, 1",1,SLC22A18
"RHABDOMYOSARCOMA, EMBRYONAL, 2",1,DICER1
RHEUMATOID ARTHRITIS,6,"PADI4, PTPN22, CIITA, NFKBIL1, CD244, SLC22A4"
"RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE",2,"IL6, MIF"
"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1",1,PEX7
"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2",1,GNPAT
"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3",1,AGPS
"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5",1,PEX5
RHIZOMELIC LIMB SHORTENING WITH DYSMORPHIC FEATURES,1,PKDCC
RHIZOMELIC SKELETAL DYSPLASIA WITH OR WITHOUT PELGER HUET ANOMALY,1,LBR
RHYNS SYNDROME,1,TMEM67
RIBOFLAVIN DEFICIENCY,1,SLC52A1
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY,1,RPIA
RIDDLE SYNDROME,1,RNF168
RIGHT ATRIAL ISOMERISM,1,GDF1
RIGID SPINE MUSCULAR DYSTROPHY 1,1,SELENON
"RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL",1,BRAT1
RING DERMOID OF CORNEA,1,PITX2
RIPPLING MUSCLE DISEASE 2,1,CAV3
RITSCHER-SCHINZEL SYNDROME 1,1,WASHC5
RITSCHER-SCHINZEL SYNDROME 2,1,CCDC22
RITSCHER-SCHINZEL SYNDROME 4,1,DPYSL5
ROBERTS-SC PHOCOMELIA SYNDROME,1,ESCO2
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES,1,EIF4A3
"ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1",2,"DVL1, WNT5A"
"ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2",1,DVL1
"ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3",1,DVL3
"ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 1",1,ROR2
"ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2",1,NXN
ROBINOW-SORAUF SYNDROME,1,TWIST1
ROIFMAN-CHITAYAT SYNDROME,2,"PIK3CD, KNSTRN"
"ROLANDIC EPILEPSY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SPEECH DYSPRAXIA, X-LINKED",1,SRPX2
"ROTHMUND-THOMSON SYNDROME, TYPE 1",1,ANAPC1
"ROTHMUND-THOMSON SYNDROME, TYPE 2",1,RECQL4
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA,2,"MPZ, PMP22"
RUBINSTEIN-TAYBI SYNDROME 1,2,"CREBBP, EP300"
RUBINSTEIN-TAYBI SYNDROME 2,1,EP300
RUIJS-AALFS SYNDROME,1,SPRTN
SACRAL AGENESIS WITH VERTEBRAL ANOMALIES,1,TBXT
SACRAL DEFECT WITH ANTERIOR MENINGOCELE,1,VANGL1
SAETHRE-CHOTZEN SYNDROME,2,"FGFR2, TWIST1"
SALIH MYOPATHY,1,TTN
"SALIVARY GLAND ADENOMA, PLEOMORPHIC",1,PLAG1
SALLA DISEASE,1,SLC17A5
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME,1,ST3GAL5
SANDESTIG-STEFANOVA SYNDROME,1,NUP188
SANDHOFF DISEASE,1,HEXB
"SARCOIDOSIS, SUSCEPTIBILITY TO, 1",1,HLA-DRB1
"SARCOIDOSIS, SUSCEPTIBILITY TO, 2",1,BTNL2
"SARCOMA, SYNOVIAL",2,"SSX1, SSX2"
SARCOSINEMIA,1,SARDH
SAUL-WILSON SYNDROME,1,COG4
SCALP-EAR-NIPPLE SYNDROME,1,KCTD1
"SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION",1,FGFR2
"SCAPULOPERONEAL MYOPATHY, MYH7-RELATED",1,MYH7
"SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT",1,FHL1
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY,1,TRPV4
"SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE",1,DES
SCHAAF-YANG SYNDROME,1,MAGEL2
SCHEIE SYNDROME,1,IDUA
SCHIMKE IMMUNOOSSEOUS DYSPLASIA,1,SMARCAL1
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME,3,"HRAS, KRAS, NRAS"
"SCHINDLER DISEASE, TYPE I",1,NAGA
SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME,1,SETBP1
SCHIZENCEPHALY,3,"EMX2, SHH, SIX3"
SCHIZOPHRENIA,9,"CHI3L1, COMT, DRD3, APOL2, HTR2A, MTHFR, RTN4R, SYN2, APOL4"
SCHIZOPHRENIA 15,1,SHANK3
SCHIZOPHRENIA 18,1,SLC1A1
SCHIZOPHRENIA 19,1,RBM12
SCHIZOPHRENIA 4,1,PRODH
SCHIZOPHRENIA 9,1,DISC1
SCHNECKENBECKEN DYSPLASIA,1,SLC35D1
SCHNYDER CORNEAL DYSTROPHY,1,UBIAD1
SCHOPF-SCHULZ-PASSARGE SYNDROME,1,WNT10A
SCHUURS-HOEIJMAKERS SYNDROME,1,PACS1
SCHWANNOMATOSIS 1,2,"NF2, SMARCB1"
SCHWANNOMATOSIS 2,1,LZTR1
"SCHWARTZ-JAMPEL SYNDROME, TYPE 1",1,HSPG2
"SCLEROSING CHOLANGITIS, NEONATAL",1,DCDC2
SCLEROSTEOSIS 1,1,SOST
SCLEROSTEOSIS 2,1,LRP4
SCOTT SYNDROME,1,ANO6
SEA-BLUE HISTIOCYTE DISEASE,1,APOE
SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS,1,ZNF750
SECKEL SYNDROME 1,1,ATR
SECKEL SYNDROME 10,1,NSMCE2
SECKEL SYNDROME 2,1,RBBP8
SECKEL SYNDROME 4,1,CENPJ
SECKEL SYNDROME 5,1,CEP152
SECKEL SYNDROME 6,1,CEP63
SECKEL SYNDROME 7,1,NIN
SECKEL SYNDROME 8,1,DNA2
SECKEL SYNDROME 9,1,TRAIP
SEDOHEPTULOKINASE DEFICIENCY,1,SHPK
"SEGAWA SYNDROME, AUTOSOMAL RECESSIVE",1,TH
"SEIZURES, BENIGN FAMILIAL INFANTILE, 2",1,PRRT2
"SEIZURES, BENIGN FAMILIAL INFANTILE, 3",1,SCN2A
"SEIZURES, BENIGN FAMILIAL INFANTILE, 5",1,SCN8A
"SEIZURES, BENIGN FAMILIAL NEONATAL, 1",1,KCNQ2
"SEIZURES, BENIGN FAMILIAL NEONATAL, 2",1,KCNQ3
"SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME",1,DIAPH1
"SEIZURES, EARLY-ONSET, WITH NEURODEGENERATION AND BRAIN CALCIFICATIONS",1,NRROS
"SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME",1,EXT2
"SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE",1,KCNJ10
SENGERS SYNDROME,1,AGK
SENIOR-LOKEN SYNDROME 1,1,NPHP1
SENIOR-LOKEN SYNDROME 4,1,NPHP4
SENIOR-LOKEN SYNDROME 5,1,IQCB1
SENIOR-LOKEN SYNDROME 6,1,CEP290
SENIOR-LOKEN SYNDROME 7,1,SDCCAG8
SENIOR-LOKEN SYNDROME 8,1,WDR19
SENIOR-LOKEN SYNDROME 9,1,TRAF3IP1
"SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS",2,"POLG, TWNK"
SEPTOOPTIC DYSPLASIA,1,HESX1
SESSILE SERRATED POLYPOSIS CANCER SYNDROME,1,RNF43
"SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION",1,NHEJ1
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION,1,DCLRE1C
"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY",1,ADA
"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE",2,"RAG1, RAG2"
"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE",1,JAK3
"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE",2,"IL7R, PTPRC"
"SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED",1,IL2RG
"SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO",2,"HLA-A, HLA-B"
SHAHEEN SYNDROME,1,COG6
SHASHI-PENA SYNDROME,1,ASXL2
SHORT QT SYNDROME 1,1,KCNH2
SHORT QT SYNDROME 2,1,KCNQ1
SHORT QT SYNDROME 3,1,KCNJ2
"SHORT SLEEP, FAMILIAL NATURAL, 1",1,BHLHE41
"SHORT SLEEP, FAMILIAL NATURAL, 2",1,ADRB1
"SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS",1,ACAN
SHORT STATURE AND MICROCEPHALY WITH GENITAL ANOMALIES,1,CENPT
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES,1,CRIPT
SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES,1,NPR2
"SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS",1,SLC10A7
"SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND SKELETAL ABNORMALITIES",1,GSC
"SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES",1,PRMT7
"SHORT STATURE, DAUBER-ARGENTE TYPE",1,PAPPA2
"SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS",1,TKT
"SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES 1",1,BMP2
"SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES 2",1,SCUBE3
"SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES",1,EXOSC2
"SHORT STATURE, IDIOPATHIC, X-LINKED",1,SHOX
"SHORT STATURE, IMPAIRED INTELLECTUAL DEVELOPMENT, MICROCEPHALY, HYPOTONIA, AND OCULAR ANOMALIES",1,ZNF407
"SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION",1,XRCC4
"SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY",1,POLR3GL
"SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS",1,POC1A
"SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY",1,NBAS
"SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY",1,ARCN1
SHORT SYNDROME,1,PIK3R1
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY,1,IFT172
SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY,1,DYNC2I2
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY,1,CEP120
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY,1,KIAA0586
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY,1,DYNC2LI1
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY,1,IFT52
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY,1,DYNLT2B
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY,1,IFT43
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY,1,IFT81
SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY,1,IFT80
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY,1,INTU
SHORT-RIB THORACIC DYSPLASIA 21 WITHOUT POLYDACTYLY,1,KIAA0753
SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY,1,DYNC2H1
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY,1,TTC21B
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY,1,WDR19
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY,1,NEK1
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY,1,WDR35
SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY,1,DYNC2I1
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY,1,IFT140
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME,1,SKI
SHUKLA-VERNON SYNDROME,1,BCORL1
SHWACHMAN-DIAMOND SYNDROME 1,3,"DNAJC21, SBDS, SRP54"
SHWACHMAN-DIAMOND SYNDROME 2,1,EFL1
SIALURIA,1,GNE
SICK SINUS SYNDROME 1,1,SCN5A
SICK SINUS SYNDROME 2,1,HCN4
"SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO",1,MYH6
SICK SINUS SYNDROME 4,1,GNB2
SICKLE CELL ANEMIA,1,HBB
SIDDIQI SYNDROME,1,FITM2
"SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY",1,TRNT1
SIFRIM-HITZ-WEISS SYNDROME,1,CHD4
SILVER-RUSSELL SYNDROME 1,1,IGF2
SILVER-RUSSELL SYNDROME 3,1,IGF2
SILVER-RUSSELL SYNDROME 4,1,PLAG1
SILVER-RUSSELL SYNDROME 5,1,HMGA2
"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1",2,"GPC4, GPC3"
"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2",1,OFD1
SINGLETON-MERTEN SYNDROME 1,1,IFIH1
SINGLETON-MERTEN SYNDROME 2,1,DDX58
SINOATRIAL NODE DYSFUNCTION AND DEAFNESS,1,CACNA1D
SITOSTEROLEMIA 1,1,ABCG8
SITOSTEROLEMIA 2,1,ABCG5
SJOGREN-LARSSON SYNDROME,1,ALDH3A2
"SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",1,ZBTB16
"SKELETAL DYSPLASIA, MILD, WITH JOINT LAXITY AND ADVANCED BONE AGE",1,CSGALNACT1
SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS,1,PRKAG3
"SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1",1,TUBB
"SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2",1,MAPRE2
SKIN FRAGILITY-WOOLLY HAIR SYNDROME,1,DSP
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1",2,"OCA2, HERC2"
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10",1,TPCN2
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11",1,TYRP1
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2",1,MC1R
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3",1,TYR
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5",1,SLC45A2
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6",1,SLC24A4
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7",1,KITLG
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8",1,IRF4
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9",1,ASIP
SKRABAN-DEARDORFF SYNDROME,1,WDR26
"SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT",1,ARHGEF10
SMALL CELL CANCER OF THE LUNG,1,RB1
SMITH-KINGSMORE SYNDROME,1,MTOR
SMITH-LEMLI-OPITZ SYNDROME,1,DHCR7
SMITH-MAGENIS SYNDROME,1,RAI1
SMITH-MCCORT DYSPLASIA 1,1,DYM
SMITH-MCCORT DYSPLASIA 2,1,RAB33B
SMOKING AS A QUANTITATIVE TRAIT LOCUS 3,2,"CHRNA3, CHRNA5"
SNEDDON SYNDROME,1,ADA2
SNIJDERS BLOK-CAMPEAU SYNDROME,1,CHD3
SNIJDERS BLOK-FISHER SYNDROME,1,POU3F3
SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1,1,TRPV4
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR,1,SHH
"SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS",1,IL6R
SORBITOL DEHYDROGENASE DEFICIENCY WITH PERIPHERAL NEUROPATHY,1,SORD
SORSBY FUNDUS DYSTROPHY,1,TIMP3
SOTOS SYNDROME,1,NSD1
"SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT",1,VAMP1
"SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE",1,KIF1C
"SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE",1,MARS2
"SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE",1,MTPAP
"SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE",1,AFG3L2
"SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY",1,NKX6-2
"SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE",1,CHP1
"SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE",1,SACS
"SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING",1,ALS2
"SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT",1,KIF5A
"SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE",1,SPG11
"SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT",1,RTN2
"SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT",1,HSPD1
"SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE",1,ZFYVE26
"SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT",1,BSCL2
"SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE",1,ERLIN2
"SPASTIC PARAPLEGIA 2, X-LINKED",1,PLP1
"SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE",1,SPART
"SPASTIC PARAPLEGIA 23, AUTOSOMAL RECESSIVE",1,DSTYK
"SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE",1,B4GALNT1
"SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE",1,DDHD1
"SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT",1,ATL1
"SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT",1,KIF1A
"SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT",1,REEP1
"SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT",1,ZFYVE27
"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION",1,FA2H
"SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE",1,PNPLA6
"SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT",1,SPAST
"SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT",1,SLC33A1
"SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE",1,C19orf12
"SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE",1,GJC2
"SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE",1,NT5C2
"SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE",1,GBA2
"SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE",1,AP4B1
"SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE",1,AP5Z1
"SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE",1,AP4M1
"SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE",1,AP4E1
"SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE",1,AP4S1
"SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE",1,VPS37A
"SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE",1,DDHD2
"SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE",1,MTRFR
"SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE",1,CYP2U1
"SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE",1,TFG
"SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE",1,CYP7B1
"SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT",1,NIPA1
"SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE",1,ARL6IP1
"SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE",1,ERLIN1
"SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE",1,AMPD2
"SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE",1,ENTPD1
"SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE",1,SPG7
"SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE",1,REEP2
"SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT",1,CPT1C
"SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE",1,IBA57
"SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE",1,MAG
"SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE",1,CAPN1
"SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE",1,FARS2
"SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE",1,ATP13A2
"SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE",1,UCHL1
"SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT",1,WASHC5
"SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT",1,UBAP1
"SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE",1,SELENOI
"SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE",1,PCYT2
"SPASTIC PARAPLEGIA 83, AUTOSOMAL RECESSIVE",1,HPDL
"SPASTIC PARAPLEGIA 84, AUTOSOMAL RECESSIVE",1,PI4KA
"SPASTIC PARAPLEGIA 85, AUTOSOMAL RECESSIVE",1,RNF170
"SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT",1,ALDH18A1
"SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE",1,ALDH18A1
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES,1,HACE1
"SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY",1,KIDINS220
"SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY",1,KLC2
"SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE",1,SOD1
"SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY",1,SLC1A4
"SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA",1,GLRX5
SPECIFIC GRANULE DEFICIENCY 1,1,CEBPE
SPECIFIC GRANULE DEFICIENCY 2,1,SMARCD2
SPECIFIC LANGUAGE IMPAIRMENT 5,1,TM4SF20
SPEECH-LANGUAGE DISORDER 1,1,FOXP2
SPERMATOGENIC FAILURE 1,1,SYCP2
SPERMATOGENIC FAILURE 10,1,SEPTIN12
SPERMATOGENIC FAILURE 11,1,KLHL10
SPERMATOGENIC FAILURE 12,1,NANOS1
SPERMATOGENIC FAILURE 13,1,TAF4B
SPERMATOGENIC FAILURE 14,1,ZMYND15
SPERMATOGENIC FAILURE 15,1,SYCE1
SPERMATOGENIC FAILURE 16,1,SUN5
SPERMATOGENIC FAILURE 17,1,PLCZ1
SPERMATOGENIC FAILURE 18,1,DNAH1
SPERMATOGENIC FAILURE 19,1,CFAP43
SPERMATOGENIC FAILURE 20,1,CFAP44
SPERMATOGENIC FAILURE 21,1,BRDT
SPERMATOGENIC FAILURE 22,1,MEIOB
SPERMATOGENIC FAILURE 23,1,TEX14
SPERMATOGENIC FAILURE 24,1,CFAP69
SPERMATOGENIC FAILURE 25,1,TEX15
SPERMATOGENIC FAILURE 26,1,TSGA10
SPERMATOGENIC FAILURE 27,1,AK7
SPERMATOGENIC FAILURE 28,1,FANCM
SPERMATOGENIC FAILURE 29,1,SPINK2
SPERMATOGENIC FAILURE 3,1,SLC26A8
SPERMATOGENIC FAILURE 30,1,TDRD9
SPERMATOGENIC FAILURE 31,1,PMFBP1
SPERMATOGENIC FAILURE 32,1,SOHLH1
SPERMATOGENIC FAILURE 33,1,CFAP251
SPERMATOGENIC FAILURE 34,1,FSIP2
SPERMATOGENIC FAILURE 35,1,QRICH2
SPERMATOGENIC FAILURE 36,1,PPP2R3C
SPERMATOGENIC FAILURE 37,1,TTC21A
SPERMATOGENIC FAILURE 38,1,ARMC2
SPERMATOGENIC FAILURE 39,1,DNAH17
SPERMATOGENIC FAILURE 4,1,SYCP3
SPERMATOGENIC FAILURE 40,1,CFAP65
SPERMATOGENIC FAILURE 41,1,CFAP70
SPERMATOGENIC FAILURE 42,1,TTC29
SPERMATOGENIC FAILURE 43,1,SPEF2
SPERMATOGENIC FAILURE 44,1,CEP112
SPERMATOGENIC FAILURE 45,1,DNAH2
SPERMATOGENIC FAILURE 46,1,DNAH8
SPERMATOGENIC FAILURE 47,1,DZIP1
SPERMATOGENIC FAILURE 48,1,M1AP
SPERMATOGENIC FAILURE 49,1,CFAP58
SPERMATOGENIC FAILURE 5,1,AURKC
SPERMATOGENIC FAILURE 50,1,XRCC2
SPERMATOGENIC FAILURE 51,1,CFAP91
SPERMATOGENIC FAILURE 52,1,C14orf39
SPERMATOGENIC FAILURE 53,1,ACTL9
SPERMATOGENIC FAILURE 54,1,CATIP
SPERMATOGENIC FAILURE 55,1,SPAG17
SPERMATOGENIC FAILURE 56,1,DNAH10
SPERMATOGENIC FAILURE 57,1,PNLDC1
SPERMATOGENIC FAILURE 58,1,IFT74
SPERMATOGENIC FAILURE 59,1,TERB2
SPERMATOGENIC FAILURE 6,1,SPATA16
SPERMATOGENIC FAILURE 60,1,TERB1
SPERMATOGENIC FAILURE 61,1,STAG3
SPERMATOGENIC FAILURE 62,1,RNF212
SPERMATOGENIC FAILURE 63,1,RPL10L
SPERMATOGENIC FAILURE 64,1,FBXO43
SPERMATOGENIC FAILURE 7,3,"CATSPER1, CATSPER2, STRC"
SPERMATOGENIC FAILURE 8,1,NR5A1
SPERMATOGENIC FAILURE 9,1,DPY19L2
"SPERMATOGENIC FAILURE, X-LINKED, 2",1,TEX11
"SPERMATOGENIC FAILURE, X-LINKED, 3",1,CFAP47
"SPERMATOGENIC FAILURE, Y-LINKED, 2",11,"RPS4Y2, DAZ1, DAZ3, DAZ2, RBMY1A1, KDM5D, USP9Y, DDX3Y, HSFY1, CDY1, CDY2A"
"SPHEROCYTOSIS, TYPE 1",1,ANK1
"SPHEROCYTOSIS, TYPE 2",1,SPTB
"SPHEROCYTOSIS, TYPE 3",1,SPTA1
"SPHEROCYTOSIS, TYPE 4",1,SLC4A1
"SPHEROCYTOSIS, TYPE 5",1,EPB42
"SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1",1,AR
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1,1,TRIP4
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2,1,ASCC1
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY,1,ASAH1
"SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1",1,IGHMBP2
"SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2",1,SIGMAR1
"SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4",1,PLEKHG5
"SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5",1,DNAJB2
"SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3",1,ATP7A
"SPINAL MUSCULAR ATROPHY, INFANTILE, JAMES TYPE",1,GARS1
"SPINAL MUSCULAR ATROPHY, JOKELA TYPE",1,CHCHD10
"SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE",1,VAPB
"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT",1,DYNC1H1
"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2A, CHILDHOOD ONSET, AUTOSOMAL DOMINANT",1,BICD2
"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT",1,BICD2
"SPINAL MUSCULAR ATROPHY, TYPE I",1,SMN1
"SPINAL MUSCULAR ATROPHY, TYPE II",1,SMN1
"SPINAL MUSCULAR ATROPHY, TYPE III",1,SMN1
"SPINAL MUSCULAR ATROPHY, TYPE IV",1,SMN1
"SPINAL MUSCULAR ATROPHY, X-LINKED 2",1,UBA1
SPINOCEREBELLAR ATAXIA 1,1,ATXN1
SPINOCEREBELLAR ATAXIA 10,1,ATXN10
SPINOCEREBELLAR ATAXIA 11,1,TTBK2
SPINOCEREBELLAR ATAXIA 12,1,PPP2R2B
SPINOCEREBELLAR ATAXIA 13,1,KCNC3
SPINOCEREBELLAR ATAXIA 14,1,PRKCG
SPINOCEREBELLAR ATAXIA 15,1,ITPR1
SPINOCEREBELLAR ATAXIA 17,1,TBP
SPINOCEREBELLAR ATAXIA 19,1,KCND3
SPINOCEREBELLAR ATAXIA 2,1,ATXN2
SPINOCEREBELLAR ATAXIA 21,1,TMEM240
SPINOCEREBELLAR ATAXIA 23,1,PDYN
SPINOCEREBELLAR ATAXIA 26,1,EEF2
SPINOCEREBELLAR ATAXIA 27,1,FGF14
SPINOCEREBELLAR ATAXIA 28,1,AFG3L2
SPINOCEREBELLAR ATAXIA 29,1,ITPR1
SPINOCEREBELLAR ATAXIA 31,1,BEAN1
SPINOCEREBELLAR ATAXIA 34,1,ELOVL4
SPINOCEREBELLAR ATAXIA 35,1,TGM6
SPINOCEREBELLAR ATAXIA 36,1,NOP56
SPINOCEREBELLAR ATAXIA 37,1,DAB1
SPINOCEREBELLAR ATAXIA 38,1,ELOVL5
SPINOCEREBELLAR ATAXIA 40,1,CCDC88C
SPINOCEREBELLAR ATAXIA 41,1,TRPC3
SPINOCEREBELLAR ATAXIA 42,1,CACNA1G
"SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS",1,CACNA1G
SPINOCEREBELLAR ATAXIA 43,1,MME
SPINOCEREBELLAR ATAXIA 44,1,GRM1
SPINOCEREBELLAR ATAXIA 45,1,FAT2
SPINOCEREBELLAR ATAXIA 46,1,PLD3
SPINOCEREBELLAR ATAXIA 47,1,PUM1
SPINOCEREBELLAR ATAXIA 48,1,STUB1
SPINOCEREBELLAR ATAXIA 5,1,SPTBN2
SPINOCEREBELLAR ATAXIA 6,1,CACNA1A
SPINOCEREBELLAR ATAXIA 7,1,ATXN7
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10",1,ANO10
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11",1,SYT14
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12",1,WWOX
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13",1,GRM1
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14",1,SPTBN2
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15",1,RUBCN
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16",1,STUB1
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17",1,CWF19L1
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18",1,GRID2
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2",1,PMPCA
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20",1,SNX14
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21",1,SCYL1
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22",1,VWA3B
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23",1,TDP2
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24",1,UBA5
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25",1,ATG5
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26",1,XRCC1
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27",1,GDAP2
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28",1,THG1L
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 29",1,VPS41
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 30",1,PITRM1
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 31",1,ATG7
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4",1,VPS13D
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7",1,TPP1
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1",1,TDP1
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2",1,SETX
"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3",1,COA7
"SPINOCEREBELLAR ATAXIA, X-LINKED 1",1,ATP2B3
SPLIT-HAND/FOOT MALFORMATION 1,1,DLX5
"SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE",1,DLX5
SPLIT-HAND/FOOT MALFORMATION 4,1,TP63
SPLIT-HAND/FOOT MALFORMATION 6,1,WNT10B
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA,1,NKX3-2
"SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1",1,HLA-B
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME,1,FLNB
"SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE",2,"DLL3, MESP2"
"SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE",1,MESP2
"SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE",1,LFNG
"SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE",1,HES7
SPONDYLOCOSTAL DYSOSTOSIS 5,1,TBX6
"SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE",1,RIPPLY2
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION,1,ACP5
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES",1,B3GALT6
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2",1,KIF22
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3",1,EXOC6B
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE",1,ACAN
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, BOROCHOWITZ-CORMIER-DAIRE TYPE",1,MATN3
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE",1,UFSP2
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE",1,RSPRY1
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE",1,NANS
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE",1,RPL13
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE",1,SIK3
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE",1,MMP13
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE",1,DDRGK1
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE",1,TONSL
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE",1,COL2A1
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED",1,BGN
"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY",1,AIFM1
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA,1,COL2A1
"SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED",1,TRAPPC2
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS,1,CHST3
"SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE",1,ACAN
"SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE",1,MBTPS1
"SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE",1,TRPV4
"SPONDYLOEPIPHYSEAL DYSPLASIA, SENSORINEURAL HEARING LOSS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND LEBER CONGENITAL AMAUROSIS",1,NMNAT1
"SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE",1,COL2A1
"SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE",1,DDR2
SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY,1,PCYT1A
SPONDYLOMETAPHYSEAL DYSPLASIA WITH CORNEAL DYSTROPHY,1,PLCB3
"SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL",1,CFAP410
"SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE",2,"COL2A1, FN1"
"SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE",1,TRPV4
"SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE",1,PAM16
"SPONDYLOMETAPHYSEAL DYSPLASIA, PAGNAMENTA TYPE",1,PRKG2
"SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE",1,GPX4
SPONDYLOOCULAR SYNDROME,1,XYLT2
SPONDYLOPERIPHERAL DYSPLASIA,1,COL2A1
SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES,1,PRNP
SQUALENE SYNTHASE DEFICIENCY,1,FDFT1
"SQUAMOUS CELL CARCINOMA, HEAD AND NECK",2,"ING1, TNFRSF10B"
STANKIEWICZ-ISIDOR SYNDROME,1,PSMD12
STAPES ANKYLOSIS WITH BROAD THUMBS AND TOES,1,NOG
STARGARDT DISEASE 1,1,ABCA4
STARGARDT DISEASE 3,1,ELOVL4
STARGARDT DISEASE 4,1,PROM1
STEATOCYSTOMA MULTIPLEX,1,KRT17
STEEL SYNDROME,1,COL27A1
"STICKLER SYNDROME, TYPE I",1,COL2A1
"STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR",1,COL2A1
"STICKLER SYNDROME, TYPE II",1,COL11A1
"STICKLER SYNDROME, TYPE IV",1,COL9A1
"STICKLER SYNDROME, TYPE V",1,COL9A2
STIFF SKIN SYNDROME,1,FBN1
"STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET",1,STING1
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS,1,SLC2A1
STORMORKEN SYNDROME,1,STIM1
"STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 1",1,PDE8B
"STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2",1,PDE10A
"STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET",1,VAC14
"STRIATONIGRAL DEGENERATION, INFANTILE",1,NUP62
"STROKE, ISCHEMIC",5,"F2, F5, ALOX5AP, NOS3, PRKCH"
STROMME SYNDROME,1,CENPF
STRUCTURAL BRAIN ANOMALIES WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CRANIOSYNOSTOSIS,1,ZIC1
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME,1,TMEM260
STURGE-WEBER SYNDROME,1,GNAQ
"STUTTERING, FAMILIAL PERSISTENT, 1",1,AP4E1
STUVE-WIEDEMANN SYNDROME,1,LIFR
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY,1,ALDH5A1
SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY,1,OXCT1
"SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL",1,SI
"SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED",1,PPA2
"SUDDEN CARDIAC FAILURE, INFANTILE",1,PPA2
SUDDEN INFANT DEATH SYNDROME,1,SCN5A
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME,1,TSPYL1
SULEIMAN-EL-HATTAB SYNDROME,1,TASP1
SULFIDE:QUINONE OXIDOREDUCTASE DEFICIENCY,1,SQOR
"SULFITE OXIDASE DEFICIENCY, ISOLATED",1,SUOX
"SUPRANUCLEAR PALSY, PROGRESSIVE, 1",1,MAPT
SUPRAVALVULAR AORTIC STENOSIS,1,ELN
"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1",1,SFTPB
"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2",1,SFTPC
"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3",1,ABCA3
"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4",1,CSF2RA
"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5",1,CSF2RB
SVEINSSON CHORIORETINAL ATROPHY,1,TEAD1
SWEENEY-COX SYNDROME,1,TWIST1
"SYMPHALANGISM, PROXIMAL, 1A",1,NOG
"SYMPHALANGISM, PROXIMAL, 1B",1,GDF5
"SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION",1,BHLHA9
"SYNDACTYLY, TYPE III",1,GJA1
"SYNDACTYLY, TYPE IV",1,LMBR1
"SYNDACTYLY, TYPE V",1,HOXD13
SYNPOLYDACTYLY 1,1,HOXD13
SYSTEMIC LUPUS ERYTHEMATOSUS,6,"TREX1, CTLA4, DNASE1, FCGR2A, FCGR2B, PTPN22"
SYSTEMIC LUPUS ERYTHEMATOSUS 16,1,DNASE1L3
"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1",1,TLR5
"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10",1,IRF5
"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11",1,STAT4
"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2",1,PDCD1
"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9",1,CR2
"T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY",1,FOXN1
"T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS",1,STK4
"T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE",1,HAVCR2
"T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT",1,FOXN1
TAKENOUCHI-KOSAKI SYNDROME,1,CDC42
TANGIER DISEASE,1,ABCA1
TARP SYNDROME,1,RBM10
TARSAL-CARPAL COALITION SYNDROME,1,NOG
TATTON-BROWN-RAHMAN SYNDROME,1,DNMT3A
TAY-SACHS DISEASE,1,HEXA
TEEBI HYPERTELORISM SYNDROME 1,1,SPECC1L
TEEBI HYPERTELORISM SYNDROME 2,1,CDH11
"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1",1,ENG
"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2",1,ACVRL1
"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5",1,GDF2
TEMPLE-BARAITSER SYNDROME,1,KCNH1
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME,1,CHSY1
TEMTAMY SYNDROME,1,C12orf57
TENORIO SYNDROME,1,RNF125
TERMINAL OSSEOUS DYSPLASIA,1,FLNA
TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE,1,GATA4
TESTICULAR GERM CELL TUMOR,4,"FGFR3, KIT, STK11, BCL10"
TETRAAMELIA SYNDROME 1,1,WNT3
TETRAAMELIA SYNDROME 2,1,RSPO2
TETRALOGY OF FALLOT,6,"NKX2-5, JAG1, ZFPM2, GATA4, GATA6, TBX1"
"THANATOPHORIC DYSPLASIA, TYPE I",1,FGFR3
"THANATOPHORIC DYSPLASIA, TYPE II",1,FGFR3
THAUVIN-ROBINET-FAIVRE SYNDROME,1,FIBP
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE),1,SLC19A3
THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE),1,SLC25A19
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE),1,TPK1
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME,1,SLC19A2
"THIOPURINES, POOR METABOLISM OF, 1",1,TPMT
"THIOPURINES, POOR METABOLISM OF, 2",1,NUDT15
THIOUREA TASTING,1,TAS2R38
THREE M SYNDROME 1,1,CUL7
THREE M SYNDROME 2,1,OBSL1
THREE M SYNDROME 3,1,CCDC8
THROMBOCYTHEMIA 1,3,"SH2B3, THPO, CALR"
THROMBOCYTHEMIA 2,1,MPL
THROMBOCYTHEMIA 3,1,JAK2
THROMBOCYTOPENIA 1,1,WAS
THROMBOCYTOPENIA 3,1,FYB1
THROMBOCYTOPENIA 4,1,CYCS
THROMBOCYTOPENIA 5,1,ETV6
THROMBOCYTOPENIA 6,1,SRC
"THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED",1,GATA1
"THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS",1,MPIG6B
"THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA",1,GATA1
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME,1,RBM8A
THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE,1,F5
THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY,1,HRG
"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT",1,PROC
"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE",1,PROC
"THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT",1,PROS1
"THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE",1,PROS1
THROMBOPHILIA DUE TO THROMBIN DEFECT,4,"F2, F13A1, HABP2, MTHFR"
THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT,1,THBD
"THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR",1,PLAT
"THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT",1,F9
"THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY",1,ADAMTS13
"THYROID CANCER, NONMEDULLARY, 1",1,NKX2-1
"THYROID CANCER, NONMEDULLARY, 2",4,"HRAS, NRAS, SRGAP1, MINPP1"
"THYROID CANCER, NONMEDULLARY, 4",1,FOXE1
"THYROID CANCER, NONMEDULLARY, 5",1,HABP2
"THYROID CARCINOMA, FAMILIAL MEDULLARY",1,RET
"THYROID CARCINOMA, HURTHLE CELL",1,NDUFA13
THYROID DYSHORMONOGENESIS 1,1,SLC5A5
THYROID DYSHORMONOGENESIS 2A,1,TPO
THYROID DYSHORMONOGENESIS 3,1,TG
THYROID DYSHORMONOGENESIS 4,1,IYD
THYROID DYSHORMONOGENESIS 5,1,DUOXA2
THYROID DYSHORMONOGENESIS 6,1,DUOX2
"THYROID HORMONE METABOLISM, ABNORMAL",1,SECISBP2
"THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT",1,THRB
"THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE",1,THRB
"THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY",1,THRB
"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1",1,CACNA1S
"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2",1,KCNJ18
THYROTROPIN-RELEASING HORMONE DEFICIENCY,1,TRH
THYROXINE-BINDING GLOBULIN QUANTITATIVE TRAIT LOCUS,1,SERPINA7
"TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY",1,LMBR1
"TIBIAL MUSCULAR DYSTROPHY, TARDIVE",1,TTN
TIETZ ALBINISM-DEAFNESS SYNDROME,1,MITF
TIMOTHY SYNDROME,1,CACNA1C
TN POLYAGGLUTINATION SYNDROME,1,C1GALT1C1
"TOBACCO ADDICTION, SUSCEPTIBILITY TO",4,"CHRNA4, CYP2A6, SLC6A3, GABBR2"
"TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS",1,CCNQ
TOLCHIN-LE CAIGNEC SYNDROME,1,SOX6
TONNE-KALSCHEUER SYNDROME,1,RLIM
"TOOTH AGENESIS, SELECTIVE, 1",1,MSX1
"TOOTH AGENESIS, SELECTIVE, 3",1,PAX9
"TOOTH AGENESIS, SELECTIVE, 4",1,WNT10A
"TOOTH AGENESIS, SELECTIVE, 7",1,LRP6
"TOOTH AGENESIS, SELECTIVE, 8",1,WNT10B
"TOOTH AGENESIS, SELECTIVE, 9",1,GREM2
"TOOTH AGENESIS, SELECTIVE, X-LINKED, 1",1,EDA
TOWNES-BROCKS SYNDROME 1,1,SALL1
TOWNES-BROCKS SYNDROME 2,1,DACT1
TRANSALDOLASE DEFICIENCY,1,TALDO1
TRANSCOBALAMIN II DEFICIENCY,1,TCN2
TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2,1,HFE
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN,1,COL7A1
"TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED",1,MED13L
TREACHER COLLINS SYNDROME 1,1,TCOF1
TREACHER COLLINS SYNDROME 2,1,POLR1D
TREACHER COLLINS SYNDROME 3,1,POLR1C
TREACHER COLLINS SYNDROME 4,1,POLR1B
TREHALASE DEFICIENCY,1,TREH
"TREMOR, HEREDITARY ESSENTIAL, 1",1,DRD3
"TREMOR, HEREDITARY ESSENTIAL, 4",1,FUS
"TREMOR, HEREDITARY ESSENTIAL, 5",1,TENM4
TRICHODENTOOSSEOUS SYNDROME,1,DLX3
"TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1",1,CYLD
TRICHOHEPATOENTERIC SYNDROME 1,1,TTC37
TRICHOHEPATOENTERIC SYNDROME 2,1,SKIV2L
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME,1,CCDC47
TRICHOMEGALY,1,FGF5
"TRICHORHINOPHALANGEAL SYNDROME, TYPE I",1,TRPS1
"TRICHORHINOPHALANGEAL SYNDROME, TYPE III",1,TRPS1
"TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE",1,ERCC2
"TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE",1,ERCC3
"TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE",1,GTF2H5
"TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE",1,MPLKIP
"TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE",1,RNF113A
"TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE",1,GTF2E2
"TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE",1,TARS1
"TRICHOTHIODYSTROPHY 8, NONPHOTOSENSITIVE",1,AARS1
"TRICHOTHIODYSTROPHY 9, NONPHOTOSENSITIVE",1,MARS1
TRICHOTILLOMANIA,1,SLITRK1
TRIGONOCEPHALY 1,1,FGFR1
TRIGONOCEPHALY 2,1,FREM1
TRIMETHYLAMINURIA,1,FMO3
TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME,1,TKFC
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY,1,TPI1
TRITANOPIA,1,OPN1SW
TROPICAL CALCIFIC PANCREATITIS,1,SPINK1
TUBEROUS SCLEROSIS 1,1,TSC1
TUBEROUS SCLEROSIS 2,2,"IFNG, TSC2"
"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 1",1,UMOD
"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 2",1,MUC1
"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4",1,REN
"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 5",1,SEC61A1
TUMOR PREDISPOSITION SYNDROME,1,BAP1
"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1",1,GALNT3
"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2",1,FGF23
"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 3",1,KL
"TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL",1,SAMD9
TURNPENNY-FRY SYNDROME,1,PCGF2
"TWINNING, DIZYGOTIC",1,FSHR
TYLOSIS WITH ESOPHAGEAL CANCER,1,RHBDF2
TYPE 1 DIABETES MELLITUS,4,"PTPN22, IL6, ITPR3, HNF1A"
TYPE 1 DIABETES MELLITUS 10,1,IL2RA
TYPE 1 DIABETES MELLITUS 12,1,CTLA4
TYPE 1 DIABETES MELLITUS 2,1,INS
TYPE 1 DIABETES MELLITUS 20,1,HNF1A
TYPE 1 DIABETES MELLITUS 22,1,CCR5
TYPE 1 DIABETES MELLITUS 5,1,SUMO4
TYPE 2 DIABETES 5,1,TBC1D4
TYPE 2 DIABETES MELLITUS,28,"IGF2BP2, SLC30A8, AKT2, GCK, GPD2, HMGA1, HNF4A, IL6, PDX1, IRS1, KCNJ11, LIPC, MTNR1B, NEUROD1, PAX4, ENPP1, PPARG, PPP1R3A, RETN, PTPN1, SLC2A2, ABCC8, HNF1A, HNF1B, TCF7L2, WFS1, IRS2, MAPK8IP1"
TYPE 2 DIABETES MELLITUS 1,1,CAPN10
"TYROSINEMIA, TYPE I",1,FAH
"TYROSINEMIA, TYPE II",1,TAT
"TYROSINEMIA, TYPE III",1,HPD
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1,3,"COL6A1, COL6A2, COL6A3"
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2,1,COL12A1
"ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY",1,WNT7A
ULNAR-MAMMARY SYNDROME,1,TBX3
UNCOMBABLE HAIR SYNDROME 1,1,PADI3
UNCOMBABLE HAIR SYNDROME 2,1,TGM3
UNCOMBABLE HAIR SYNDROME 3,1,TCHH
"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1",1,ABCG2
"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4",1,SLC17A3
"URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO",1,NT5C3A
URIDINE-CYTIDINEURIA,1,SLC28A1
UROCANASE DEFICIENCY,1,UROC1
UROFACIAL SYNDROME 1,1,HPSE2
UROFACIAL SYNDROME 2,1,LRIG2
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME,1,FHL1
"USHER SYNDROME, TYPE I",2,"USH1C, MYO7A"
"USHER SYNDROME, TYPE IC",1,USH1C
"USHER SYNDROME, TYPE ID",2,"CDH23, PCDH15"
"USHER SYNDROME, TYPE IF",1,PCDH15
"USHER SYNDROME, TYPE IG",1,USH1G
"USHER SYNDROME, TYPE IIA",2,"USH2A, PDZD7"
"USHER SYNDROME, TYPE IIC",2,"PDZD7, ADGRV1"
"USHER SYNDROME, TYPE IID",1,WHRN
"USHER SYNDROME, TYPE IIIA",1,CLRN1
"USHER SYNDROME, TYPE IIIB",1,HARS1
"USHER SYNDROME, TYPE IJ",1,CIB2
"USHER SYNDROME, TYPE IV",1,ARSG
"USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT",1,AP1G1
"USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL RECESSIVE",1,AP1G1
UV-SENSITIVE SYNDROME 1,1,ERCC6
UV-SENSITIVE SYNDROME 2,1,ERCC8
UV-SENSITIVE SYNDROME 3,1,UVSSA
"VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS",2,"FANCB, ZIC3"
VAN BUCHEM DISEASE,1,SOST
VAN DEN ENDE-GUPTA SYNDROME,1,SCARF2
VAN DER WOUDE SYNDROME 1,1,IRF6
VAN DER WOUDE SYNDROME 2,1,GRHL3
VAN ESCH-O'DRISCOLL SYNDROME,1,POLA1
VAN MALDERGEM SYNDROME 1,1,DCHS1
VAN MALDERGEM SYNDROME 2,1,FAT4
VARIEGATE PORPHYRIA,2,"HFE, PPOX"
"VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF",1,CFTR
"VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED",1,ADGRG2
"VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS",1,ELMO2
"VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME",1,ADA2
"VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS",1,TREX1
VELOCARDIOFACIAL SYNDROME,5,"DGCR8, TBX1, DGCR6, ESS2, DGCR2"
"VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL",1,TEK
VENTRICULAR ARRHYTHMIAS DUE TO CARDIAC RYANODINE RECEPTOR CALCIUM RELEASE DEFICIENCY SYNDROME,1,RYR2
"VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1",1,SCN5A
"VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2",1,DPP6
VENTRICULAR SEPTAL DEFECT 1,1,GATA4
VENTRICULAR SEPTAL DEFECT 2,1,CITED2
VENTRICULAR SEPTAL DEFECT 3,1,NKX2-5
"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY",3,"TRDN, RYR2, CASQ2"
"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2",1,CASQ2
"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3",1,TECRL
"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4",1,CALM1
"VENTRICULAR TACHYCARDIA, FAMILIAL",1,GNAI2
VENTRICULOMEGALY AND ARTHROGRYPOSIS,1,KIDINS220
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE,1,CRB2
VERHEIJ SYNDROME,1,PUF60
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION,1,TBX2
VERTEBRAL HYPERSEGMENTATION AND OROFACIAL ANOMALIES,1,GDF11
"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1",1,HAAO
"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2",1,KYNU
"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3",1,NADSYN1
"VERTEBRAL, CARDIAC, TRACHEOESOPHAGEAL, RENAL, AND LIMB DEFECTS",1,WBP11
"VERTICAL TALUS, CONGENITAL",1,HOXD10
VERVERI-BRADY SYNDROME,1,QRICH1
VESICOURETERAL REFLUX 2,1,ROBO2
VESICOURETERAL REFLUX 3,1,SOX17
VESICOURETERAL REFLUX 8,1,TNXB
VEXAS SYNDROME,1,UBA1
VIBRATORY URTICARIA,1,ADGRE2
VICI SYNDROME,1,EPG5
VISCERAL MYOPATHY 1,1,ACTG2
VISCERAL MYOPATHY 2,1,MYH11
"VISCERAL NEUROPATHY, FAMILIAL, 1, AUTOSOMAL RECESSIVE",1,ERBB3
"VISCERAL NEUROPATHY, FAMILIAL, 2, AUTOSOMAL RECESSIVE",1,ERBB2
VISS SYNDROME,1,IPO8
VISSERS-BODMER SYNDROME,1,CNOT1
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI,1,MARK3
VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1,1,FUT2
"VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A",1,CYP27B1
"VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B",1,CYP2R1
"VITAMIN D-DEPENDENT RICKETS, TYPE 2A",1,VDR
"VITAMIN D-DEPENDENT RICKETS, TYPE 3",1,CYP3A4
"VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1",1,GGCX
"VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2",1,VKORC1
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1,1,NLRP1
"VITREORETINAL DEGENERATION, SNOWFLAKE TYPE",1,KCNJ13
VITREORETINOCHOROIDOPATHY,1,BEST1
VITREORETINOPATHY WITH PHALANGEAL EPIPHYSEAL DYSPLASIA,1,COL2A1
"VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY",1,CAPN5
VOHWINKEL SYNDROME,1,GJB2
VON HIPPEL-LINDAU SYNDROME,2,"CCND1, VHL"
"VON WILLEBRAND DISEASE, TYPE 1",1,VWF
"VON WILLEBRAND DISEASE, TYPE 2",1,VWF
"VON WILLEBRAND DISEASE, TYPE 3",1,VWF
VULTO-VAN SILFHOUT-DE VRIES SYNDROME,1,DEAF1
"WAARDENBURG SYNDROME, TYPE 1",1,PAX3
"WAARDENBURG SYNDROME, TYPE 2A",1,MITF
"WAARDENBURG SYNDROME, TYPE 2D",1,SNAI2
"WAARDENBURG SYNDROME, TYPE 2E",1,SOX10
"WAARDENBURG SYNDROME, TYPE 3",1,PAX3
"WAARDENBURG SYNDROME, TYPE 4A",1,EDNRB
"WAARDENBURG SYNDROME, TYPE 4B",1,EDN3
"WAARDENBURG SYNDROME, TYPE 4C",1,SOX10
WAGNER VITREORETINOPATHY,1,VCAN
WAISMAN SYNDROME,1,RAB39B
WARBURG MICRO SYNDROME 1,1,RAB3GAP1
WARBURG MICRO SYNDROME 2,1,RAB3GAP2
WARBURG MICRO SYNDROME 3,1,RAB18
WARBURG MICRO SYNDROME 4,1,TBC1D20
WARBURG-CINOTTI SYNDROME,1,DDR2
"WARFARIN SENSITIVITY, X-LINKED",1,F9
WARSAW BREAKAGE SYNDROME,1,DDX11
WATSON SYNDROME,1,NF1
WEAVER SYNDROME,1,EZH2
WEBB-DATTANI SYNDROME,1,ARNT2
WEILL-MARCHESANI SYNDROME 1,1,ADAMTS10
WEILL-MARCHESANI SYNDROME 2,1,FBN1
WEILL-MARCHESANI SYNDROME 3,1,LTBP2
WEILL-MARCHESANI SYNDROME 4,1,ADAMTS17
WEISS-KRUSZKA SYNDROME,1,ZNF462
WELANDER DISTAL MYOPATHY,1,TIA1
WERNER SYNDROME,1,WRN
"WEST NILE VIRUS, SUSCEPTIBILITY TO",1,CCR5
WEYERS ACROFACIAL DYSOSTOSIS,2,"EVC2, EVC"
WHIM SYNDROME 1,1,CXCR4
WHIM SYNDROME 2,1,CXCR2
WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1,1,ACKR1
WHITE SPONGE NEVUS 1,1,KRT4
WHITE SPONGE NEVUS 2,1,KRT13
WHITE-KERNOHAN SYNDROME,1,DDB1
WHITE-SUTTON SYNDROME,1,POGZ
WIEACKER-WOLFF SYNDROME,1,ZC4H2
"WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED",1,ZC4H2
WIEDEMANN-RAUTENSTRAUCH SYNDROME,1,POLR3A
WIEDEMANN-STEINER SYNDROME,1,KMT2A
WILLIAMS-BEUREN SYNDROME,2,"ELN, MLXIPL"
WILMS TUMOR 1,5,"GPC4, GPC3, IGF2, BRCA2, WT1"
WILMS TUMOR 5,1,POU6F2
WILMS TUMOR 6,1,REST
"WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION SYNDROME",2,"PAX6, WT1"
WILSON DISEASE,1,ATP7B
WINCHESTER SYNDROME,1,MMP14
WISKOTT-ALDRICH SYNDROME,1,WAS
WISKOTT-ALDRICH SYNDROME 2,1,WIPF1
WITKOP SYNDROME,1,MSX1
WITTEVEEN-KOLK SYNDROME,1,SIN3A
WOLF-HIRSCHHORN SYNDROME,5,"CPLX1, CTBP1, LETM1, FGFRL1, NSD2"
WOLFF-PARKINSON-WHITE SYNDROME,1,PRKAG2
WOLFRAM SYNDROME 1,1,WFS1
WOLFRAM SYNDROME 2,1,CISD2
"WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT",1,WFS1
WOODHOUSE-SAKATI SYNDROME,1,DCAF17
"WOOLLY HAIR, AUTOSOMAL DOMINANT",1,KRT74
"WOOLLY HAIR, AUTOSOMAL RECESSIVE 3",1,KRT25
WRINKLY SKIN SYNDROME,1,ATP6V0A2
"XANTHINURIA, TYPE I",1,XDH
"XANTHINURIA, TYPE II",1,MOCOS
"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A",1,XPA
"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B",1,ERCC3
"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C",1,XPC
"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D",1,ERCC2
"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E",1,DDB2
"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F",1,ERCC4
"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G",1,ERCC5
"XERODERMA PIGMENTOSUM, VARIANT TYPE",1,POLH
XFE PROGEROID SYNDROME,1,ERCC4
XIA-GIBBS SYNDROME,1,AHDC1
YAO SYNDROME,1,NOD2
YOON-BELLEN NEURODEVELOPMENTAL SYNDROME,1,OGDHL
YOU-HOOVER-FONG SYNDROME,1,TELO2
YT BLOOD GROUP ANTIGEN,1,ACHE
YUNIS-VARON SYNDROME,1,FIG4
ZAKI SYNDROME,1,WLS
ZIMMERMANN-LABAND SYNDROME 1,1,KCNH1
ZIMMERMANN-LABAND SYNDROME 2,1,ATP6V1B2
ZIMMERMANN-LABAND SYNDROME 3,1,KCNN3
"ZINC DEFICIENCY, TRANSIENT NEONATAL",1,SLC30A2
ZTTK SYNDROME,1,SON
